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New techniques for rapid identification of complex mixtures of viral and bacterial DNA 
and for visualising multi-copy plasmids in single bacterial cells have been developed 
using a combination of methyltransferase-directed labelling, molecular combing, and 
widefield microscopy.  
In Chapter 2 the protocol for methyltransferase-directed labelling was optimised. A 
maximum labelling efficiency of 50% (as measured by single molecule counting results) 
was obtained for Atto 647N-labelled pUC19.  
In Chapters 3 and 4 the optimised labelling protocol was used to label genomic DNA for 
optical mapping and identification. The in silico results in Chapter 3 show that the 
combination of techniques used in this thesis represents the ‘sweet-spot’ for optical 
mapping and identification of microorganisms. In Chapter 4 this combination of 
techniques was used along with a new algorithm, for rapid identification of 
bacteriophages, Adenovirus A, resistance plasmids and bacterial strains in complex 
mixtures of genomic DNA.  
Finally, Chapter 5 uses methyltransferase-directed labelling to investigate the 
mechanisms bacteria use to maintain and transfer resistance plasmids. Atto647N-
labelled pUC19 and pRSET B plasmids were visualised in E. coli bacteria and diffusion 
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CHAPTER 1 INTRODUCTION 
1.1 DNA Structure and Function 
1.1.1 DNA as the molecule of inheritance 
“The apple doesn’t fall far from the tree”. Humans have always been aware that traits are 
inherited from one generation to the next and have used this knowledge for selective 
breeding of domestic plants and animals. However, it wasn’t until 1865 that Gregor 
Mendel, the father of genetics, discovered the fundamental laws of inheritance, which 
were rediscovered at the start of the 20th century and began the field of classical 
genetics1. 
Despite this, the molecular basis of inheritance was unknown. In 1928 Frederick Griffith 
showed that genetic material could be transferred between bacteria2. Mice injected with 
a mixture of heat-killed virulent bacteria and nonvirulent bacteria died, as the cell debris 
of the virulent bacteria transformed the nonvirulent bacteria. The nature of this 
‘transforming principle’ was determined by Avery and co-workers in 19443 when they 
separated the classes of molecules found in the cell debris and found that only one 
molecule, deoxyribonucleic acid, DNA, induced the transformation. DNA was confirmed 
to be the molecule of genetic inheritance by the 1952 Hershey-Chase experiment, in 
which it was shown, using radioactive isotopes, that primarily DNA, rather than 
proteins, entered the cell upon phage infection4. 
1.1.2 Structure of DNA 
The apparent simplicity of the structure of DNA belied its importance. It was first 
isolated by Friedrich Miescher in 18695 and due to its presence in the cell nuclei, he 
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termed the substance ‘nuclein’. It was known to be a long polymer composed of four 
types of nucleotide subunits, chemically identical except for the nitrogen base (Figure 
1.1)6. Each nucleotide consists of a phosphate group, a deoxyribose sugar and one of 
four bases: adenine (A), guanine (G), cytosine (C) and thymine (T). Adenine and guanine 
are known as purines, whilst cytosine and thymine are pyrimidines. 
 
Figure 1.1 The chemical structure of nucleotides.  A) Chemical structure of a 
nucleotide, showing the basic building blocks: a nitrogenous base, a 
deoxyribose sugar and a phosphate group. B) The structure of each of the 
naturally-occurring DNA bases. These are purines (adenine and guanine) 




Watson and Crick showed how these simple building blocks were put together when 
they published the structure of DNA in 19537. X-ray diffraction data by Rosalind 
Franklin and Maurice Wilkins had suggested DNA was a helical molecule, whilst Erwin 
Chargaff had established that the amount of pyrimidines and purines was always the 
same, as was the amount of adenine and thymine and conversely the amount of guanine 
and cytosine8. From these results, Watson and Crick derived the famous double helix 
(Figure 1.2), in which each helix is a chain of nucleotides linked by phosphodiester 
bonds. The two helices are held together by hydrogen bonds between base pairs, with 
each pair consisting of a purine and a pyrimidine, in which adenine pairs with thymine 
and guanine with cytosine. Two hydrogen bonds are formed between adenine and 
thymine and three hydrogen bonds between guanine and cytosine. The directionality of 
a DNA chain is denoted 5’ to 3’ (named from the orientation of the ribose carbons) and 




Figure 1.2 The chemical structure of DNA. The structure is a double helix, in which 
each helix is a chain of nucleotides held together by phosphodiester bonds. 
The direction of the chain is denoted 5’ to 3’ and the two helices run 
antiparallel. The chains are held together by hydrogen bonding between 
base pairs, base-stacking interactions and hydrophobic effects. In Watson-
Crick base-pairing adenine forms two hydrogen bonds with thymine and 




In the 3-dimensional structure of DNA the bases partly stack on top of one another in the 
double helix structure (Figure 1.3). This allows for favourable electrostatic interactions 
between bases and the exclusion of water allows for stabilisation by hydrophobic 
effects. The stacking results in a double helix with two grooves known as the major and 
minor grooves. The primary physiological form of DNA is the B-form, in which there are 
10 bases per helical turn and 0.34 nm between base pairs, although at least two other 
biologically relevant forms, the A- and Z-form, also exist.  
 
Figure 1.3 The structure of the B-form of DNA. Crystal structure from Drew et al9. The 
primary physiological form of DNA is the B-form, in which there are 10 
bases per helical turn and 0.34 nm between base pairs. In DNA the bases 
partly stack on top of one another in the double helix structure resulting in 
two grooves known as the major and minor grooves. (Grey=carbon, 




1.1.3 The Central Dogma 
The structure of DNA makes it clear how DNA can be used to store and replicate genetic 
information. The bases can be considered a four-letter code that spells out biological 
messages, whilst the complementary base pairing means each helix can be used as a 
template for replication of DNA. 
The flow of genetic information from DNA is explained by the central dogma of 
molecular biology (Figure 1.4), first stated by Francis Crick in 195810, that “information 
cannot be transferred back from protein to either protein or nucleic acid”. This describes 
the flow of genetic information, in which DNA is transcribed to produce mRNA, which is 
then translated to synthesise proteins, which are in turn responsible for biological 
functions in cells. 
 
Figure 1.4 The central dogma of molecular biology. This describes the flow of genetic 
information in a biological system.  There are three general transfers (solid 
black arrows): replication of DNA; transcription of DNA to mRNA; 
translation of mRNA to proteins. Two other special transfers are known to 
naturally occur (dashed arrows): reverse transcription of RNA to DNA and 
replication of RNA. There are no known transfers of information that occur 
from proteins to either proteins or nucleic acids. 
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Ribonucleic acid (RNA) is also a nucleic acid that shares a similar structure to DNA and 
also has important biological roles. It is also composed of a chain of nucleotides, but 
unlike DNA is usually single-stranded, forming secondary structures rather than a 
double helix. Chemically it is similar to DNA, but thymine is replaced with uracil (lacking 
a methyl group) and deoxyribose is replaced by ribose (adding a hydroxyl group at the 
2’ position). These differences give DNA greater stability than RNA, which has more 
transient roles. The main forms of RNA are: messenger RNA (mRNA), which is used to 
code for synthesis of proteins; transfer RNA (tRNA), which delivers amino acids for 
protein synthesis; and ribosomal RNA (rRNA), the RNA component of ribosomes, which 
are responsible for protein synthesis. Other roles include gene regulation and post-
transcriptional modification of RNA. 
There are 20 naturally occurring amino acids, which are coded for by the four bases in 
DNA (Table 1.1). Three letter codes, known as codons, give 64 possible combinations. In 
1961 Nirenberg and Matthaei deciphered the first of these 64 combinations11. They 
prepared an extract from bacterial cells, from which protein could be synthesised, 
before adding artificial RNA, composed of a single repeated codon. Each RNA yielded a 
specific polypeptide chain composed of a single amino acid which could be identified 
and used to decode all 64 combinations. These codons also include ‘Stop’ codons to 




Table 1.1 DNA codons. There are 20 naturally occurring amino acids, which are 
coded for by the four bases in DNA. Three letter codes, known as codons, 
give 64 possible combinations and all are shown here. These codons also 
include, ‘Stop’ codons to terminate protein synthesis as well as significant 
degeneracy in the code. This degeneracy is usually in the third base of the 
codon known as ‘third-base wobble’. 
1.1.4 Importance of the DNA sequence 
Each non-cloned individual and each species will have a unique genetic code and 
therefore a unique DNA sequence, producing a unique set of proteins. This can be used 
to identify species or individuals when identification by phenotype alone is difficult, for 
instance microorganisms.  In addition, the DNA sequence can also provide information 
about the evolutionary history of an organism. As species evolve changes are 
accumulated in the DNA sequence, such as mutations, insertions, deletions and 
translocations. Closely related species will therefore share more sequence identity than 
species which are less related and this information can be used to produce a 
phylogenetic tree, detailing the evolutionary history of a group12. 
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The DNA code is also related to genetic diseases13. A single error in a single gene can 
cause a protein to be incorrectly coded and therefore affect its folding and function. An 
example of this is sickle-cell disease, a blood disorder in which a single nucleotide is 
mutated, (a single nucleotide polymorphism or SNP), resulting in a single amino acid 
substitution from glutamate to valine. At low oxygen concentrations this change causes 
protein aggregation and contributes to several health problems. Larger changes in the 
genome can include: duplications, which are common in many types of cancer and can 
cause protein to be overexpressed; deletions, for instance having a single copy of the 
SHOX gene is associated with short stature; and rearrangements14. 
To diagnose disease, both transmitted (e.g. infections) and genetic, it is therefore useful 
to be able to read the DNA code and identify DNA sequences. This allows for accurate 
diagnosis of diseases, which can then be targeted with the appropriate treatment. This is 
an important motivation behind the development of several techniques that are capable 




1.2 Identifying the DNA code 
1.2.1 Restriction mapping 
One of the earliest techniques used to identify DNA was restriction mapping. Restriction 
enzymes are naturally occurring enzymes that are used in the restriction-modification 
(RM) system in bacteria, a defence mechanism used by the bacterium against foreign 
DNA. This system was first observed in 1952-53 by Luria and Human15 and Bertani and 
Weigle16, who reported that bacteriophages varied in their ability to grow on different 
host strains.  
In 1970 the first restriction enzyme that cleaved DNA into specific fragments, 
endonuclease R, was described by Smith and Wilcox17. This was used a year later by 
Kathleen Danna and Daniel Nathans to produce specific fragments of SV5018. Smith and 
Wilcox had used sucrose gradients to analyse fragments, but they lacked the resolution 
for proper separation. Nathans instead used polyacrylamide gel electrophoresis, 
described by Ulrich Loening19. An electric field is applied across the gel, causing DNA 
molecules to move towards the cathode. Smaller molecules will move through the gel 
faster than larger molecules, effectively separating molecules by size. 
Differences in DNA sequences can be identified by differences in restriction patterns, 
known as restriction fragment length polymorphisms. For instance those found in 
human mini-satellites (regions of the genome that contain repeat sequences) were first 
used by Alec Jeffreys in 198520 to identify individuals in the process of DNA 
fingerprinting. DNA from an individual is extracted, restricted and separated by gel 
electrophoresis. Mini-satellites are identified by Southern blotting (see later) and since 
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the length of these repeat regions tends to vary in length between individuals, the 
resultant restriction patterns will vary and allow for identification. 
It is also possible to use multiple restriction enzymes to map DNA (Figure 1.5)21. If two 
restriction enzymes are used and both single and double digests carried out, then the 
location of the restriction sites can be inferred. This is still commonly used to determine 
the orientation of a cloned insert but was particularly useful when automated 
sequencing (see later) was still prohibitively expensive. 
 
Figure 1.5 Restriction mapping of pUC19.  A) Circular representation of pUC19, 
showing position of restriction sites for two enzymes: TaqI and AclI. B) 
Linear representation, showing the distance between restriction sites. C) 
Example of restriction digests. pUC19 is digested with each restriction 
enzyme and with a combination of both, then fragments are separated by 
gel electrophoresis. By comparing differences in restriction pattern, it is 
possible to map the relative position of the restriction sites. For example, 
the 1444 bp fragment in the TaqI digest is restricted into three fragments 
(1019, 373 and 52 bp) in the combined digest, implying the position of the 
two AclI sites. 
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1.2.2 DNA Hybridisation 
Although restriction mapping can help identify DNA fragments and map restriction sites 
it doesn’t give any information on the sequence of the DNA. One of the simplest ways to 
probe the sequence is to take advantage of complementary Watson-Crick base pairing. 
In these methods single-stranded DNA or RNA will bind, or hybridise, to the 
complementary base sequence.  
This was exploited in 1975 by Edwin Southern, in a technique now known as ‘Southern 
blotting’ (Figure 1.6)22. Southern used restriction enzymes and gel electrophoresis to 
separate DNA molecules but wanted to know which restriction fragments contained a 
specific sequence, complementary to a given RNA. This could be done by a time-
consuming process: cutting out the fragments, eluting the DNA and hybridising to RNA. 
However, to speed up the process Southern transferred the DNA from the gel to a 
nitrocellulose membrane and then hybridised with radiolabelled RNA, that could be 
detected by autoradiography. This gives a relatively high throughput method of 
identifying the position and copy number of specific DNA sequences. 
 
Figure 1.6 Southern blotting procedure. A DNA sample is restricted, and fragments 
separated by gel electrophoresis. Fragments are then transferred from the 
gel onto a nitrocellulose membrane before exposure with a labelled nucleic 




A related technique is fluorescence in situ hybridization (FISH) (Figure 1.7). This built 
on earlier methods that used radiolabelled probes23, in which radiolabelled RNA was 
incubated with chromosomes and imaged by autoradiography. The first use of 
fluorescent in situ detection was in 1980 and allowed for significantly better resolution, 
speed and safety24. Single stranded nucleic acid probes are covalently labelled with 
fluorescent dyes and can be used to detect single genes when bound to chromosomal 
DNA, which has been attached to a substrate, typically a glass slide. 
 
Figure 1.7 Fluorescent in situ hybridisation (FISH) procedure. An interphase or 
metaphase chromosome spread is prepared, in which chromosomes are 
usually fixed to a glass slide. In addition, probe DNA is prepared, ranging in 
size from around 50 bp to over 100 kbp. This is specific for a region of the 
target DNA and is fluorescently labelled by, for example, nick translation. 
The probe and target DNA are denatured, followed by hybridisation on the 
glass slide, allowing visualisation of the specific region of interest, for 
example the position of genes.  
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The inherent resolution of FISH is limited by the chromatin condensation state to 
around 1-3 megabases. However, by using de-condensed chromatin and by combing out 
DNA fibers, in a technique known as fiber-FISH this resolution can be dramatically 
increased to the order of kilobases (Figure 1.8)25. The order and number of genes can be 
identified, in a way complementary to restriction mapping and, for instance, can show 
whether gene rearrangements have occurred. 
 
Figure 1.8 Example of Fiber-FISH. Taken from Jackson et al26. Fiber-FISH uses the 
same probe hybridisation as FISH, but target DNA is now stretched when 
immobilised on glass slides. Molecular combing of DNA follows protein 
digestion in high salt and detergent, to remove histones and de-condense 
chromatin. Using this the order and number of genes can be identified. A) A 
431 kbp DNA construct, consisting of six bacterial artificial chromosome 
(BAC) clones (T07M07, T04M15, T02P04, T07D17, T20B05 and T03K09) is 
used for physical mapping. The clones were detected by alternating green-
red probes, with overlapping regions shown in yellow. B) Fiber-FISH signal 
from a single DNA fiber from the 431 kbp DNA construct. 
DNA hybridisation is also exploited in DNA microarray technology, where the aim is to 
detect and quantify the expression of thousands of genes at a time27. Traditionally, single 
stranded probes are attached to a solid support in an orderly collection of spots. Each 
spot contains many copies of a single known sequence and a microarray will contain 
thousands of ordered spots, therefore can detect thousands of different genes. The 
target DNA is fluorescently labelled, added to the microarray and allowed to bind to the 
probes. Non-specific DNA is washed away, and a fluorescent signal is detected from each 
spot when hybridisation has occurred, allowing for a read-out of the number of copies of 
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a gene that are present (based on the fluorescence intensity). Microarrays are 
particularly well-suited to detecting single nucleotide polymorphisms and the variation 
in expression levels of genes. 
The polymerase chain reaction (PCR) is another common technique that exploits 
hybridisation to DNA (Figure 1.9). PCR is able to amplify a few copies of a specific region 
of DNA by many orders of magnitude and though not usually a technique that is used for 
DNA identification directly, it has enabled many of these other technologies, by allowing 
very large amounts of pure DNA to be produced.  PCR was developed by Kary Mullis in 
1983 and involves several steps28. First the target DNA is melted or denatured, then the 
reaction is cooled, and specifically designed primers are allowed to anneal at either end 
of the target DNA. A DNA polymerase is then allowed to extend the primers to synthesise 
new strands of DNA. The cycle is repeated, with an effective doubling of the number of 
target DNA molecules during each cycle. 
 
Figure 1.9 Polymerase chain reaction (PCR) procedure. First the two strands of the 
target DNA are denatured by heating the mixture to 95oC. The mixture is 
cooled to 55-70oC to allow the annealing of specific primers to either end of 
the target DNA, before the primers are extended by heat-resistant DNA 
polymerase at 72oC. This is cycle is run many times with an effective 
doubling of DNA in each cycle. For instance, after 30 cycles the target DNA 




An extension of this method is quantitative PCR (qPCR), which allows for direct 
quantification of the amount of sample DNA29. The amplification of DNA is monitored in 
real-time by using dyes that intercalate into double-stranded DNA or by using 
fluorescently-labelled primers which will fluoresce when annealed to the target DNA. 
This allows for the presence and quantity of the target DNA to be tested. 
These methods share the common feature that a known sequence of interest is required, 
however when the DNA of a completely novel organism needs to be identified then the 
DNA code itself must be read. 
1.2.3 DNA Sequencing 
DNA sequencing is used to provide the base sequence of a piece of DNA30. Initial efforts 
in the 1960s focused on sequencing RNA, for which pure samples were more readily 
available and for which the molecule is uncomplicated by the complementary strand. By 
combining analytical chemistry techniques and partial digestion of RNA, Robert Holey 
and colleagues were able to sequence the first whole nucleic acid in 1965, that of alanine 
tRNA from S. cerevisiae31. The first complete protein-coding gene sequence, the coat 
protein of bacteriophage MS2, was produced in 1972 by Walter Fiers’ laboratory32. The 
method used 2-dimensional gel electrophoresis (i.e. a gel run twice in perpendicular 
directions in two different buffer conditions) to separate and detect radiolabelled, 
partially digested, RNA fragments, the sequences of which could be deciphered. The MS2 
genome was the first complete genome to be published in 197633 using the same 
method. 
These methods were adapted to sequence DNA, with two complex methods being 
developed in the mid-1970s: Alan Coulson and Sanger's ‘plus and minus’ system34 and 
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Allan Maxam and Walter Gilbert's chemical cleavage technique35. Using the plus and 
minus system Sanger and colleagues reported the first DNA sequence, of bacteriophage 
phiX174 in 197736.  
However, the most commonly used first generation sequencing technology was the 
dideoxy chain-termination method, developed by Sanger and colleagues in the same 
year (Figure 1.10)37. Dideoxynucleotides lack the 3’ hydroxyl group required for 
extension of the DNA and therefore, by mixing a fraction of these with standard 
deoxynucleotides, chain termination is caused randomly at every position within the 
DNA molecule during replication. If four parallel reactions are carried out for each base 
and the fragments run on a gel, the order of bases can effectively be read out. 
Various improvements were made to this first generation of technology, for instance 
using fluorescently labelled dideoxynucleotides allows the DNA to be sequenced and 
read out in a high throughput manner in a single reaction rather than four separate 
reactions. Rather than using gels, capillary electrophoresis can be used to separate DNA 
fragments by length. As the DNA is run through the capillary the fluorescent signal can 
be detected, which will report the dideoxynucleotide that was incorporated at that point 
and which can therefore be used to record the sequence. 
Sanger sequencing can be used to sequence fragments accurately but only those of 
around 700-900 bases in length, so for sequencing longer fragments ‘shotgun-
sequencing’ can be used38. In shotgun sequencing DNA is randomly fragmented to 
produce a large number of overlapping fragments, which can be sequenced separately, 
before being assembled in silico. This process can be used on small fragments, but also to 
reconstruct whole genomes. A complementary approach to whole genome sequencing is 
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to use bacterial artificial chromosomes (BACs). These are DNA constructs based on 
bacterial plasmids, into which a small fragment (~150 kbp) from a larger genome is 
inserted. This essentially divides the genomes into sections, which are amplified by 
replication in bacterial cells, sequenced (for instance by shotgun sequencing) and used 
to reconstruct the whole genome.  
 
Figure 1.10 Dideoxy chain-termination (Sanger) method of DNA sequencing. 
Dideoxynucleotides lack the 3’ hydroxyl group required for extension of 
the DNA and therefore, by mixing a fraction of these with standard 
deoxynucleotides, chain termination is caused randomly at every position. 
If four separate reactions are carried out with each of the 
dideoxynucleotides in turn then the following fragments are generated for 
the example sequence. When separated by size the sequence can effectively 
be read out. Automated sequencing uses fluorescently labelled 
dideoxynucleotides that allow the DNA to be sequenced from a single 
reaction, rather than four separate reactions. 
A second generation of sequencing technologies has taken advantage of shotgun 
sequencing to vastly speed up and lower the cost of DNA sequencing. In the late 1990s 
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Pål Nyrén and colleagues developed a method that inferred nucleotide identity, by 
measuring pyrophosphate production, as each nucleotide is washed through the system, 
over template DNA bound to a solid support39. This method allowed for real-time 
observations rather than lengthy electrophoreses, was licensed by 454 Life Sciences and 
evolved into the first major next generation sequencing (NGS) technology, allowing the 
mass parallelisation and sequencing of a much greater amount of DNA.  
The development of low-cost, rapid NGS technologies has continued in subsequent 
decades allowing for production of huge amounts of sequencing data. The first human 
genome took years to sequence and is estimated to have cost roughly $2.7 billion, whilst 
the same results can now be achieved in days for under $1000, enabling the application 
of DNA sequencing in a clinical context40.  
However, these technologies generally have greater error rates (~0.1-15%) and shorter 
reads (35-700bp) than traditional Sanger sequencing methods, which can be 
problematic. DNA hybridisation techniques have shown that large genomes often have 
repetitive and complex regions, which are difficult to resolve using short-read 
sequencing approaches41. Large scale structural variations, such as duplications, 
deletions, insertions, inversions and translocations and ranging typically from one 
kilobase to many megabases have been linked to several genetic traits, as discussed 
previously, underlining their importance. Long-read sequencing approaches can 
overcome some of these issues as they deliver reads in excess of several kilobases. If 




The most widely used approach currently for long read sequencing is single-molecule 
real-time (SMRT) sequencing, commercialised by Pacific Biosciences42. This has 
thousands of individual wells, with transparent bottoms, known as zero-mode 
waveguides. A DNA polymerase is fixed to the bottom of the well and guides the DNA 
through the zero-mode waveguide. As a single labelled nucleotide is incorporated a 
camera records the light emitted, which allows for the sequence to be read. 
Another type of long read sequencer is a nanopore sequencer, commercialised by Oxford 
Nanopore Technologies43. This doesn’t use the incorporation of nucleotides to detect the 
sequence, unlike most other platforms, but can be used to directly read the sequence for 
single-stranded DNA. Strands are passed through a protein pore and as they are the DNA 
modulates this current that is set across the pore. Shifts in the voltage are characteristic 
of the DNA sequence and by training the data against known sequences, the sequence of 
an unknown fragment can be inferred. Large repeats of a single base or base 
modifications remain challenging to detect however30. 
Currently these long-read sequencing approaches have considerably lower throughput 
and higher cost than short-read NGS approaches, which has limited their adoption30. 
One major issue is the single-pass error (i.e. error for a single read), which approaches 
15% for SMRT. However, since these are randomly distributed a consensus sequence is 
still reliable, and these platforms seem ideal for de novo genome assembly. Single 
molecule real time sequencing has also been used successfully to fill gaps within the 
human genome reference sequence44.  
Another method to help understand structural and copy number variation is to return to 
restriction mapping and more recent applications of similar approaches.  
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1.3 Optical Mapping 
1.3.1 Origins of optical mapping 
Optical restriction mapping was first reported in the mid-1990s by the Schwartz 
laboratory45. In the first mapping experiment a restriction digest (as used in restriction 
mapping) of elongated individual molecules was visualised after fixation in agarose gel. 
The DNA fragments could be sized and mapped back to the genome based on the known 
restriction pattern (Figure 1.11).  
 
Figure 1.11 Optical restriction mapping procedure. DNA fragments are elongated and 
fixed in agarose gel, typically on a glass slide. Restriction enzymes are used 
to digest fragments at specific sites, so when fragments are imaged they can 




The optical restriction map contains long-range information that is complementary to 
the base-level resolution obtained by NGS methods and can effectively be used as a 
scaffold for de novo genome assembly and gap filling46,47. However its use is limited since 
it is still relatively low throughput, for instance it can take approximately 1 month to 
scan a human genome image by image48. There are also issues with the inherent limit of 
the minimum size of molecules and significant sizing errors for small fragments. 
There have been two broad approaches used to improve the throughput and application 
of optical mapping: nanofluidic devices49 and molecular combing of DNA. 
1.3.2 Optical Mapping in nanofluidic devices 
DNA is a large polymer with a persistence length of around 60 nm50. In solution, a free 
DNA molecule will coil to minimise the free energy of the system, with a size given by 
the radius of gyration (Figure 1.12A). If the DNA is introduced into a channel it will act in 
three ways depending on the size of the channel, the persistence length and the radius of 
gyration. If the channel is larger than the radius of gyration the DNA will act as it does in 
solution. If the channel is smaller than radius of gyration but still much larger than the 
persistence length, then the DNA will act like a string of non-interacting blobs. Finally, if 
the channel is smaller than the persistence length the DNA will be completely uncoiled 
(Figure 1.12A). If the channels are of the order of the persistence length then the DNA 
molecule will be confined and extended to a length proportional to the length of the 
molecule (Figure 1.12B)50.  
DNA can be visualised in nanochannels by fluorescent molecules that bind to DNA. These 
include dyes that will bind to the major or minor groove in DNA (e.g. DAPI) and dyes 
which will insert between the stacked DNA base pairs, known as intercalators. One 
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commonly used intercalating dye is YOYO-1 which has a high binding constant, is highly 
fluorescent when bound to DNA, but practically non-fluorescent when free in solution. 
DNA can also be labelled to produce a fluorescence pattern dependent on the underlying 
DNA sequence (see later). 
By visualising dyes that bind to DNA the size of large, individual, DNA molecules can be 
measured and the location of labels on DNA can be correlated to the DNA sequence. The 
main advantage of these devices is their flexibility and ease of use to image individual 
stretched DNA molecules. However, the thermal motion of DNA means the fluorescence 
pattern along the intensity profile is blurred during imaging. This must be corrected by 
recording movies of the intensity profile, a stack of which is known as a kymograph 
(Figure 1.12B). Individual intensity profiles from each frame can be aligned to produce a 
consensus of the fluorescence pattern51, although this results in longer image acquisition 
and a loss in resolution. 
DNA nanofluidics were used by Riehn et al. in 2005 for visualisation of DNA in 
restriction mapping52. The DNA was confined in nanochannels and the restriction 
carefully controlled by electrophoresis and the diffusion of magnesium ions and EDTA, 
to prevent restriction before the DNA entered the channels. The restriction sites of SmaI, 





Figure 1.12 Nanofluidic devices for optical mapping of DNA molecules. A) The 
behaviour of DNA in channels is dependent on the size of the channel, the 
persistence length and the radius of gyration of the DNA. If the channel is 
smaller than the persistence length the DNA will be completely uncoiled. If 
the channel is smaller than radius of gyration but still much larger than the 
persistence length, then the DNA will act like a string of non-interacting 
blobs. If the channel is larger than the radius of gyration the DNA will act as 
it does in solution. B) Example of optical mapping in nanochannels, adapted 
from Reisner et al53. DNA molecules are stained for affinity mapping and 
confined in nanochannels. A single DNA molecule is highlighted and a time 
trace of intensity (kymograph) is shown, showing thermal fluctuations of 
the molecule. The kymograph is aligned to produce a single average 
intensity profile that can be used for optical mapping. 
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1.3.3 Optical Mapping by molecular combing 
The deposition and linearization of DNA on a surface is used for fiber-FISH and can also 
be used for optical mapping of DNA molecules. A detailed experimental and theoretical 
description was given by Bensimon in the mid 1990s54. Typically, DNA is deposited on a 
surface carrying a net charge, for instance poly-L-lysine, or a surface coated with a 
hydrophobic compound, for instance PDMS. At low pH DNA molecules will adsorb 
strongly and non-specifically to the surface, whilst at high pH they will adsorb weakly. In 
between these extremes, at around pH 6, DNA will bind strongly and specifically to the 
surface at its extremities55. In molecular combing a receding meniscus is used to 
uniformly stretch the DNA across the surface using this phenomenon (Figure 1.13).  
 
Figure 1.13 Principle of molecular combing of DNA. At around pH 6, DNA in solution 
will bind strongly and specifically at its extremities to a hydrophobic or 
positively-charged surface. As the air-solution interface is moved DNA is 
stretched uniformly on the surface, perpendicular to the receding 
meniscus. 
Ideally molecules are deposited in an absolutely linear and uniformly stretched manner. 
This enables the length of DNA fragments to be easily extracted (for instance for optical 
restriction mapping) or a fluorescent pattern along the DNA to be extracted (see later). 
Molecular combing has been studied extensively to achieve this aim, with the surface 
coating, pH, ionic strength and manner of deposition all being carefully controlled 
(Figure 1.14)56,57.  An early example of its utility was improved restriction mapping 
using molecular combing techniques to stretch the DNA fragments, allowing for far more 
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accurate sizing58. Good molecular combing from droplets containing picograms of DNA 
is now possible, but it remains challenging to get ideal deposition of samples57. If there 
are any sheared DNA molecules, or other impurities, in the sample then they will also be 
deposited on the surface. 
 
Figure 1.14 pH-dependent molecular combing of DNA on hydrophobic PDMS surfaces. 
Adapted from Benke et al56. At pH 2-3 adhesion is too strong to allow 
stretching of DNA molecules. At pH 4-10 a large, but reducing, number of 
molecules are adsorbed and stretched. 
1.3.4 Labelling DNA for optical mapping 
Alternatives to optical restriction maps label rather than cut the DNA, since if labels are 
added with high specificity, their location on the DNA can be used to map the DNA. This 
makes handling the DNA more straightforward, since the order of fragments does not 
need to be preserved and can also be used to overcome the inherent size limitations 
with restriction mapping. Combing, imaging and size estimation of small fragments (<1 
kbp) is virtually impossible, since the fragments will only be a few pixels long. Hence 
restriction enzymes with a low density of sites are used, for instance an 8-site 
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recognition sequence occurs on average every 48=65,536 bp. However, this makes 
optical restriction mapping of small genomes (e.g. viral, bacterial, 50-5000 kbp) difficult 
since there will be few, or no, restriction sites for mapping. Higher density labelling can 
be used to overcome these issues and can be affinity-based, or enzymatic.  
Affinity-mapping (Figure 1.15) generally uses the difference in hydrogen bonding 
between AT and GC base pairs. AT base pairs can form two hydrogen bonds, whilst GC 
pairs will form three hydrogen bonds (Figure 1.2), meaning GC-rich regions are more 
stable. In denaturation mapping the DNA is stained with an intercalating dye, which 
dissociates from AT-rich regions as they melt before GC-rich regions (Figure 1.15A). This 
will give a fluorescent pattern along DNA fragments, dependent on the GC-content and 
degree of melting. This was first demonstrated by Reisner et al in 2010 and an example 
is shown for lambda DNA in Figure 1.12B53.  
An alternative approach is to use a competitive inhibitor to bind to specific regions of 
the DNA (Figure 1.15B). This produces a fluorescent pattern if used together with an 
intercalating dye that is excluded from these regions by the inhibitor. For example 
affinity mapping has been demonstrated with netropsin which competitively binds to 
AT-rich regions59 and actinomycin D which binds to GC-rich regions60. This mapping 
approach has been used to develop diagnostic techniques and has been applied in 
nanofluidic devices to identify bacteriophages59, resistance plasmids61,62, bacterial 
strains63 and resistance outbreaks64. The main limitation of these approaches is that the 
information content is relatively low. For unique identification of a DNA fragment the 
fluorescent pattern must contain a number of contrasting peaks and troughs. However, 
for high density labelling based on GC-content there are relatively small intensity 
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modulations, which do not give well defined peaks and troughs (Figure 1.15E) and make 
assignment of the fragment, to a reference DNA sequence, difficult. 
 
Figure 1.15 Affinity-based optical mapping of DNA. A) Denaturation of AT-rich regions 
causes dissociation of DNA intercalating dyes (e.g. YOYO). B) Competitive 
binding to specific regions of DNA (e.g. netropsin to AT-rich regions) 
prevents binding of intercalating dyes. C) Representation of the expected 
intensity profile from the approaches in A) and B). D-E) Example of affinity-
based approach, taken from Nyberg et al59. D) A single T4 DNA molecule 
(166.5 kbp), stained using the competitive binding approach and mapped 
in a nanochannel. E) Traces of the intensity along the molecule: theoretical 
(dashed line), raw kymograph (dotted line) and aligned kymograph (solid 
line). 
Enzymatic approaches can be used to increase the information content for reliable 
optical mapping. Enzymes can have high sequence specificity, therefore can be used to 
label with lower density which will improve the contrast between peaks and troughs in 
the intensity signal. These approaches include the use of nicking enzymes (Figure 
1.16)65. In 2006 Xiao et al. used Nb.BbvCl to produce nicks (i.e. breaks in a single strand 
of the double-stranded DNA) at 5’-GCTGAGG-3’ sites, followed by the incorporation of 
fluorescently-labelled nucleotides by DNA polymerase at the same sites. After combing 
on a surface, the labelled sites can be readily visualised and used for optical mapping. 
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The main limitation with this approach is the labelling of non-specific and naturally 
occurring nicks since the DNA polymerase will be unable to distinguish between these 
and nicks produced at specific sites. Fragmentation of DNA is also a problem when two 
nicks are close together. 
 
Figure 1.16 Nicking enzyme approach for optical mapping of DNA. A) Nicking enzymes 
produce nicks at specific sites, followed by the incorporation of 
fluorescently-labelled nucleotides by DNA polymerase. B) Representation 
of the expected intensity profile. C-D) Example of nicking enzyme approach, 
taken from Xiao et al65. C) Expected nick sites for Nb.BbvCI (5’-GCTGAGG-3’) 
and lambda DNA (48.5 kbp). D) Composite image of linearised lambda DNA 
(blue) and labelled nick sites (green). Four spots only, corresponding to 
clusters of the seven nick sites, are visible due to the diffraction limit. 
Fragments A and B are fully labelled, whilst fragment C has three spots 
visible.  
The first use of optical mapping using nicking enzyme was by Jo et al. in 2007 to map 
three BACs, labelled using the same method66. Das et al. used a different nick labelling 
scheme67, where DNA polymerase lacking 5′-3′ exonuclease activity was used to 
incorporate fluorescently-labelled nucleotides as normal, but also leaving a short single-
stranded flap of bases that could subsequently be targeted with fluorescently-labelled 
nucleotide probes. Therefore, as well as mapping nick sites, specific target sequences 
can be mapped, which has clear applications when only specific areas of large genomes 
are of interest. These approaches have been extended further to dual colour47 (using two 
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nicking enzymes) and by using CRSIPR/Cas9 approaches to increase specificity for 
identification of individual genes68. 
An alternative enzymatic approach is to use methyltransferase-directed labelling, which 
can label DNA highly specifically, without damage and with high density. Neely et al. first 
reported optical mapping using methyltransferase-directed labelling in 201069. For 
comparison, in optical restriction maps, the density of modified sites is typically only 
one site per 10-100kb, whilst the average density for M.TaqI, which labels DNA at 5’-
TCGA-3’ sites, is one site every 256 bases. This is the labelling method that will be used 
for optical mapping methods in this research.  
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1.4 Methyltransferase-directed labelling of DNA 
1.4.1 DNA methyltransferases 
DNA methylation is found in many organisms ranging from bacteria and viruses to 
mammals70. The enzymes that undertake DNA methylation are known as DNA 
methyltransferases and fall into three groups, depending on the target of methylation 
and therefore the final product: C5-methylcytosine, N4-methylcytosine and N6-
methyladenine (Figure 1.17A-C). All known classes of DNA methyltransferases use the 
cofactor S-adenosyl-L-methionine (AdoMet, Figure 1.17D) as the methyl donor and most 
are active as monomeric enzymes. Methyltransferases that transfer methyl groups to 
other substrates, including proteins, RNA or small molecules (e.g. histamine), are also 
common, but will not be discussed here. 
DNA methyltransferases are the other part of the restriction-modification system in 
bacteria, mentioned previously in section 1.2.1 (restriction mapping). In bacteria, 
methylation and the respective restriction by the sister endonuclease occurs within the 
same DNA target, typically consisting of a palindromic sequence, up to 8 base pairs in 
length. When foreign DNA is introduced into a bacterium it will be cleaved by the 
restriction enzymes, whilst at the same site the bacteria will methylate its own DNA, 
protecting it from destruction. In eukaryotes, modification occurs predominantly at CpG 
sites and has more diverse roles, including gene regulation. There are now thousands of 





Figure 1.17 The transfer of methyl groups to DNA by methyltransferases. A-C) 
Schematic representation of the types of DNA methylation catalysed by 
different groups of methyltransferases: A) C5-methylcytosine, B) N4-
methylcytosine and C) N6-methyladenine. D) The structure of the substrate 







1.4.2 Synthetic AdoMet analogues  
Since methyl-transfer from AdoMet is highly specific and efficient, DNA 
methyltransferases are an attractive target for the transfer of functionalised groups to 
DNA. This can be achieved using synthetic AdoMet analogues, which transfer groups 
other than methyl groups and which can be divided into two main classes: 
aziridinoadenosines and doubly-activated AdoMet analogues. 
Methyltransferase-directed modification of DNA with synthetic AdoMet analogues was 
first reported in 1998 by Elmar Weinhold’s group, using aziridinoadenosines (Figure 
1.18)72. A reactive aziridine group replaces the homocysteine moiety in AdoMet, 
allowing the whole cofactor to be covalently transferred to DNA. Subsequently in 2004 a 
fluorescent reporter group was attached to the adenine base in order to sequence-
specifically label the DNA73,74. Propargyl substitutions on the 5’-N of the base have also 
been used to enable click chemistry75. However, aziridinoadenosines require a 
stoichiometric amount of enzyme for labelling DNA since the reaction product is a 
potent inhibitor of methyltransferases and therefore prevents rapid catalytic turnover. 
Also, the cofactors are highly reactive and may be unstable or cause non-specific 
labelling. For instance, aromatic nitrogen mustards are known DNA-alkylating agents.  
In 2005 Dalhoff et al. first reported the synthesis of doubly-activated AdoMet analogues 
(Figure 1.18), with extended carbon chains which could be efficiently and specifically 
transferred by DNA methyltransferases76,77. It was known that ethyl and propyl groups 
were inefficiently transferred by DNA methyltransferases, however the addition of an 




This has been extended to allow the addition of various functional groups, including: 
amines78, allowing conjugation with NHS-esters; alkynes79–81  and azides81, both capable 
of click chemistry; ketones82, which can react with hydroxylamines or hydrazides; or 
directly coupled to fluorophores83 . Therefore, there exists a wide variety of AdoMet 
analogues which can be used by methyltransferases to covalently attach a range of 
reactive groups to DNA, site-specifically and with high efficiency84–86. 
 
Figure 1.18 Overview of methyltransferase-directed labelling of DNA by synthetic 
AdoMet analogues. Labelling can occur using two main classes of molecule: 
aziridinoadenosines (top) and doubly-activated AdoMet analogues 
(bottom). Aziridinoadenosines will transfer the whole cofactor and require 
stoichiometric amounts of methyltransferase. In contrast doubly-activated 
AdoMet analogues transfer only the extended carbon chain in a catalytic 
manner. Various functional or reporter groups can be transferred to DNA 
bases by both classes of molecule. 
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1.4.3 Methyltransferases for labelling DNA 
A number of DNA methyltransferases have been reported which can be used for the 
transfer of functional groups from AdoMet analogues (Table 1.2). This highlights the 
flexibility of this labelling approach, since these methyltransferases have different target 
sequences, two to six base pairs in length, which allows labelling density to be varied.  
For example, in the first report of doubly-activated AdoMet analogues a DNA 
methyltransferase of each class was used76: the DNA N6-adenine methyltransferase 
M.TaqI (5’-TCGA-3’)87; DNA C5-cytosime methyltransferase  M.HhaI  (5’-GCGC-3’)88 and 















M.FokI GGATG and CATCC 
* Mutant enzyme 
Table 1.2 Alternative DNA methyltransferases for labelling of DNA. A number of 
different methyltransferases have been reported, varying in their efficiency 
and target sequence. 
It was noted that a mutation within the AdoMet binding pocket of M.HhaI increased the 
rate of transalkylation76, which suggested that engineering the cofactor binding sites can 
improve methyltransferase-directed labelling efficiency.  If this could be applied more 
widely, to the thousands of known DNA methyltransferases, since many of them share 
structurally similar AdoMet binding pockets, this would allow for a whole library of 
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modifications of DNA at specific sequences. This also raises the prospect of in vivo 
modification of DNA, since it is possible a methyltransferase could be engineered to 
preferentially transalkylate using an AdoMet analogue, rather than naturally-occurring 
AdoMet.  
This type of engineering has been demonstrated by the Klimašauskas group, who 
modified the cofactor binding pocket of M.HhaI by directed mutagenesis and systematic 
replacement of three non-essential positions with smaller residues89,90, leading to 
substantial increases in activity. Analogous replacements of residues in DNA C5-cytosine 
methyltransferases M.HpaII (5’-CCGG-3’) and M2.Eco31I (5’-GGTCTC-3’) also showed 
catalytic activity could be obtained.  
1.4.4 Applications of methyltransferase-directed labelling of DNA 
One application of methyltransferase-directed labelling is the selective capture of DNA 
molecules (Figure 1.19). The enrichment of DNA samples is important for NGS methods, 
as there is such a large amount of sequencing data produced (see section 1.2.3). Also, 
DNA methylation in humans is associated with some cancers and so selective capture 
based on methylation state may have diagnostic uses. If DNA is selectively modified by 
methyltransferases it can be captured by the reactive group. For instance alkyne-
modified lambda bacteriophage DNA has been captured using click chemistry onto 
silica-based beads91 and amine- and azide-modified genomic DNA has been captured by 





Figure 1.19 Procedure for DNA capture of unmethylated genomic DNA. Genomic DNA is 
sheared and labelled will functional groups (e.g. biotin, alkyne) at specific 
sites (e.g. CpG sites). If a site is already methylated, then no labelling occurs. 
Labelled fragments are captured onto activated beads (e.g. streptavidin or 
azide-coated) to separate from methylated fragments. The fragments are 
removed from beads prior to detection or sequencing. 
Another application has been the use of methyltransferase-directed labelling for optical 
mapping, as previously discussed in section 1.3.4 (Figure 1.20). The main advantages 
over nicking enzymes are that the DNA is labelled without fragmentation, with greater 
efficiency and with greater density. Neely et al. first reported optical mapping using 
methyltransferase-directed labelling in 2010 with M.HhaI (5’-GCGC-3’ sites)69 and 
similar results have subsequently been reported with M.TaqI (5’-TCGA-3’ sites)93. These 
applications used molecular combing to stretch DNA molecules, which enabled super-
resolution of fluorophores to localise sites with 80 bp resolution (see 1.6.2 for a 
discussion of super-resolution microscopy). Following deposition the fluorophores are 
photobleached and based on the stochastic nature of this bleaching individual emitters 
can be localised94. Kim et al. have used mapping as a reference to locate protein-binding 
sites95. M.BseCI (5’-ATCGAT-3’) was used to fluorescently label T7 DNA molecules with 
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an aziridinoadenosine cofactor, to which labelled T7 RNA Polymerase was bound. After 
combing on a poly-L-lysine surface, DNA molecules could be extracted and although the 
labelling was rather sparse, the methyltransferase sites could be used as a reference to 
localise promoters with five-fold greater accuracy than using distance measurements 
alone.  
M.TaqI-labelled bacteriophage DNA has also been mapped using nanofluidic devices by 
the Ebenstein group83. Here bacteriophage DNA was identified by the intensity profile, 
however because of the relatively high density of labels and thermal motion, high 
resolution maps could not be obtained. More recently however the same group has 
demonstrated super-resolution mapping in silicon nanochannels, using a low density of 
labels and single molecule tracking, to overcome the effect of thermal motion96. 
 
Figure 1.20 Methyltransferase-directed labelling approach for optical mapping of DNA. 
A-B) Schematic of methyltransferase-directed approach for enzymatic-
based labelling of DNA. A) Methyltransferase label DNA with fluorophores 
at specific sites, either directly or via coupling (e.g. amines and NHS esters, 
azides and alkynes via Click chemistry). B) Representation of the expected 
intensity profile. C-D) Example of methyltransferase-directed labelling 
approach, taken from Grunwald et al83. M.TaqI (5’-TCGA-3’ sites) was used 
to directly transfer fluorophores to bacteriophage DNA, which were 
subsequently mapped in nano-channels. Expected intensity profiles and 
representative molecules are shown for: C) lambda (48.5 kbp) and D) T7 
(40.0 kbp) bacteriophage DNA. 
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The attachment of fluorophores to DNA can also allow its visualisation in situ, for 
instance in FISH, or in live-cell imaging (Figure 1.21). There are a number of approaches 
for fluorescent-labelling of plasmids97, but methyltransferase-directed labelling gives an 
advantage over other approaches since it allows for non-destructive, covalent 
attachment of fluorophores at specific positions and in densities that can be readily 
controlled. Schmidt et al. used an aziridinoadenosine cofactor and M.TaqI to covalently 
label plasmids pUC19 and pRB322 with Cy3 dyes, before transfection of mammalian 
cells and visualisation of plasmids98. The transfection of similar plasmids in bacteria, 
rather than eukaryotic cells, has not been reported, but is a topic that could be explored 
further using this labelling technique. 
 
Figure 1.21 Localisation of plasmids by methyltransferase-directed fluorescent 
labelling. A) General procedure for localisation of plasmids. Plasmids are 
fluorescently labelled by methyltransferase-directed labelling before cell 
transfection and imaging. B) Example of cells transfected with labelled 
plasmids, taken from Schmidt et al98. pUC19 (2686 bp) was labelled with 
Cy3 using an aziridinoadenosine cofactor before transfection into CHO-K1 
cells. The plasmid (yellow) was found in the cytoplasm (A and C) and the 
nucleus (A only). Overlays of A and C with DAPI staining of the nucleus 
(blue) are shown in B and D respectively. 
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1.5 Bacteria, plasmids and antibiotic resistance 
1.5.1 Bacteria structure and overview 
Bacteria are prokaryotic single cell organisms which do not contain any membrane-
bound organelles, in contrast to eukaryotic cells. They were among the first lifeforms on 
Earth, are typically a few microns in length and come in a variety of forms 99. The small 
size of cells and lack of membrane-bound organelles belies the complexity of the 
underlying subcellular architecture of bacteria, which are highly ordered and dynamic 
cells100.  
 
Figure 1.22 Typical structure of a bacteria cell. The cytoplasm, where most essential 
functions are carried out, is enclosed by a cell envelop composed of several 
layers: a plasma membrane; a peptidoglycan cell wall; and in some species 
a capsule composed of polysaccharides. In addition, many species have 
hair-like projections, known as pili, that aid attachment and some have 
flagella that aid movement. The cytoplasm contains the genetic material 
and ribosomes for protein synthesis. Many bacteria have a single large, 
circular genome which is localised in the nucleoid as well as small 




The basic features of bacteria are shown in Figure 1.22. However, like eukaryotic cells, 
they also have a range of cytoskeletal proteins and intercellular signalling systems to 
coordinate growth, as well as to localise proteins and DNA to specific subcellular 
localisations at specific times. Apart from chromosomal DNA, which is responsible for 
most cellular functions, bacteria can contain DNA in the form of plasmids. 
1.5.2 Plasmids and antibiotic resistance 
Plasmids are small pieces of DNA that are found naturally in bacteria and have essential 
roles in metabolism, pathogenesis and resistance. The term ‘plasmid’ was first used by 
Lederberg in 1952 to describe any extrachromosomal genetic particle101,102. They are 
separate from the chromosome and capable of replicating independently. Plasmids are 
usually circular, the copy number (i.e. the number of copies in a cell), can range from a 
few copies to hundreds, whilst the size can range from around 1 kbp to 100 kbp103. 
Plasmids carry genes that include those which promote replication, maintenance and 
proliferation of the plasmid, but also genes that help the host to adapt to the 
environment. Plasmids are capable of being transferred between bacteria, (horizontal 
gene transfer), as well as between generations of bacteria (vertical gene transfer) and 
are dynamic enough to control the expression of genes that may only be useful 
transiently. One of the most important classes of gene spread by plasmids is genes for 
antibiotic resistance. 
Antibiotics are antimicrobial drugs used to treat bacterial infections. Paul Ehrlich first 
developed a drug to specifically target disease-causing microbes in 1910, to treat 
syphilis104. In 1929 Fleming discovered penicillin105, which was successfully synthesised 
in 1940106 and went into mass production and distribution in 1945, revolutionising 
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medicine in the 20th century. However even before the extensive use of penicillin, it was 
observed that some bacteria could use enzymes to degrade it, therefore developing 
antibiotic resistance107. 
Generally antibiotic resistance is conferred by the conjugation of mobile genetic 
elements, the most important of which are transposons and plasmids108. Genes are 
expressed from these genetic elements and the proteins that are synthesised are used in 
a variety of strategies to confer resistance. These strategies include modification, 
destruction, removal and reduced uptake of the antibiotic molecule and modification 
and protection of the target site of the antibiotic.  
Antibiotic resistance is now one of the greatest public health threats and by 2050 it has 
been estimated that the societal and financial cost, if not tackled, will be US$100 
trillion109. As well as developing new treatments and novel antibiotics, preventive 
measures are recommended, such as public awareness, good sanitation and reducing 
and controlling the use of antibiotics in healthcare, agriculture and the environment. 
Also recommended is the development of new rapid molecular diagnostics to quickly 
and accurately diagnose infections and inform early appropriate antibiotic therapy110. 
This would improve clinical outcomes, and reduce antibiotic use, limiting the selection 
of antibiotic-resistant bacteria. 
Current molecular diagnostics take around two days, as bacteria are cultivated and then 
identified111. Meanwhile the patient is treated based on empirical observations and the 
likely pathogens. This obviously leads to ineffective treatment and inappropriate use of 
antibiotics. Rapid diagnosis by biomarkers or identification without the need for 
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cultivation would accelerate diagnosis. Optical mapping therefore has the potential to be 
applied as it needs only a small amount of pure DNA. 
The mechanisms of horizontal and vertical gene transfer are also being investigated in 
this context, to help fully understand mechanisms for development of antibiotic 
resistance112.  
1.5.3 Plasmid organisation and dynamics 
To ensure plasmid transmission to daughter cells bacteria have active partitioning 
systems. There are a number of well-characterised partition system which share 
similarities113. The Type I and II are the most common partition systems, both involving 
three components, an adaptor protein, a motor protein, and a centromere (a specific 
sequence on the plasmid). The adaptor protein binds to the centromere and recruits the 
motor protein, leading to filament formation and either the plasmids are pulled apart 
(type I) or pushed toward opposite ends of the cell (type II). 
It is thought that no such active partition mechanisms are involved for high copy 
number plasmids. Instead it is thought they are randomly segregated during division, 
meaning by chance each daughter cell should retain at least a single copy114. However 
there is some debate about this mechanism, as microscopy of fluorescently-labelled 
plasmids has shown clustering at the poles of cells115,116. This has been attributed to 
displacement by the nucleoid117 although there is also evidence of plasmids randomly 
distributed throughout the cytoplasm, observable by localisation of individual plasmids 
(Figure 1.23)118. It has also been shown that localization can be driven by other 
processes, for instance transcription119. 
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The investigation of plasmid localisation, clustering and dynamics showcases how 
fluorescence microscopy, and its recent advances beyond the diffraction limit, has 
become an invaluable tool for studying biological systems. Figure 1.23 shows examples 
of how both conventional widefield fluorescence microscopy (Figure 1.23B and E) and 
super-resolution microscopy (Figure 1.23C and F) can be used to investigate a biological 
system. These types of fluorescence microscopy are also vital for optical mapping of 
DNA and so the principles will be discussed in more detail. 
 
Figure 1.23 Plasmid localisation in bacteria. Taken from Wang et al118. Single-molecule 
fluorescence in situ hybridization (smFISH) was used to localise a ColE1-
derivative plasmid in fixed and permeabilised Escherichia Coli. A) 
Immobilised bacteria viewed in brightfield. B) Conventional widefield 
fluorescence microscopy. Fluorescent foci are clusters of smFISH-labelled 
plasmids. C) E. Coli imaged by localisation microscopy. D-F) Show an 
enlargement of the highlighted region in A-C). In the localisation image, as 
well as clusters of plasmids around the poles of the cell, there are plasmids 
located within the nucleoid region.  
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1.6 Fluorescence and Microscopy 
1.6.1 Fluorescence and the emission of light 
Fluorescence was first described by George Stokes in 1852120. He coined the term when 
he observed that the mineral fluorspar emitted red light when illuminated by UV light. 
Fluorescence is a type of luminescence (a termed introduced by Eilhard Wiedemann in 
1888121), which is the general term for emission of UV, visible or infrared photons from 
an electronically excited species.  
The processes involved in luminescence are illustrated in Figure 1.24122. In a molecule, 
electrons occupy orbitals which exist at discrete energy levels (many vibrational levels 
are associated with each orbital), the lowest of which is known as the ground state, S0. A 
pair of electrons in an occupied orbital will have the opposite spin, meaning the total 
quantum spin is zero, which is termed a singlet state. When light interacts with matter it 
is either scattered or absorbed. If absorbed, a photon can promote an electron from S0 to 
one of the vibrational levels in an unoccupied orbital, for example the first singlet 
excited state, S1. In principle the electron spin is unchanged, so the transition will be 
singlet-singlet. However, if the election undergoes conversion to another state and 
changes spin, the overall quantum spin is one and the state is known as a triplet state, 
e.g. first excited triplet state, T1. 
The excited species is de-excited by a number of possible processes: including internal 
conversion, fluorescence, intersystem crossing and phosphorescence. Internal 
conversion (IC) is a non-radiative transition between two electronic states of the same 
spin multiplicity. If this is from S1 to S0 then vibrational relaxation towards the lowest 
vibrational level of S0 can occur without emission of light. In fluorescence the S1 to S0 
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relaxation is accompanied by the emission of a photon. Usually this occurs from the 
lowest vibrational level of S1.  
Another process for de-excitation is intersystem crossing (ISC), a non-radiative 
transition between electronic states of different multiplicities, for instance from S1 to T1. 
This is in principle forbidden, however coupling between the spin magnetic moment and 
the orbital magnetic moment can be large enough to make such a transition possible. 
From T1 a molecule may be de-excited by further ISC and vibrational relaxation, or a 
radiative de-excitation in a process called phosphorescence.  
 
Figure 1.24 The energy states and transfers involved in photoluminescent processes. In 
a molecule, electrons occupy orbitals which exist at discrete electronic 
energy levels, including the ground state (S0), excited singlet states (S1, S2…) 
and excited triplet states (T1, T2…). Each electronic state will have many 
vibrational levels. When absorbed a photon can promote an electron from 
S0, to one of the vibrational levels in an unoccupied orbital, for example the 
first singlet excited state, S1, from which vibrational relaxation towards the 
lowest vibrational level can occur. Internal conversion (IC) is a non-
radiative transition between two electronic states of the same spin 
multiplicity (e.g. S1 and S0). Intersystem crossing (ISC) is a non-radiative 
transition between electronic states of different multiplicities (e.g. S1 and 
T1). Fluorescence is a radiative transition from an excited singlet state to 
the ground state (e.g. S1 to S0). Phosphorescence is a radiative transition 
from an excited triplet state to the ground state (e.g. T1 to S0). 
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Some of the main factors that should be considered when choosing a luminescent probe 
are: the maximum excitation and emission wavelengths; the difference between them 
(Stokes shift); the molar absorption coefficient; the quantum yield; and the lifetime and 
photostability of the probe. 
The maximum excitation and emission wavelengths are determined by the energy levels 
of the system. For instance, in linear and cyclically conjugated systems it is usually the 
overlap between π-orbitals that determines the wavelength of absorption. Greater 
conjugation can therefore lower the energy of the transition and consequently lengthen 
the maximum excitation wavelength. Typically, fluorophores are selected that are 
suitable for the microscope setup (e.g. the wavelength of the excitation laser) and which 
are excited far from background fluorescent species. For instance, most cells exhibit a 
natural fluorescence from a range of species (e.g. flavins, NADH, collagen), termed 
‘autofluorescence’, that must be overcome. Practically a large Stokes shift also usually 
makes it easier to distinguish fluorescent species. 
The brightness of a fluorophore depends on its ability to absorb and emit photons. The 
ability to absorb photons is described by the molar absorption coefficient, which is the 
amount of light absorbed, at a given wavelength, depending on the concentration of the 
fluorophore. The efficiency of photon emission is described by the quantum yield, which 
is the number of fluorescence photons emitted per excitation photon absorbed. 
Fluorescence brightness is proportional to the product of the molar absorption 
coefficient and quantum yield, so usually high absorption coefficient and quantum yields 
are desirable.  
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Another factor is the lifetime of the excited state. Non-radiative de-excitation processes 
will compete with fluorescence when they take place on a timescale comparable with 
the lifetime of the excited state. This means for example fluorescence is typically more 
intense than phosphorescence, as the lifetime is much shorter. This is because in 
phosphorescence the emission occurs from a triplet state to the singlet ground, which is 
a ‘forbidden’ transition and therefore kinetically slow.  
Under a high intensity of photons, the limiting factor is often the photostability of a 
fluorophore. If fluorophores were infinitely photostable then even dim fluorophores 
could be used with very high laser powers and long excitation times. However, in reality 
fluorophores are eventually destroyed, in a process known as photobleaching, which 
reduces the signal to noise ratio. This process can also be exploited to probe dynamic 
processes, for instance by using the recovery of fluorescence due the diffusion of 
fluorescent molecules, or for localisation (see section 1.6.2). During photobleaching the 
fluorophore is irreversibly destroyed and will no longer fluoresce. This usually involves 
a permanent structural change from the excited state, for example conversion to a triplet 
excited state and subsequent destruction of covalent bond, for instance by oxygen free 
radicals123,124. 
The choice of fluorophore is dependent on the application and careful consideration of 
these parameters. Generally, for imaging in biochemical applications fluorophores 
should be: excitable at a suitable wavelength; detectable at a suitable wavelength; 
bright; photostable; soluble and easily synthesised. The main types of fluorophores that 
are used to fulfil these requirements are small organic molecules125, fluorescent 
proteins126 and quantum dots127. 
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The first fluorophores based on small organic molecules was quinine sulfate, identified 
by John Herschel in 1845128. Since then a whole range of organic fluorophores have been 
developed, many based on fluorescein129, rhodamine130, BODIPY131 and cyanines132 
(Figure 1.25). Development of derivatives and novel small organic molecules is ongoing, 
but due to the difficulty of predicting photophysical properties, rational design has 
proved difficult. However, there are many dyes widely available across the UV/vis 
spectrum, capable of a range of easy coupling chemistry and which are relatively bright 
and photostable. Also, their size means they are unlikely to interfere with biological 
function. 
 
Figure 1.25 Common organic fluorophores. Many commercially available small organic 
fluorophores are derivatives of these four molecules: fluorescein, 
rhodamine, BODIPY and cyanine. Note the large linear or cyclically 





1.6.2 Fluorescence Microscopy 
These probes are used along with microscopy to probe the structure and function of 
biomolecules. When producing an image there is an inherent trade-off between image 
resolution, imaging speed, signal-to-noise and photobleaching133. Each available 
technique will provide advantages in some of these aspects but be poor in others, so 
careful consideration is necessary.  
Optical microscopy uses the transmission or reflectance of visible light to produce an 
image. Various techniques exist to increase contrast in images produced by light, such as 
phase contrast and dark illumination microscopy, however one of the most powerful 
tools available is fluorescence microscopy. Here it is the fluorophores, discussed 
previously, that provide the contrast in the image by emitting light. If the fluorophores 
are conjugated to specific structures, then they can be used to study localisation and 
dynamics. 
Several fluorescence microscopy techniques exist, with various advantages and 
disadvantages133. The most basic technique is wide-field fluorescence microscopy 
(Figure 1.26.A), which typically consists of a light source, a dichroic mirror, excitation 
and emission filters, an objective and a detector. Photons from the light source are 
focused by the objective onto the sample for excitation of fluorophores. The photons 
emitted from fluorophores following de-excitation are collected by the objective and 
used to produce a magnified image of the position of the fluorophores, which may be 
observed through microscope eyepieces or by a camera. The dichroic mirror is used to 
separate photons from the light source and the sample, by reflecting photons from the 
light source and allowing photons from the sample (at a longer wavelength due to the 
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Stokes shift) to pass through. These systems now typically have lateral resolution of up 
to 200 nm and millisecond time resolution.  
The maximum resolution is fundamentally limited by the diffraction limit, described by 
the Abbe diffraction limit, first described in 1873134. The maximum lateral resolution is 
approximately 0.61𝜆/𝑁𝐴, where λ is the wavelength of light and NA is the numerical 
aperture of the microscope. The numerical aperture is a measure of how much light can 
be collected by the objective, given by 𝑛sin (𝛼), where 𝛼 is one half the angular aperture 
of the objective. For a high NA, (around 1.4) the maximum lateral resolution is around 
200 nm.  
The main drawback with wide-field fluorescence microscopy is poor axial resolution as 
a result of light emitted from out-of-focus planes. Structured illumination microscopy is 
a form of wide-field microscopy that overcomes this limitation by inserting a moveable 
grid pattern into the optical path of the excitation light. This creates a pattern that can be 
used to reduce light from out-of-focus planes and in some cases can be used to improve 
lateral resolution two times beyond the diffraction limit135. However, multiple images 
must be taken which can lead to photobleaching. 
Laser scanning confocal microscopy is another common form of fluorescence 
microscopy that looks to overcome the axial limitations of wide-field microscopy (Figure 
1.26.B). Typically, in laser scanning confocal microscopy a pinhole is inserted in front of 
the light source. The point of light generated by this is focused on the sample and light 
collected as normal; however, another pinhole is inserted into the optical path prior to 
the detector. This prevents light which originates from above or below the plane of focus 
from reaching the detector and eliminates the light from out-of-focus planes. However, 
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to construct an image the point of light must be scanned across the whole sample which 
means photobleaching is a major concern and the speed of acquisition is inherently 
slow. Multipoint or slit confocal microscopes have been used to accelerate image 
acquisition. 
The axial resolution of laser scanning confocal microscopy is still only on the order of 
600-1000 nm. This can be improved by using total internal reflection fluorescence 
microscopy (TIRF) (Figure 1.26.C). Here an oblique angle of excitation is used, which 
when set beyond the critical angle to the coverslip, means the light will undergo total 
internal reflection. This sets up an evanescent wave which only propagates around 200 
nm above the coverslip surface, exciting only those molecules close to the surface. As 
well as increasing axial resolution this can reduce background emission from out-of-
focus planes, and since the only requirement is angled excitation light, it is easy to 
implement.  
Only fluorophores in the first 200 nm can be excited however. This has led to the 
development of light sheet microscopes136. These illuminate the sample from a plane 
orthogonal to the imaging plane, therefore have the same advantage as TIRF, of 
eliminating out-of-focus light, but also allow for 3D images to be produced with fast 
image acquisition. 
Finally the other main type of fluorescence microscopes are those that are aimed at 
breaking the diffraction limit by an order of magnitude or more137. These fall into two 
main categories: stimulated emission depletion (STED) microscopy and single-molecule 




Figure 1.26 Common fluorescence microscopy techniques. A) A typical widefield 
microscope. Excitation light is passed through a filter, before being 
delivered to the sample. Out of focus planes are illuminated, causing poor 
signal to noise when the emitted light is collected and used to generate an 
image. B) A typical laser scanning confocal microscope. Many features are 
shared with a widefield microscope, but there is the addition of pinhole 
apertures to prevent out of focus planes being illuminated. However, this 
also means a sample must be scanned to generate a whole image. C) A 
typical total internal reflection fluorescence (TIRF) microscope. Many 
features are also shared with widefield microscopy, but the incident laser is 
tilted beyond the critical angle. Total internal reflection occurs and sets up 
an evanescent field close to the surface of the sample, eliminating light 
from out of focus planes and increasing axial resolution. However, imaging 
is restricted to the surface of the sample. 
In STED an excitation laser is used, as in laser scanning confocal microscopy, but a 
second doughnut-shaped laser is also used to quench the fluorophores where the 
excitation spot and doughnut overlap. Depending on the power of the STED laser this 
typically gives lateral resolutions of around 20-70 nm. The photobleaching caused by the 




Figure 1.27 Approaches for super-resolution microscopy. The maximum resolution of 
optical microscopy is fundamentally limited by the diffraction limit, 
described by the Abbe diffraction limit ~𝟎. 𝟔𝟏𝝀/𝑵𝑨 ~200 nm. Super-
resolution approaches break this diffraction limit by an order of magnitude 
or more. A) Stimulated emission depletion (STED) microscopy. A second 
doughnut-shaped laser (STED beam) is used to quench the fluorophores 
where the excitation beam and doughnut overlap. This generates a 
narrower effective point spread function (PSF) that can be used to scan the 
sample. B) Single molecule localisation microscopy (e.g. PALM, STORM). 
Stochastic switching of fluorophores means that in any single frame there 
are no overlapping emitters. This means Gaussian fitting can be used to 
localise individual molecules and if many frames are combined then all 
molecules can be localised. 
In comparison, single-molecule localization methods approaches, such as PALM and 
STORM, exploit the localisation of individual fluorophores. If fluorophores can be 
stochastically switched on and off, such that there are no overlapping fluorophores, the 
position of individual molecules can be estimated by fitting a 2D Gaussian profile. By 
taking many images, the positions of individual molecules can be combined to form a 
single super-resolution image with lateral resolution of the order of 10-30 nm. The 
advantage of these approaches over STED is that standard fluorescence microscopes, for 
instance TIRF, can be used, as long as stochastic fluctuations can be generated. However, 
the number of images that must be required sets a limitation on the speed of acquisition 





Antibiotic-resistance is an increasing problem, which needs to be tackled and better 
understood. It is usually conferred by the transfer of mobile genetic elements, such as 
resistance plasmids, which need to be identified and their gene organisation and 
transmission investigated. A large number of techniques have been developed to 
identify and image DNA and a broad overview of techniques has been given here, 
highlighting their development, strengths, weaknesses and applications.   
For identification of the DNA code, hybridisation techniques, (e.g. Southern blots, FISH, 
DNA microarrays), can identify specific genes or SNPs, but lack the single base 
information required to understand the whole genome. In contrast, DNA sequencing 
techniques (e.g. NGS, SMRT sequencing) can provide base-pair resolution for unknown 
genomes, but lack the contextual information required to easily assemble large 
genomes.  
Optical mapping of DNA can help bridge the gap between these traditional techniques, 
as it provides long-range contextual information that can be used to rapidly identify 
complex mixtures of DNA as well as large-scale genomic variations (Figure 1.28). In 
addition, it can be used on small amounts of genetic material and can give single 
molecule information that is otherwise obscured in a large population. This makes it an 
ideal method to apply to studying resistance plasmids. 
Optical mapping can be carried out on single DNA molecules in nanofluidic devices or 
using molecular combing. Nanofluidic devices provide clean images of individual DNA 
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molecules, but thermal fluctuations reduce the apparent resolution and require time 
lapses to be taken. Imaging DNA molecules that have been combed is inherently faster 
and higher resolution is possible, but suffers from experimental difficulties in obtaining 
single, well-separated and stretched molecules. 
 
Figure 1.28 Overview of techniques for DNA identification. There are three main 
techniques families of techniques that can be used to identify DNA: 
sequencing, hybridisation and mapping. Sequencing approaches give single 
base resolution of unknown sequences, but there is generally a trade-off 
between longer reads (giving contextual information) and 
throughput/cost. Hybridisation approaches can be used with specific, 
known sequences to give either good resolution (e.g. microarrays to detect 
SNPs) or good long-range information (e.g. FISH). However, DNA mapping 
techniques bridge these two, by providing information on genome 
structure with ~100-1000 bp resolution, with moderate throughput and 





Several labelling methods that rely on the underlying sequence can be used to obtain 
unique patterns for optical mapping. Affinity labelling approaches are generally easy to 
apply but suffer from relatively low information content (i.e. how different intensity 
profiles are) compared to enzymatic approaches. Methyltransferase-directed labelling 
can be used at variable densities to provide unique intensity profiles for DNA 
identification and doesn’t cause DNA damage or suffer from many non-specific labels.  
1.7.2 Aim and objectives 
The aim of this research is to develop novel applications for methyltransferase-directed 
fluorescent labelling of DNA. The first objective is to develop a robust technique for 
identification of viruses, resistance plasmids, bacterial populations and other complex 
mixtures of DNA. Taking the strengths and weaknesses of current techniques into 
account, this research will use an optical mapping approach, utilising methyltransferase-
directed labelling and molecular combing of DNA fragments. A combination of small 
organic fluorophores and fluorescence widefield/TIRF microscopy will be used for 
imaging. 
The other objective of this research is to apply methyltransferase-directed labelling to 
visualise plasmids transfected into bacteria. The development of this technique will 
allow it to be applied for study of the partition mechanism of high copy number 
plasmids and of the transfer and maintenance of low copy number plasmids, such as 
resistance plasmids. 
To achieve these aims this thesis will be split into three main sections. The first 
(CHAPTER 2) will focus on the optimisation of methyltransferase-directed labelling, 
applied to fluorescent labelling for optical mapping and visualisation of plasmids. The 
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next section (CHAPTER 3 and CHAPTER 4) will focus on the computational and 
experimental aspects of optical mapping using methyltransferase-directed labelling. 
These approaches will be applied on simple genomes and mixtures, through to more 
complex mixtures. In the final section (CHAPTER 5) methyltransferase-directed labelling 
will be applied to small plasmids, followed by transformations into bacteria for 




CHAPTER 2 OPTIMISATION OF METHYLTRANSFERASE-
DIRECTED FLUORESCENT LABELLING OF DNA 
Robert K. Neely provided supervision and guidance for the research undertaken in this 
chapter. Nathaniel O. Wand (the author) designed, performed and analysed all labelling 
experiments, including restriction assays and single molecule counting experiments. 
Andrew Wilkinson designed, performed and analysed all stability and purity 
experiments.    
2.1 Introduction 
2.1.1 Enzymes and DNA identification 
Enzymes have been used to identify specific DNA sequences and map genomes since the 
1970s. This family of techniques exploits the natural sequence specificity of enzymes, to 
help produce a unique pattern that is representative of the underlying DNA sequence. 
For example restriction enzymes were used to produce specific fragments of DNA by 
Danna and Nathans in 197118, which were separated by gel electrophoresis and 
visualised. This is a powerful technique, since as well as confirming the identity of DNA 
it allows the relative position of enzyme recognition sites to be found, which can be used 
to determine the orientation and position of an insert in a cloning vector. 
For the identification of microorganisms, restriction mapping has been largely 
superseded by DNA hybridisation techniques (e.g. DNA Microarrays, FISH), to detect 
specific, known sequences, and DNA sequencing techniques (e.g. Sanger, NGS), to map 
and sequence whole genomes. However, the specificity of enzymes has been exploited 
again more recently, for the identification of DNA by optical mapping. This has the 
potential to bridge the resolution and contextual information provided hybridisation 
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and sequencing techniques, in particular to determine the arrangement of genomes in a 
costly and timely manner. In optical mapping individual DNA molecules are stretched 
and imaged, before being identified by unique patterns, which are representative of the 
underlying sequence. Optical mapping, using restriction enzymes to generate the unique 
pattern, was first demonstrated in the mid-1990s45. Since then a number of other 
enzymes have been used to sequence-specifically label, rather than cut, DNA, for 
instance nicking enzymes65 and DNA methyltransferases69.  
2.1.2 Methyltransferase-directed labelling of DNA 
DNA methyltransferases and restriction enzymes together form the restriction-
modification system in bacteria, of which thousands of examples are now known71. In 
bacteria, methylation and the respective restriction by the sister endonuclease occurs 
within the same DNA target, consisting of a palindromic sequence, typically 2 to 8 base 
pairs in length. DNA methyltransferases are an attractive target for labelling DNA, since 
they can be used to modify DNA efficiently, covalently, without damage, with a broad 
range of densities, and with high specificity and fidelity138,139. 
In nature all known classes of DNA methyltransferases use the cofactor S-adenosyl-L-
methionine (AdoMet) as the methyl donor. It has been demonstrated that synthetic 
AdoMet analogues can also be used to catalyse the transfer of more complex chemical 
groups to DNA. Fluorophores and other modifications can be targeted to specific sites in 
a DNA sequence, efficiently and non-destructively86. This labelling has been used for a 
number of applications, such as capturing DNA, visualising it in situ, as well as for optical 
mapping. The efficacy of this approach for these applications will depend on the 
efficiency of the labelling. For instance, optical mapping of 100% labelled DNA 
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fragments will be more reliable than optical mapping of fragments with only 10% 
labelling, since it is the unique pattern that is required for alignment to a reference (see 
section 3.2.4). 
2.1.3 Quantifying DNA methyltransferase labelling efficiency 
Quantifying labelling efficiency has not proved a straightforward task and there has 
been little attempt to systematically assess the efficiency of labelling by synthetic 
cofactors. Traditionally the protection of DNA by methyltransferases is quantified by 
restriction assays140 (Figure 2.1A). In these a restriction enzyme, which recognises the 
same sequence as the methyltransferase, is incubated with the methylated DNA. Non-
methylated sites will be cleaved, and the DNA sample can be analysed by gel 
electrophoresis.  
Figure 2.1C shows the restriction pattern that can be expected, depending on the 
labelling efficiency, for pUC19, which is 2686 base pairs long, and the DNA 
methyltransferase M.TaqI (5’-TCGA-3’), for which there are four sites on the plasmid 
(Figure 2.1B). When pUC19 is unlabelled, and therefore fully digested, three fragments 
are clearly visible (1444, 736 and 476 bp). The smallest fragment (30 bp) is not visible 
since the intensity of bands is dependent on the mass of DNA. When pUC19 is partially 
labelled there is incomplete digestion and a number of longer fragments appear. When 
labelling reaches 100% one single band is seen, as the DNA is unrestricted. In practice 
the plasmid will exist in a supercoiled conformation, so a fragment will be present that 
runs faster than the linear fragment. In acidic solutions and at high temperatures, the 
DNA can be damaged. Nicking will cause the plasmid to adopt the open circular 
conformation, whilst a break will lead to linear DNA. This can be a problem in real 
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experiments, since the expected restriction pattern for 50-60% labelling and the 
restriction pattern for the fully protected plasmid can be difficult to discriminate.  
 
Figure 2.1 Quantifying labelling efficiency by restriction assays. A) General restriction 
assay procedure. First DNA is labelled at specific sites (e.g. TaqI, 5’-TCGA-3’ 
sites) by the methyltransferase. Next the sister restriction enzyme, that will 
cut at the same site, is incubated with the DNA and will fragment un-
methylated DNA. The resulting restriction fragments are separated by gel 
electrophoresis. B) Map of pUC19 showing TaqI sites. C) Expected 
restriction pattern for pUC19 restricted by R.TaqI from 0% to 100% 
methylation efficiency.  
As well as this issue, restriction assays do not directly report on the labelling efficiency 
by synthetic cofactors. For instance the site may be hemi-methylated only (R.TaqI 
doesn’t restrict hemi-methylated sites71) or the site may not be labelled with the desired 
synthetic group, it could for instance be labelled with a methyl group only. This can lead 
to misleading results and alternative methods should be used as validation. 
For optical mapping using methyltransferases, labelling by fluorophores gives the 
unique pattern for DNA identification. However, simple quantification of labelling 
efficiency by absorption spectroscopy is not possible since the concentration of DNA is 
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typically of the order of nanomolar. For instance, pUC19 at a concentration of 100 ng/μl 
is equivalent to around 50 nM, which for 8 dyes per plasmid equates to 0.4 μM dye. For 
Atto647N, with a molar extinction coefficient of 1.5x105 M-1cm-1, and a path length of 1 
cm this would equate to an absorbance of just 0.06. To address this we have previously 
reported a single molecule counting procedure141 (Figure 2.2), which in tandem with 
restriction assays, can now be used to give a more comprehensive description of 
labelling efficiencies. 
 
Figure 2.2 Single molecule counting procedure. Fluorescently-labelled plasmids are 
stained with YOYO-1 and adsorbed onto a poly-L-lysine surface. A bleaching 
movie is taken of the fluorophore labels and used to localise them. An 
intensity time trace for each molecule is effectively used, in which 
individual bleaching steps correspond to individual fluorophores. A 
separate movie is taken of the YOYO-1 and used to localise plasmids. The 
fluorophore and plasmid localisations are overlaid using custom Matlab 
software to produce a histogram which reports the number of fluorophores 
counted per plasmid. 
64 
 
In the single molecule counting procedure fluorescently-labelled plasmids are stained 
with YOYO-1 (a DNA intercalator) and adsorbed onto a positively-charged poly-L-lysine 
surface. A bleaching movie is then taken of both the fluorophore and of YOYO-1. The 
YOYO-1 movie can then be used to localise plasmids, whilst the number of fluorophores 
can be counted by running backwards through the bleaching movie and localising 
fluorophores as they appear. This can be done using freely available Localizer 
software94. The positions of fluorophores and positions of plasmids can be used to 
determine the overlap, and therefore used directly to count the number of fluorophores 
coupled per plasmid (i.e. a maximum of 8 per pUC19 plasmid).  
Figure 2.3 shows the expected distributions for pUC19 (generated by stochastic 
modelling), for labelling efficiencies ranging from 10 to 100%. At low labelling 
efficiencies, only a few fluorophores are counted per plasmid, for example at 20% 
labelling efficiency the peak is at 1 fluorophore per plasmid. At 50% labelling efficiency a 
distribution of plasmids is expected, centred on 4 fluorophores per plasmid. Finally, at 
very high labelling efficiencies most plasmids should have all 8 fluorophores. 
 
Figure 2.3 Calculated distributions for single molecule counting, for pUC19 labelled by 




Here a range of experimental factors that affect the efficiency of fluorescent labelling of 
DNA by M.TaqI will be tested. The optimisation of fluorescent labelling demonstrates 
how the maximum labelling efficiency by methyltransferases can be achieved and 
should serve as a guide for other methyltransferase labelling strategies.  
The factors that will be discussed include: dye and cofactor coupling strategies; the 
effect and removal of bound AdoMet; the decomposition of the cofactor; the reaction 
conditions, including the reaction buffer, temperature and time of reaction; dye purity 
and choice; and the choice of methyltransferase. Finally, the reliability of single molecule 




2.2 Results and Discussion 
2.2.1 Dye and cofactor coupling strategies 
Here four strategies for the conjugation of fluorophores to DNA are discussed. These 
involve pre- or post-transalkylation coupling of the fluorophore using amine-NHS or 
strain-promoted alkyne-azide cycloaddition (SPAAC) coupling (Figure 2.4). These are 
well known reactions that can be readily used in aqueous conditions. The amine-NHS 
reaction couples primary amines to NHS esters to form peptide bonds, but suffers from 
competing hydrolysis of the NHS-ester.142 For example at pH 7.0 at 0oC the NHS-ester 
half-life is around 4-5 hours, whilst at pH 8.6 at 4oC this is reduced to 10 minutes. The 
dibenzocyclooctyne (DBCO) and azide groups used in the SPAAC coupling are by 
contrast far more stable.143   
The structures of the AdoMet analogues that have been used for these schemes are 
shown in Figure 2.5. In all the analogues the methyl group in AdoMet has been replaced 
by an extended side chain. Side chains are activated by incorporating a double or triple 
bond in the beta position to the sulfonium centre76 and a terminal functional group is 
incorporated for coupling. 
The length of the sidechain is also important81. But-2-ynyl cofactors which contain an 
electron-withdrawing group close to the unsaturated bound are susceptible to 
nucleophilic attack, for instance by water. However, by using hex-2-ynyl groups, 
extending the carbon chain by two units, the stability of cofactors is markedly increased. 
Longer chains are also beneficial for post-transalkylation coupling, as they permit better 
accessibility and enhanced reactivity of the terminal functional group. There is some 
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increased steric hindrance, however M.TaqI has a cofactor binding pocket which can 
accommodate longer chains well144.  
 
Figure 2.4 Labelling and reaction schemes. A) Pre-transalkylation fluorophore 
coupling: labelling with AdoHcy-dye after amine-NHS coupling or SPAAC 
coupling. B) Post-transalkylation fluorophore coupling: labelling with 
AdoHcy-amine or -azide followed by amine-NHS coupling or SPAAC 





Figure 2.5 AdoMet analogues used for transalkylation. A) Naturally occurring 
cofactors: AdoMet and AdoHcy. AdoMet is the natural cofactor used for DNA 
methylation. AdoHcy is the natural product of DNA methylation and can be 
used as a precursor for synthesis of AdoMet analogues. B) Hex-2-ynyl 
AdoMet analogues: AdoHcy-amine and AdoHcy-azide. Both cofactors 
replace the methyl group in AdoMet with a hex-2-ynyl chain. AdoHcy-amine 
has a primary amine group at the end of this chain, whilst AdoHcy-azide has 
an azide functional group. C) Hex-2-ynyl AdoCys analogues: AdoCys-amine 
and AdoCys-azide. Both cofactors replace the homocysteine in AdoHcy with 
a cysteine and the methyl group in AdoMet with a hex-2-ynyl chain. AdoCys-
amine has a primary amine group at the end of this chain, whilst AdoCys-
azide has an azide functional group. 
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Novel cysteine cofactors which differed from homocysteine analogues by one fewer 
carbon in the amino acid chain were also tested. These would have applications if the 
enzyme binding pocket could be designed to accommodate them and should show 
enhanced stability, as ring closing of the amino acid is one of the prominent 
decomposition pathways. However, in this application they showed significantly lower 
activity with the wild-type M.TaqI enzyme and were therefore not used further. 
Restriction assays are shown for each of these cofactors (Supplementary Figure 7.3: 
AdoHcy-amine, AdoCys-amine and AdoCys-azide and Figure 2.13: AdoHcy-azide).  
2.2.2 Comparing restriction assays and single molecule counting 
It has been clear from previous labelling experiments that although restriction assays 
appear to show full protection of DNA (to the extent that any restricted fragments are 
beyond the limits of detection), this does not equate to 100% fluorescent labelling of 
DNA141. This is shown in Figure 2.6 where a two-step labelling scheme is used: first the 
DNA is transalkylated using M.TaqI and AdoHcy-azide; then the azide functionalised 
groups are SPAAC-coupled to a fluorophore. Figure 2.6A, lanes 2-7, show full protection 
of pUC19 by M.TaqI and AdoHcy-azide at high concentrations of M.TaqI. For comparison, 
the concentration of pUC19 is around 20 nM, therefore the concentration of labelling 
sites for M.TaqI is around 200 nM, and the concentration of M.TaqI in lane 2 is around 
300 nM. This means for lane 4 (which appears to have complete protection) there is 
turnover of at least two times. The corresponding single molecule counting results after 
SPAAC coupling however only show a maximum of around 45% labelling efficiency 
(Figure 2.6B and Figure 2.6C). 
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It is important to note that M.TaqI is not preventing restriction by binding to DNA 
(Supplementary Figure 7.1) and also that there is no evidence that the palindromic 
target sites are only being modified on one site. The expected distributions this would 
give in single molecule counting experiments can be modelled and compared to 
experimental results (Supplementary Figure 7.2). 
 
Figure 2.6 M.TaqI labelling of pUC19 with AdoHcy-azide. A) Restriction assay for 
M.TaqI labelling of pUC19 with AdoHcy-azide and without added cofactor. 
Lane 1 = 2 log ladder; lanes 2-7 = AdoHcy-azide, 2x dilution of M.TaqI; lanes 
8-13 = no cofactor, 2x dilution of M.TaqI; lane 14 = AdoMet control; lane 15 
= no cofactor control; lane 16 = no M.TaqI control; lane 17 = restricted 
pUC19; lane 18 = unrestricted pUC19. B) Single molecule counting results, 
for labelling conditions equivalent to lanes 2-7, followed by post-





2.2.3 Effect and removal of bound AdoMet 
One of the factors which could cause this apparent discrepancy is the protection of DNA 
by AdoMet instead of the desired AdoMet analogue, leading to a methyl group being 
transferred instead of the reactive chemical moiety. It has been previously reported that 
purified M.TaqI is able to protect DNA even when no AdoMet is added to the reaction. 
Bound AdoMet is co-purified with M.TaqI and has been observed in, for example, the 
crystal structure, despite not being deliberately added to the crystallisation buffer144. 
Figure 2.6A, lanes 8-13, are consistent with this and show protection of DNA despite no 
AdoMet being added to the reaction and there is a concomitant increase in labelling 
efficiency with a reduction in M.TaqI concentration (Figure 2.6B and Figure 2.6C). 
However, it also of note that the amount of protection by bound AdoMet is non-linear, in 
other words as the enzyme concentration is halved the protection does not also half. 
Therefore, at even very low concentrations of M.TaqI labelling by bound AdoMet is seen. 
This may be due to complex characteristics of the enzyme and labelling reaction. For 
instance, for other methyltransferases it has been shown that an enzyme dimer may be 
formed during labelling145 and that AdoMet may bind in different sites and in different 
conformations146. 
Previously reported methods have used incubations with oligonucleotides to remove 
this bound AdoMet144. However, the results here do not suggest this has a significant 
effect and indeed this can reduce labelling efficiency if oligonucleotides are not used 
carefully. Oligonucleotides containing the labelling site (e.g. TCGA for M.TaqI) can be 
added directly to the reaction mixture before pUC19 is added. In principle this should 
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use up all the bound AdoMet before the transalkylation reaction is carried out on pUC19, 
as M.TaqI uses the bound AdoMet to methylate the oligonucleotides.  
This does appear to prevent protection in the restriction assays when no AdoMet 
analogue is added (Figure 2.7A, lanes 1-6), and there is still significant protection when 
AdoHcy-azide is added (Figure 2.7A, lanes 7-12). However, single molecule counting 
results suggest there is no improvement in labelling efficiency. The best labelling is 
achieved when no oligonucleotides are added (Figure 2.7B and Figure 2.7C), likely due 
to labelling of the oligonucleotides in preference to the pUC19, due to the large 
concentration of labelling sites on oligonucleotides. For comparison lane 1 contains 10 
μM oligonucleotides, equivalent to 80 μM labelling sites, whilst pUC19 is at a 






Figure 2.7  M.TaqI labelling of pUC19 with AdoHcy-azide in the presence of 
oligonucleotides. A) Restriction assay for M.TaqI labelling of pUC19 with 
AdoHcy-azide and without added cofactor, in the presence of 
oligonucleotides. Lanes 1-6 = no cofactor, 2x dilution of oligonucleotides; 
lanes 7-12 = AdoHcy-azide, 2x dilution of oligonucleotides; lanes 13-18 = no 
M.TaqI, 2x dilution of oligonucleotides; lane 19 = restricted pUC19; lane 20 
= unrestricted pUC19. B) Single molecule counting results for conditions 
equivalent to lanes 7-12, but a 4x dilution of oligonucleotides starting from 
lane 8 and finishing with no oligonucleotides, followed by post-
transalkylation coupling with TAMRA-DBCO. C) Labelling efficiencies from 
counting results 
A more careful method is to incubate M.TaqI with oligonucleotides, followed by removal 
of the oligonucleotides before labelling of pUC19. This has been carried out using anion 
exchange columns after overnight incubation of M.TaqI with oligonucleotides. However 
even after overnight incubation there is still evidence of bound AdoMet present (Figure 
2.8A, lanes 1-6) and labelling efficiency is not improved (Figure 2.8C). This is in 




Figure 2.8  M.TaqI labelling of pUC19 with AdoHcy-azide after incubation with 
oligonucleotides. A) Restriction assay for M.TaqI labelling of pUC19 with 
AdoHcy-azide, AdoMet and without added cofactor, after incubation with 
oligonucleotides. Lanes 1-6 = no cofactor, 2x dilution of M.TaqI; lanes 7-12 
= AdoMet, 2x dilution of M.TaqI; lanes 13-18 = AdoHcy-azide, 2x dilution of 
M.TaqI; lane 19 = restricted pUC19; lane 20 = unrestricted pUC19. B) Single 
molecule counting results for conditions equivalent to lanes 13-18, but a 4x 
dilution of oligonucleotides starting from lane 13 and finishing with no 
oligonucleotides, followed by post-transalkylation coupling with TAMRA-
DBCO. C) Labelling efficiencies from counting results. 
Here the single molecule counting results also show that at very high enzyme 
concentrations, where there is significant protection by bound AdoMet, there are a large 
amount of plasmids with no labels (Figure 2.8B). This distribution is surprising, since it 
is not predicted by the modelling carried out previously (Figure 2.3 and Supplementary 
Figure 7.2). When modelling labelling efficiency the chance of labelling each site on the 
pUC19 was independent of the labelling of the other three sites. However here it appears 
that if one site is methylated by bound AdoMet then there is an increased probability of 
other sites being methylated.  At this point it is not clear what causes this behaviour. 
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Another method we propose to remove bound AdoMet is incubation of M.TaqI with a 
competitive inhibitor. Sinefungin, a naturally occurring competitive inhibitor of AdoMet 
(Figure 2.9A)147, was incubated with M.TaqI prior to the transalkylation reaction. Figure 
2.9B shows an example restriction assay for this reaction. In lanes 1-6 there is a 
decrease in protection by bound AdoMet at higher sinefungin concentrations, however 
importantly there is still some protection even at very high concentrations of sinefungin. 
This is unexpected, since the bound AdoMet is at a concentration of no greater than the 
M.TaqI, around 300nM, whilst the dissociation constants for AdoMet and sinefungin are 
2.0 µM and 0.34 µM respectively. Therefore, at such high concentrations of sinefungin, 
for example lane 1 contains 10 mM sinefungin, virtually all the bound AdoMet should be 
displaced by sinefungin, which is incapable of labelling pUC19. 
 
Figure 2.9 M.TaqI labelling of pUC19 with AdoHcy-azide after incubation with 
sinefungin. A) Structure of sinefungin. This is structurally similar to 
AdoMet and AdoHcy (Figure 2.5A) and is a naturally occurring competitive 
inhibitor of transalkylation by AdoMet. B) Restriction assay for M.TaqI 
labelling of pUC19 with AdoHcy-azide, AdoMet and without added cofactor, 
after incubation with sinefungin. Lanes 1-6 = no cofactor, 2x dilution of 10 
mM sinefungin; lanes 7-12 = AdoMet, 2x dilution of 10 mM sinefungin; lanes 
13-18 = AdoHcy-azide, 2x dilution of 10 mM sinefungin; lane 19 = restricted 




These results suggest removal of bound AdoMet is not straightforward and its presence 
should be taken into consideration. The non-linear protection of DNA by bound AdoMet 
may explain some of the difficulty in complete removal of bound AdoMet. Extensive 
washing and dialysis of methyltransferases as well as oligonucleotide or sinefungin 
treatments should be considered to remove as much bound AdoMet as possible148. It is 
also important to note that the concentration of M.TaqI should be minimised to reduce 
labelling by bound AdoMet, which requires optimisation of reaction conditions. 
2.2.4 Efficiency of coupling strategies and decomposition of cofactor 
In the previous section a two-step labelling scheme was used: first the DNA is 
transalkylated using M.TaqI and AdoHcy-azide; then the azide functionalised groups are 
SPAAC-coupled to a fluorophore. However, a number of alternative strategies were 
outlined in Figure 2.4, which should each be considered. For example, it has been shown 
previously that the alternative two-step labelling scheme using post-transalkylation 
amine-NHS coupling is remarkably inefficient141. This is due to competing processes 
such as hydrolysis of the NHS ester and dye decomposition.  
For amine-NHS coupling pre-transalkylation coupling of the AdoMet analogue, AdoHcy-
amine, to the NHS ester dye is a more successful strategy and showcases the extent to 
which very large synthetic groups can be transferred to DNA by M.TaqI. However, this 
approach still has a number of drawbacks, particularly the breakdown of the AdoMet 
analogue. AdoMet is well known to be unstable at high pH149, however amine-NHS 
coupling reactions require a slightly alkaline pH (7.2-9.0) to occur.  
Therefore, balancing the pH for maximum coupling but minimal degradation of the 
cofactor and NHS-ester is difficult. Various conditions were trialled for coupling. 1xPBS 
77 
 
does not buffer the mixture sufficiently, so the buffer is too acidic, (due to the formic acid 
used for cofactor storage), whilst 0.1M sodium bicarbonate, pH 8.3, is too basic and gave 
poor labelling, presumably as a result of cofactor degradation. A 10x PBS solution, pH 
7.4, at 4oC, gives the best conditions, balancing coupling and degradation of the cofactor 
and NHS-ester.  
Cofactor degradation will also continue during the transalkylation reaction and a 
balance between conditions must be struck. More acidic conditions will slow cofactor 
degradation but reduce the activity of M.TaqI. The competition between these is shown 
in Figure 2.10, where pH is varied between 5.75 and 6.75. With AdoMet as the cofactor 
the activity of M.TaqI slightly decreases with decreasing pH (lanes 7-11), however with 
the pre-transalkylation coupled cofactor, AdoHcy-Atto647N (lanes 2-6), there is an 
increase in protection with decreasing pH, until pH 5.75, where the inactivity of the 
enzyme becomes the overriding factor.  
 
Figure 2.10 Variation in protection with pH. M.TaqI labelling of pUC19 with AdoHcy-
amine coupled pre-transalkylation to Atto647N NHS Ester. Lane 1 = 2 log 
ladder; lanes 2-6 = AdoHcy-Atto647N, pH 6.75-5.75; lanes 7-11 = AdoMet, 
pH 6.75-5.75; lanes 12-16 = no M.TaqI control, pH 6.75-5.75; lanes 17/18 = 





These results can also be clearly demonstrated in single molecule counting results 
(Figure 2.11). Here just two pHs are tested: pH 5.7 and pH 7.2, corresponding to 
commercial CutSmart from New England Biolabs with Tris as the buffer system, and an 
identical buffer with MES as the buffering agent. The restriction pattern in Figure 2.11A 
indicates that protection is more complete at lower pH (lanes 2-6 compared to lanes 7-
11), and this is confirmed in the single molecule counting results (Figure 2.11B), which 
give labelling efficiencies of 35% and 26% at pH 5.7 and 7.2 respectively.  
 
Figure 2.11 Variation in labelling efficiency at pH 7.2 vs pH 5.7. M.TaqI labelling of 
pUC19 with AdoHcy-amine coupled pre-transalkylation to Atto647N NHS 
Ester. A) Restriction assay. Lane 1 = 2 log ladder; lanes 2-6 = pH 7.2, 2x 
dilution of M.TaqI; lanes 7-11 = pH 5.7, 2x dilution of M.TaqI; lanes 12/13 = 
AdoMet control, pH 7.2/5.7; lanes 14/15 = no cofactor, pH 7.2/5.7; lanes 
16/17 = no M.TaqI, pH 7.2/5.7; lanes 18/19 = restricted pUC19 , pH7.2/5.7. 
B) Single molecule counting results. Labelling at pH 7.2 (blue) and pH 5.7 
(red) with the same concentration of M.TaqI. 
SPAAC coupling to the cofactor can also be used pre-transalkylation. Here the coupling 
can be carried out at low pH in 0.05% formic acid to slow degradation of the cofactor, 
since there are no competing reactions as during amine-NHS coupling143. However, the 
same dependence on pH is seen for the pre-transalkylation reaction (Figure 2.12). 




Figure 2.12 Variation in labelling efficiency at pH 7.2 vs pH 5.7. M.TaqI labelling of 
pUC19 with AdoHcy-azide coupled pre-transalkylation to TAMRA-DBCO. 
Single molecule counting results. Labelling at pH 7.2 (blue) and pH 5.7 
(red), with the same concentration of M.TaqI. 
An alternative approach is to return to SPAAC coupling post-transalkylation. It has 
previously been shown that coupling efficiency is high and the kinetics fast141. This also 
has the advantage that coupling with AdoHcy-azide alone is not so dependent on pH 
(Figure 2.13), lanes 2-7 at both pHs show similar restriction patterns. This is either 
because the cofactor is more stable, as the side-chain introduced is not such a capable 
leaving group, or because the transalkylation reaction is faster and so the competing 
degradation of the cofactor is not as important. Single molecule counter results for this 
approach are reported in Figure 2.6-Figure 2.8. 
 
Figure 2.13 Variation in labelling efficiency at pH 7.2 vs pH 5.7. M.TaqI labelling of 
pUC19 with AdoHcy-azide. A) pH 7.2, B) pH 5.7. Lane 1 = 2 log ladder; lanes 
2-7 AdoHcy-azide, 2x dilution of M.TaqI; lane 8, unrestricted pUC19; lane 9, 
AdoMet and M.TaqI; lane 10, M.TaqI only; lane 11, AdoHcy-azide only; lane 
12, restricted pUC19. 
80 
 
The decomposition of the AdoMet analogues can be followed by HPLC81 (carried out by 
Andrew Wilkinson). Figure 2.14A shows the HPLC trace of AdoHcy-Azide over the 
course of 160 minutes, in CutSmart, pH 5.7 and 7.2 at 50oC. The peaks can be assigned to 
the cofactor (3) and its breakdown products (1, 2, 4, 5) and the area of these peaks used 
to report on the concentration of the cofactor during a typical labelling reaction. Figure 
2.14B shows that after little over an hour (around the length of a typical reaction) the 
cofactor is completely degraded at pH 7.2, but at pH 5.7 only around half of the initial 
cofactor has degraded. 
 
Figure 2.14 Decomposition of AdoHcy-azide. A) HPLC trace for breakdown of AdoHcy-
azide. Taken over 160 minutes, every 20 minutes, incubated at 50oC at pH 
5.7 or pH 7.2. Peaks can be assigned by mass spectrometry. B) 
Decomposition of AdoHcy-azide over 160 minutes at 50oC, pH 7.2 (green), 
pH 5.7 (red). HPLC experiments carried out by Andrew Wilkinson. 
These results suggest that the decomposition of the AdoMet analogues is happening 
rapidly enough to compete with the transalkylation reaction. These reactions can be 
driven to completion by a high concentration of M.TaqI, but this is undesirable due to 
labelling by bound AdoMet. However careful consideration of the labelling strategy and 
reaction conditions can be used to maximise labelling efficiency. 
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2.2.5 Reaction conditions 
It is desirable to use the minimum amount of methyltransferase, not only to reduce the 
effect of bound AdoMet, but also to reduce the cost of materials, particularly when 
labelling large quantities of DNA. In the previous section it was shown that varying the 
pH of the reaction mixture can greatly affect enzyme activity. As well as the pH there are 
a number of factors that should be considered, including the composition of the reaction 
buffer (e.g. the buffer system, types of salt, additives) and the reaction conditions (e.g. 
temperature and time). The general reaction buffer components and reaction conditions 
are shown in Table 2.1. 
 
Table 2.1 Reaction conditions for M.TaqI-directed labelling. There are two main parts 
of the reaction that should be optimised: the reaction buffer, for which the 
pH, buffer system, salts and additives should be considered; and the 
reaction conditions, in which the time and temperature of reaction should 
be considered. 
Buffers are used to keep the pH of a solution constant and are usually composed of a 
weak acid and one of its salts. They will resist changes in pH when a small amount of 
acid or base are added to a solution, by removing the added protons or hydroxide ions. 
The range of pH that a buffer is useful for is based on the pKa of the weak acid, HA, 
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where pH = pKa + log [A-]/[HA]. At the mid-point of the buffering range pH = pKa and 
[A-] = [HA], and small amounts of protons or hydroxide ions will not affect the pH. 
Ideally biological buffers should have a pKa of around 6-8 (the pH range most enzymes 
work at), a low ionic strength and be inert in the biological system, highly soluble and 
readily available. In the past inorganic buffers were used for biological systems, e.g. 
phosphate, borate, bicarbonate, however many of these buffers are not inert, for 
instance they can inhibit enzymes. So these are usually replaced by buffers developed by 
Norman Good and colleagues150–152. These remain crucial tools in biology and examples 
of these are shown in Figure 2.15. 
 
Figure 2.15 Good’s buffers. These are readily available, highly soluble buffers, which 
are commonly used as biological buffers as they have pKa values of 6-8 and 
are relatively inert. HEPES and PIPES are based on piperazine and MOPS 
and MES are based on morpholine. Here the buffers are presented in 
increasing pKa, which gives an indication of the effective pH range. 
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In the commercially available NEB Cutsmart buffer, Tris is used as the buffer, and it is 
commonly used elsewhere, since it is highly soluble, inexpensive, has a high buffer 
capacity and is generally inert. However, it has a number of drawbacks. The pKa of Tris 
is 8.06, which is at the top end of desired pH for most biological systems, and it has a 
high temperature and concentration dependence. For instance, at 25oC NEB CutSmart is 
pH 7.9, but at 50oC (the reaction temperature for M.TaqI) it is around pH 7.3. Tris is also 
a primary amine, which will couple to NHS esters and is cationic, therefore interacts 
strongly with DNA. This is known to cause problems for DNA-binding enzymes, for 
instance the restriction enzyme EcoRV is less active in Tris buffer153, and the DNA 
methyltransferase Dam is inhibited by Tris154. 
Based on this knowledge a number of Good’s buffers were trialled, to investigate the 
effect on M.TaqI (Figure 2.15). These range in pKa from 6.1 to 7.5 and therefore at 
around pH 7 will charged to different extents e.g. MES is largely anionic at pH 7 and will 
not interact with DNA. The results of these tests for M.TaqI and AdoHcy-azide, coupled 
to TAMRA pre-transalkylation are shown in Figure 2.16. There is no significant 
difference between buffers (lanes 2-5), suggesting that buffer identity does not affect 




Figure 2.16 Variation in labelling efficiency with buffer system. M.TaqI labelling of 
pUC19 with AdoHcy-azide, coupled pre-transalkylation to TAMRA. A) pH 
7.3: PIPES, MOPS, HEPES and Tris. B) pH 6.7: MES, PIPES, MOPS, HEPES. 
Lane 1 = 2 log ladder; lanes 2-5 = AdoHcy-TAMRA; lanes 6-9 = AdoMet; 
lanes 10-13 = AdoHcy-TAMRA only; lanes 14-17 = M.TaqI only; lane 18 = 
restricted pUC19; lane 19 = unrestricted pUC19.  
Another component of the labelling buffer is the identity and concentration of salt. 
Cations and anions can interact with amino acid residues and therefore affect the 
structure and function of enzymes. This hasn’t been tested in detail, however Figure 2.17 
shows an example where pH was adjusted by varying amounts of sodium hydroxide, and 
alongside this the same amount of sodium in the form of sodium chloride. As well as 
increasing protection at lower pH (lanes 2-7), as seen previously, this shows increasing 
protection at decreasing sodium concentrations (lanes 8-13). This suggests that salt 





Figure 2.17 Variation in labelling efficiency with salt concentration. M.TaqI labelling of 
pUC19 with AdoHcy-azide, coupled pre-transalkylation to TAMRA, in MES 
CutSmart, pH 5.75. Lane 1 = 2 log ladder; lanes 2-7 = AdoHcy-TAMRA, 2x 
dilution of NaOH, lane 2 = 10mM NaOH, ~pH 6.5; lanes 8-13 = AdoHcy-
TAMRA, 2x dilution of NaCl, lane 8 = 10mM NaCl; lane14 = restricted pUC19; 
lane 15 = AdoMet control; lane 16 = no cofactor control; lane 17 = no M.TaqI 
control; lane 18 = unrestricted pUC19. 
The final part of the reaction buffer are the additives. These are generally added to 
stabilise and increase the activity of enzymes, for instance BSA is added to CutSmart for 
these reasons and to prevent dilute protein solutions degrading or binding to the 
reaction tube. Other additives can be used such as: DTT, to reduce disulphide bonds that 
form between cysteine residues (e.g. Grunwald et al155); a surfactant, such as Triton X-
100, to prevent protein aggregation; or EDTA, to chelate multivalent cations. In the 
reactions carried out here DMSO is commonly added to improve solubility of dyes, 
which are generally poorly soluble in aqueous solution. 
As well as the reaction buffer, the reaction conditions should be carefully controlled to 
optimise the reaction. For example, M.TaqI has a maximum efficiency at 65oC and only 
around a quarter as much activity at 37oC. However, the cofactor will decompose faster 
at higher temperatures, so a balance is necessary. Figure 2.18 shows that in an hour the 
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reaction does not go to completion at 30-40oC (lanes 7 and 8), but is complete at 50oC 
(lane 9), the temperature that has been used for all other reactions. 
 
Figure 2.18 Variation in labelling efficiency with temperature. M.TaqI labelling of 
pUC19 with AdoHcy-azide. Lane 1 = 2 log ladder; lanes 2-6 = AdoMet, 30-
70oC; lanes 7-11 = AdoHcy-azide, 30-70oC; lanes 12-16 = no cofactor, 30-
70oC; lane 17 = restricted pUC19; lane 18 = unrestricted pUC19. 
The time the reaction takes depends on how rapidly the transalkylation occurs. This is 
shown in Figure 2.19, which shows when AdoMet is used, at high M.TaqI concentrations, 
the reaction is very rapid and complete protection is seen within 5 minutes (lanes 2-6). 
In contrast the AdoHcy-azide reaction is not complete until around 40 minutes (lanes 7-
11), which is on the same timescale as cofactor decomposition (Figure 2.14) and why 




Figure 2.19 Variation in labelling efficiency with time of reaction. M.TaqI labelling of 
pUC19 with AdoHcy-azide. Lane 1 = 2 log ladder; lanes 2-6 = AdoMet, 5-60 
minutes; lanes 7-11 = AdoHcy-azide, 5-60 minutes; lanes 12-16 = no 
cofactor, 5-60 minutes; lane 17 = restricted pUC19; lane 18 = unrestricted 
pUC19. 
The reaction conditions can also be controlled to reduce the effect of cofactor 
decomposition. For example, AdoHcy is one of the decomposition products, will also be 
generated as a by-product during labelling, and is known to inhibit methyltransferases. 
Therefore, removal of AdoHcy should result in an increased rate of reaction and a 
reduced concentration of M.TaqI should be required. AdoHcy hydrolase is an enzyme 
which catalyses the hydrolysis of AdoHcy to adenosine and homocysteine, effectively 
removing AdoHcy from the reaction mixture (Figure 2.20A). At low methyltransferase 
concentrations where inhibition by AdoHcy is important, this can be used to increase the 




Figure 2.20 Effect of AdoHcy hydrolase. A) General reaction scheme. 
Methyltransferases use AdoMet for labelling of DNA, but the product, 
AdoHcy inhibits this reaction. AdoHcy Hydrolase removes AdoHcy by 
hydrolysis to adenosine and homocysteine. B) Variation in labelling 
efficiency with concentration of AdoHcy Hydrolase.  M.TaqI labelling of 
pUC19 with AdoHcy-amine. Lane 1 = 2 log ladder; lanes 2-8 = AdoHcy-
amine, 2x dilution of AdoHcy Hydrolase; lanes 9, 11, 13 unrestricted pUC19, 
5-60 minutes; lane 10 = AdoMet control; lane 12 = no cofactor control; lane 
14 = restricted pUC19. 
2.2.6 Cofactor and dye purity and choice 
A range of factors which affect the rate of reaction have been discussed. By reducing the 
required methyltransferase concentration, the amount of labelling by bound AdoMet, 
which results in discrepancies between restriction assays and single molecule counting 
experiment, can be reduced to a minimum. However, the purity of the dye and cofactor 
can also lead to differences in restriction assay and single molecule counting results. If 
the correct reactive chemical moiety is not transferred to the DNA and there is no 
fluorescent dye, then the DNA may be protected but no fluorophore will be counted.  
The AdoHcy-azide cofactor is 61% pure, after storage at -20oC for two months, as 
determined by Mass spectrometry following HPLC (Figure 2.21A, carried out by Andrew 
Wilkinson). However, it is important to note that although some of the breakdown 
products will slow the reaction (for instance AdoHcy, peak 2) by inhibiting M.TaqI none 
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of the breakdown products are AdoMet analogues and therefore none should lead to 
protection of DNA by methyltransferases. This is therefore not expected to be a major 
contribution to the discrepancy between the restriction assays and single molecule 
counting results. 
The DBCO-TAMRA dye used in all SPAAC coupling reactions thus far is purchased 
commercially and is around 94% pure by HPLC (Figure 2.21B). The two major peaks can 
be attributed to the two isomers supplied. However, this does not report on how much 
of the dye is fluorescent, which is an important consideration. If a fluorophore is in a 
dark state, e.g. photobleached, oxidised or quenched, then it will not be counted in single 
molecule counting experiments and this will reduce the apparent labelling efficiency.  
For example the photophysical properties of TAMRA are known to be affected when 
conjugated to DNA and other biomolecules156,157. TAMRA is hydrophobic and therefore 
tends to aggregate in aqueous solutions at high concentrations, for instance when local 
concentration is increased by labelling of the same biomolecule. These dye-dye 
interactions can lead to fluorescence self-quenching but also a splitting of the normal 
absorption peak at around 550 nm to obtain an additional peak at 520nm. These kinds 
of effects may reduce the apparent labelling efficiency, even if DNA has been labelled 





Figure 2.21 HPLC traces to test purity of cofactor and dye. A) HPLC of AdoHcy-azide 
after 2 months @-20oC, 61% pure. The major peak is the AdoHcy-azide 
cofactor (3), however decomposition has occurred, primarily via loss of the 
amino acid (6). AdoHcy is only a minor product (2). B) HPLC of TAMRA-
DBCO, 94% pure. Two major peaks are seen, corresponding to the two 
isomers. 
To consider these effects several different commercial dyes have been tested, the 
structures of which are given in Figure 2.22A. Here TAMRA can be directly compared to 
two alternative DBCO dyes, Texas Red and Cy5.5 and to Atto647N and Atto565 which 
were NHS esters coupled via an amine-DBCO intermediate. Single molecule counting 
results are given in Figure 2.22B and Figure 2.22C, for azide-modified and unmodified 






Figure 2.22 Single molecule counting results for different commercial dyes. All were 
coupled post-transalkylation. pUC19 was unlabelled or labelled with 
M.TaqI and AdoHcy-azide. A) Structures of commercial dyes, Atto647N NHS 
Ester*, Atto565 NHS Ester, TAMRA DBCO, Texas Red DBCO and Cy5.5 DBCO. 
B) Labelling efficiencies for each dye, unlabelled and labelled pUC19 and 
the difference. C) Single molecule counting results for each dye, unlabelled 
and labelled pUC19. *Full structure not available from supplier but with 
perchlorate ion this would fit molecular weight. 
Cy5.5 is an anionic dye and gives no labelling141, whilst Atto647N is cationic and shows 
an especially large degree of non-specific labelling, i.e. labelling of unmodified DNA. Of 
the neutral dyes Atto565 gives the poorest labelling, due to either the purity of the dye 
(only given as ≥70% by the manufacturer) or the extra coupling step. Texas Red gives 
the best labelling but is within the range of results seen previously for TAMRA. The 
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degree of photobleaching or quenching is difficult to speculate on, however it is clear 
from these results that the choice and condition of the dye is important to achieve the 
maximum apparent labelling efficiency. 
2.2.7 Other methyltransferases 
In the literature there several different enzymes that have been used for 
methyltransferase-directed labelling of DNA, showing the flexibility of this labelling 
approach. Various sequence specificities are available to give different labelling 
densities, which may be useful for different applications. The results above are all for 
M.TaqI, which has proved particularly robust for this application, possibly due to the 
nature of the cofactor binding site and the high pH and temperature tolerance inherent 
to the enzyme. However, other enzymes will have different optimum reaction conditions 
and may favour different labelling strategies (e.g. different cofactors). 
Here two alternative methyltransferases have been used to fluorescently label DNA: 
M.HhaI (5’-GCGC-3’) and M.MpeI (5’-CG-3’). The main characteristic of these enzymes is 
that they will label DNA with different densities. For example, for pUC19 there are only 
four M.TaqI sites, but 17 M.HhaI and 173 M.MpeI sites.  
Restriction assays are shown for M.HhaI and M.MpeI in Figure 2.23 and show that 
labelling is incomplete. For commercially available M.HhaI there is negligible activity. 
This is consistent with the literature, since it has been reported that mutations of the 
binding site are required to activate the enzyme for transfer of extended groups90. 
M.MpeI protection by AdoHcy-azide appears to be complete, however there appears to 
be a large amount of bound AdoMet present. Here the number of sites is very large, 
which will make full protection difficult if it is not optimised. 
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Single molecule counting experiments can be used to support these results. There is no 
non-specific labelling for dye coupling, post-transalkylation, with TAMRA and the 
number of labels directed by M.HhaI is insignificant. When compared to M.TaqI there 
should be ~60x more labels for M.MpeI, however this is not seen. Labelling density is 
only marginally increased for M.MpeI when compared to M.TaqI, suggesting that 
labelling efficiency is low. 
 
Figure 2.23 Restriction assays for alternative methyltransferases: A) M.HhaI and B) 
M.MpeI. Lane 1 = 2 log ladder; lanes 2-7 = AdoHcy-azide, 2x dilution of 
methyltransferases; lanes 8-13 = no AdoHcy-azide, 2x dilution of 
methyltransferases; lane 14 = AdoMet control; lane 15 = no cofactor 
control; lane 16 = 9, 11, 13 unrestricted pUC19, 5-60 minutes; lane 10 = 




Figure 2.24 Single molecule counting results for alternative methyltransferases. pUC19 
was labelled with AdoHcy-azide and coupled post-transalkylation to 
TAMRA-DBCO using: No methyltransferase, M.TaqI (four 5’-TCGA-3’ sites), 
M.HhaI (seventeen 5’-GCGC-3’ sites) and M.MpeI (173 5’-CG-3’ sites). 
2.2.8 Reliability of single molecule counting 
Single molecule photobleaching experiments have been used in a variety of systems to 
calculate labelling efficiency158–160. A range of labelling efficiencies has been reported, 
commonly around 70% for labelling of biomolecules using coupling strategies like those 
discussed here. However, the experimental limitations are generally not discussed in 
detail, although it is known that noise, high numbers of fluorophores and simultaneous 
bleaching events can all lead to underestimation in single molecule counting 
experiments161. When a brightly, but sparsely, labelled molecule bleaches we expect to 
see several bleaching steps, from which the number of fluorescent labels can be 
determined (Figure 2.2). However, consider an example intensity trace for a single 
molecule labelled by M.MpeI (Figure 2.25B). The brightness and number of fluorescent 
labels makes it difficult to reliably determine individual bleaching steps. 
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These problems are illustrated in Figure 2.25A. There is a rapid bleaching event at the 
beginning of illumination, followed by blinking of the molecule as fluorophores begin 
emitting once more, with relatively high noise. If bleaching is too rapid it is not possible 
to count the number of individual bleaching events, also a fluorophore that is in a dark 
state initially, but then emits later in the time trace will not be included in the counting 
results. Along with incomplete bleaching, these effects will lead to an underestimate in 
the number of fluorophores. There is also an issue with cumulative noise in the 
bleaching approach, since any incorrectly identified events will affect the rest of the 
bleaching movie.  
These problems demonstrate how counting results will be unreliable for large numbers 
of labels. However, a comparison can still be made based on the initial intensity. For 
example, the intensity of M.MpeI-labelled pUC19 molecules should be ~50x that of 
M.TaqI-labelled molecules, however this is not the case. See for example the trace in 
Figure 2.25B for an M.MpeI-labelled pUC19 molecule, which starts at an intensity of 
around 16,000, and compare this to a trace for M.TaqI labelling in Figure 2.26A, which 
was recorded using similar laser intensity and gain, and begins at an intensity of around 
8,000. These are typical results and reflect the incomplete protection from the 




Figure 2.25 Single molecule counting limitations. A) Schematic of issues in single 
molecule intensity time traces. This shows rapid and simultaneous 
bleaching events, noise and blinking events, which can all lead to problems 
when estimating the number of fluorophores. B) An example intensity trace 
for M.MpeI-directed TAMRA-labelled pUC19. Here the limitations can 
clearly be seen, and it is difficult to reliably identify bleaching steps (blue 
dashed lines). However, the initial intensity does give an indication of the 
number of fluorophores. 
Example traces for single molecules, for the results in Figure 2.22, are shown below 
(Figure 2.26). Each of these traces displays the rapid bleaching and blinking 
characteristics that will lead to an underestimate of the number of labels. TAMRA and 
Texas red in particular have lower signal to noise, therefore a relatively high laser 
intensity is needed, and they are rapidly bleached in these experiments. This could 
suggest that the difference between the dyes may be due to errors in counting, rather 
than differences in the inherent labelling efficiency. These problems are the main 
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limitations with single molecule counting approaches to assess labelling efficiency, 
however the apparent efficiency is still relevant when assessing the quality of labelling 
for optical mapping. 
 
Figure 2.26 Intensity traces for single pUC19 molecules, labelled with AdoHcy by 
M.TaqI and coupled post-transalkylation with: A) TAMRA, B) Texas Red and 
C) Atto 647N. Each of these display similar characteristics: rapid 
simultaneous bleaching events at the beginning of the trace, followed by 
transient blinking events. TAMRA and Texas Red also have a large amount 
of noise in the traces. All these make estimation of the number of 
fluorophores difficult. 
Experimentally it is also important to consider incomplete bleaching if photostable dyes 
are used, although this is not usually a problem for the dyes used here (e.g. Figure 2.26). 
Incomplete bleaching can be caused by low laser power, or alternatively a time trace 
that is too short. Supplementary Figure 7.4 shows that if care is taken to completely 




In CHAPTER 2 several factors have been considered to optimise methyltransferase 
labelling by synthetic AdoMet analogues. These factors have been discussed in detail for 
fluorescent labelling by M.TaqI, with applications for optical mapping and imaging DNA. 
However, these results will be broadly applicable to other labelling strategies, other 
methyltransferases and synthetic groups. 
When labelling with methyltransferases it is important to consider the efficiency of each 
step of the reaction, as one would during any synthesis. The factors that influence 
labelling efficiency are shown in Figure 2.27A and include: 1) the purity of the starting 
materials including the cofactor and dye; 2) the yield of the coupling reaction; 3) the 
yield of the labelling reaction, including labelling by bound AdoMet and factors which 
can inhibit labelling; and 4) the imaging experiment, including factors which will lead to 
non-photoactive dye. 
Since the research for this thesis was completed, results have been obtained by the 
Neely group that have shed further light upon the discrepancy between the restriction 
assays and single molecule counting results and provide more robust evidence for steps 
1-3. Andrew Wilkinson labelled hairpin oligonucleotides 60 bp in length, which 
contained one TaqI site. The oligonucleotides were run on HPLC before labelling; after 
labelling with the cofactor; and after labelling with TAMRA. 
One relatively broad peak in the HPLC trace is obtained for pure, unlabelled DNA. 
Labelled DNA splits into two peaks of equal size, attributable to each DNA with either 
one or two labels. There are no other significant peaks, in particular no peak that can be 
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attributed to DNA labelled by bound SAM. This demonstrates a labelling yield (step 3) of 
around 75%.  When the dye is coupled to the DNA there are still only two peaks 
obtained, meaning the yield of the coupling reaction (step 2) is greater than 90%. This 
evidence means that if labelling is carefully performed, greater than 75% efficiency for 
steps 1-3 can be achieved. However, for imaging experiments (step 4) the number of 
labels that are actually fluorescent will be limiting, as discussed in sections 2.2.6 and 
2.2.8. 
Regardless, fluorescent labelling efficiency approaching 50% has been demonstrated. 
The contribution of each step to this final efficiency is illustrated in Figure 2.27B. Steps 
1-3 have been carefully optimised to achieve maximum efficiency (80% or greater), 
although it should be noted that a decrease in efficiency at any step can have a large 
effect on the overall labelling efficiency.  
Step 4 appears limiting and is more relevant to the use of methyltransferase labelling for 
optical mapping. It appears that there is a large amount of dye molecules that are not 
fluorescent, although it is hard to speculate on the reasons for this. Therefore, 
alternative dyes should be tested to obtain the highest fluorescent labelling efficiency 
possible.  
These results also demonstrate that simple restriction assays or HPLC experiments do 
not give a complete picture of fluorescent labelling and alternative methods, such as 
single molecule counting, should be used to give a more accurate measure of labelling 





Figure 2.27  Overview of factors influencing labelling efficiency during fluorescent 
labelling of DNA by methyltransferases. A) Schematic illustrating the steps 
that must be considered to maximise labelling efficiency. B) Efficiencies of 
each step are estimated based on results and discussion as referenced. 
Overall, high labelling efficiency can be achieved for steps 1-3, but during 
step 4 there is a large decrease in efficiency due to non-photoactive dye 
(e.g. quenched or bleached) 
101 
 
As well as providing a fluorescent labelling efficiency  that is sufficient for optical 
mapping (see CHAPTER 3 and CHAPTER 4) and localisation of plasmids (see CHAPTER 
5), these results should represent an important step towards broadening the application 




2.4 Materials and Methods 
2.4.1 AdoMet analogues and Enzymes 
AdoMet-azide (50 mM, in 0.1% formic acid) was provided by Andrew Wilkinson. 
AdoHcy-amine (15 mM, 0.1% formic acid), AdoCys-amine (8.1 mM, 0.1% formic acid) 
and AdoCys-azide (55 mM, 0.1% formic acid) were provided by Volker Leen’s group, KU 
Leuven. They were prepared by methods as described by Lukinavičius et al.81 
M.TaqI (0.3 mg/ml) was provided by Ashleigh Rushton and M.MpeI (10 mg/ml) 
provided by Su Wang. Both were expressed, purified and stored based on standard 
techniques. M.HhaI was purchased from New England Biolabs (NEB). 
2.4.2 Restriction assays 
Full details of the conditions for each restriction assay are given in the Appendix, section 
7.2. A typical 10 µl lane would be prepared as follows: A 10 µl solution containing 1x 
CutSmart (NEB), 500 ng pUC19 (NEB), 0.15 µg M.TaqI and 320 µM AdoMet (NEB) is 
incubated at 50oC for 1 hour. 0.5 µl R.TaqI (20,000 units/ml, NEB) is added and the 
sample is incubated at 65oC for 1 hour followed by addition of 0.5 µl 18 mg/ml 
Proteinase K (NEB)/0.1% Triton X-100 (Sigma-Aldrich) and incubation at 50oC for 1 
hour. 2 µl 6x purple loading dye (NEB) is added and the sample is run by gel 
electrophoresis followed by post-staining by gel red (Cambridge BioScience) and 
visualisation. 
2.4.3 Single Molecule Counting – Labelling conditions 
Full details of the conditions for each counting experiment are given in the Appendix, 
section 7.2. A typical 40 µl reaction would be carried out as follows. A 40 µl solution 
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containing 1x CutSmart, 2 µg pUC19, 0.6 µg M.TaqI and 750 µM AdoMet-azide is 
incubated at 50oC for 1 hour. 2 µl 20 mg/ml proteinase K is added and incubated at 50oC 
for 1 hour, before purification by GenElute PCR Clean-up kit (Sigma-Aldrich) and elution 
into 50 µl 1xTE (Sigma-Aldrich). 10 µl DMSO (Sigma-Aldrich) and 0.3 µl 50 mM TAMRA-
DBCO (Jena Bioscience) are added and incubated at room temperature for 1 hour, before 
purification by GenElute PCR Clean-up kit and elution into 50 µl 1xTE. 
2.4.4 Single Molecule Counting – Imaging conditions 
For imaging, a 50 μl mixture of 50% DMSO, 0.5xTE, 0.2 μM YOYO-1 and ~5 ng DNA was 
incubated at 37oC for 30 minutes. 450 μl 1xTE was added and 100 μl was placed on poly-
l-lysine coated coverslips for ~30 seconds. Subsequently, the sample was washed with 3 
ml molecular grade water and dried. Samples were imaged using an Olympus IX81 
inverted widefield/epifluorescent/TIRF microscope equipped with 491, 560, 640 lasers, 




CHAPTER 3 OPTICAL MAPPING FOR IDENTIFICATION OF 
COMPLEX MIXTURES OF VIRAL AND BACTERIAL DNA – IN 
SILICO GENERATION AND ALIGNMENT OF DNA FRAGMENTS 
Robert K. Neely and Iain B. Styles provided supervision and guidance for the research 
undertaken in this chapter. Nathaniel O. Wand (the author) designed, performed and 
analysed all labelling experiments including optical mapping experiments.  Nathaniel O. 
Wand (the author) also developed and performed all extraction and alignment 
procedures unless otherwise stated. 
3.1 Introduction 
3.1.1 Identification of microorganisms 
The rapid identification of microorganisms is critical for samples ranging from water162 
or soil163, to clinical samples such as blood or urine164. One application is the rapid 
diagnosis of infections, which can help inform appropriate antibiotic therapy111. Current 
molecular diagnostics can take around two days, as bacteria are cultivated and then 
identified. Meanwhile, the patient is treated based on empirical observations and the 
likely pathogens, which leads to ineffective treatment and inappropriate use of 
antibiotics. Antibiotic resistance is now one of the greatest public health threats and by 
2050 it has been estimated that the societal and financial cost, if not tackled, will be 
US$100 trillion109.  
Various methods have been employed to accelerate diagnosis without cultivation. DNA 
hybridisation techniques, (e.g. PCR, DNA microarrays), can identify specific pathogens or 
resistance genes. This is useful for following outbreaks or for common pathogens but 
will not allow for comprehensive screening since hybridisation techniques rely on 
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known targets. In contrast, DNA sequencing techniques (e.g. NGS, SMRT sequencing) can 
be used to recognise all pathogens. However, most high-throughput, low-cost 
technologies use short sequence reads, which lack the contextual information required 
to easily assemble large genomes, making the task of identifying pathogens non-trivial. 
The base-pair resolution offered by sequencing is not necessary for the unique 
identification of pathogens. For example, restriction enzymes have been used since the 
1970s to identify and map viral genomes21, exploiting the natural sequence-specificity of 
enzymes. More recently, optical mapping of DNA has been demonstrated, using 
enzymatic and affinity-based approaches to generate unique fluorescent patterns for 
DNA identification. Optical mapping is a complementary technique to sequencing, as it 
provides long-range contextual information that can be used to rapidly identify both 
complex mixtures of DNA and large-scale genomic variations.  
3.1.2 Optical mapping of DNA 
Optical mapping of DNA fits into several broad categories: mapping in nanofluidic 
devices or by molecular combing; and sequence labelling by affinity or enzymatic 
approaches. A summary of each of these approaches, including examples, is given in 




Figure 3.1 Overview of optical mapping for DNA identification. Optical mapping of 
DNA is split into several broad categories: mapping in nanofluidic devices 
or by molecular combing; and sequence labelling by affinity or enzymatic 
approaches. There are many examples available for these techniques, of 
which various publications are highlighted (and cited in the main text).  
In nanofluidic devices DNA molecules are introduced to channels which have a diameter 
of the order of the persistence length of DNA (~50nm). DNA will be confined in the 
channels and extended to a length proportional to the length of the molecule. The main 
advantage of these devices is their flexibility and ease of use to image individual 
stretched DNA molecules. However, the thermal motion of DNA means the fluorescence 
pattern is blurred during imaging. This must be corrected by recording movies and 




An alternative approach is to the deposition, linearization and fixation of DNA on a 
surface. This is generally achieved by molecular combing. At around pH 6, DNA will bind 
strongly and specifically to hydrophobic or cationic surfaces at its extremities55. 
Therefore, a receding meniscus can be used to uniformly stretch DNA across the surface. 
The main advantage over nanofluidic devices is that the DNA is fixed, enabling more 
straight-forward high-throughput or super-resolution imaging. However, if there are 
any sheared DNA molecules, or other impurities, in the sample then they will also be 
deposited on the surface which can make extracting the length and fluorescent pattern 
along individual DNA molecules impossible. 
To generate a fluorescent pattern, enzymatic or affinity-based approaches have been 
used. The earliest optical mapping approaches were based on restriction enzymes, and 
these are still commonly used. Typically, these methods use molecular combing to 
deposit DNA on a surface, before digestion at specific sequences, producing an ordered 
restriction map up to several megabases in length. These have been used extensively on 
large genomes, particularly as a scaffold for de novo genome assembly and gap 
filling48,167,168. However, the low density of restriction sites used for mapping means 
large DNA molecules are required for reliable assignment to a reference. It is slow and 
difficult to extract large DNA fragments169 which has made the identification of 
microorganisms challenging, although maps for several prokaryotes have been 
reported170–172. Restriction mapping has also been applied in microfluidic devices on 
lambda DNA52, but the information content  (i.e. the number and size of fragments) is 
too low for reliable identification of short genomes. 
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Affinity-based approaches have been used as an alternative to map shorter genomes. 
Typically, in these approaches the difference in hydrogen bonding between AT and GC 
base pairs is used to generate a unique pattern, either by exploiting the difference in 
melting temperature or by binding to a molecule that competes with a DNA stain. These 
methods have far denser labelling than restriction mapping and have been exploited to 
map viral genomes53,59,60, resistance plasmids61,62 and bacterial genomes63. However, the 
information content (i.e. the number of peaks and valleys) in these approaches is 
relatively low, which can make unambiguous assignment difficult. It is also difficult to 
use such approaches for molecular combing since the dyes are not covalently bound. 
An alternative approach which covalently labels DNA and has an intermediate labelling 
density is to use enzymatic labelling. These approaches include labelling with nicking 
enzymes, which produce breaks in a single strand of the double-stranded DNA, at 
specific sites. DNA at these sites can be extended with fluorescently-labelled nucleotides 
for visualisation. This approach has been used to map viral genomes65,67,173 and BACs, to 
aid genome assembly46,47,66. The main limitations with this approach are the labelling of 
non-specific and naturally occurring nicks and the fragmentation of DNA when two 
nicks are close together. 
These limitations are avoided by using methyltransferase-directed labelling. DNA 
methyltransferases and restriction enzymes together form the restriction-modification 
system in bacteria, of which thousands of examples are now known71.  
Methyltransferases can be used to covalently transfer complex chemical groups, such as 
fluorophores and other modifications, to specific sites in a DNA sequence86. The labelling 
density is variable, depending on the target site, typically 2 to 8 base pairs in length, 
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which spans the labelling densities available for other approaches. This labelling has 
been used in both nanofluidic devices and with molecular combing, to identify viral 
genomes69,83,93. No commercial kit is currently available for methyltransferase-directed 
labelling of DNA. However, this approach was used and developed in CHAPTER 2 and 
can therefore be used in this research. 
3.1.3 Procedures for matching DNA 
Alongside experimental techniques for optical mapping, automated procedures for 
aligning and identifying DNA molecules have been developed. The procedures that have 
been reported vary depending on the labelling density and length of DNA fragments. An 
excellent review of computational methods used for low density labelling methods (e.g. 
restriction mapping, nicking enzymes) is given by Mendelowitz and Pop174. 
The type of data given by low density labelling methods is an ordered set of fragment 
lengths, estimated by imaging DNA fragments and automated processing (Figure 3.2). 
This data commonly contains a number of errors, such as sizing errors and missing or 
extra restriction sites or fragments. Also, this data will only span individual DNA 
molecules, so if they originate from a larger genome they must be assembled and 





Figure 3.2 Data generated by optical restriction mapping. Taken from Mendelowitz 
and Pop174. a) DNA samples are deposited onto coated glass surfaces and 
stained for visualisation. b) Restriction enzymes are used to digest the DNA 
at specific sites. c) Fragments are automatically extracted, and sizes 
estimated. d) An ordered set of fragment lengths is generated for each 
molecule. 
The exact alignment procedure will also depend on the problem. If there is already a 
consensus map (e.g. for known, sequenced genomes) then individual maps can be 
aligned to the consensus map. This can be used for identification of pathogens or 
investigations of large scale structural variations, for instance to aid assembly of genome 
sequences. Alternatively, if the sequence is unknown then individual maps must be 
aligned to each other, to produce a de novo consensus map. If a consensus map is 
generated this can be used to identify genomes more rapidly, since only the consensus 
map must be identified, rather than many inaccurate individual maps.  
Dynamic programming algorithms are usually used for alignment since they can 
accommodate missing and false restriction sites and missing fragments. The alignment 
scoring functions used can also allow for small sizing errors. Dynamic programming 
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algorithms are usually based on the Smith-Waterman algorithm175,176. In this algorithm 
two strings are compared, in this case a list of segments (e.g. distance between 
restriction sites), by matching each segment from the optical map to each segment of the 
reference. 
An example is shown in Figure 3.3. The first segment of the optical map (Xi where i=1) is 
compared to all segments of the reference map (Yj for j=1 to 9) and a score is given 
depending on the quality of the match (e.g. the similarity in length) and stored in a 
matrix. Next the second fragment (X2) is compared to all segments of the reference map 
(Yj for j=1 to 9) and scored based on the quality of its match, but also the quality of the 
match between Xi-1 and Yj-1, i.e. the previous segments. This is continued for all segments 
and the alignment of the DNA fragment becomes clear along the diagonal of the scoring 
matrix. The score of the last segment of the optical map is the final alignment score of 
the map and the highest score can be used to find the diagonal path through the matrix.  
The Smith-Waterman algorithm has been modified to take in to account false restriction 
or missing restriction by the possibility of combining two or more segments at 
each175,176. 
Approaches for higher density labelling methods (e.g. affinity-based, 
methyltransferases) can use Dynamic programming algorithms if the position of labels 
can be localised (Figure 3.4B). For instance, by photobleaching the fluorophores the 
position of individual emitters can be estimated, based on the stochastic nature of this 
bleaching. However this type of localisation usually requires DNA fragments to be fixed 
to a surface, for instance via molecular combing, since time-lapses are required for the 
localisation procedure93. However, if labelling is more sparse and conditions are 
112 
 
carefully controlled then localisation can be achieved in nanofluidic devices96. The main 
drawback with localisation is the relatively long acquisition time and the processing 
required for localisation, which both reduce throughput. 
 
Figure 3.3 The Smith-Waterman algorithm for alignment of restriction maps. Every 
segment of an optical map (X1-X7) is compared to every segment of a 
reference map (Y1-Y9). The first segment (X1) is compared to all segments of 
the reference map (Y1-Y9) and a score is given depending on the quality of 
the match (e.g. the similarity in length) and stored in a matrix. Next the 
second fragment (X2) is compared to all segments of the reference map (Y1-
Y9) and scored based on the quality of its match, but also the quality of the 
match between Xi-1 and Yj-1, i.e. the previous segments. Two or more 
segments can be combined for comparisons, for example if a restriction site 
is missing (red) or a false restriction site is present (blue). The score of the 
last segment of the optical map is the final alignment score of the map and 
the highest score can be used to find the diagonal path through the matrix 




To increase throughput, alignment procedures that do not require localisation can be 
used, and these typically use intensity profiles automatically extracted along DNA 
molecules51,83 (Figure 3.4A). These are then matched by assessing the overlap between a 
reference signal and the intensity profile, typically using cross-correlation. The 
reliability of alignment by cross correlation will depend on the characteristics of the 
profiles. For instance bright regions in a signal are a known problem for cross 
correlation, as a high score will be recorded when two bright signals are aligned, despite 
other parts of the profile being misaligned177. 
 
Figure 3.4 Data for alignment of densely-labelled DNA fragments. Shown here is an 
image of M.TaqI-directed, Atto647N-labelled T7 phage DNA, combed onto a 
modified surface (image from Robert Neely). A) The intensity profile can be 
extracted along individual DNA molecules. For example, the intensity of the 
zoomed molecule (highlighted in red) is shown. This can be aligned by 
convolution or cross-correlation with a reference intensity profile. B) 
Alternatively, individual labels can be localised, for instance by 
photobleaching. The localisation of fluorophores along the same molecule 
is shown. Localisations can be used in conjunction with Smith-Waterman 




In this thesis, optical mapping using methyltransferase-directed labelling and molecular 
combing will be used to identify microorganisms. This combination is well suited to 
rapid identification of pathogens, since it is high-throughput and can be used for 
intermediate labelling density, which is suitable for reliable identification of 
microorganisms. Intensity profiles will be used rather than localisations for alignment, 
as throughput will be higher. 
In CHAPTER 3 the methyltransferase-directed fluorescent labelling (based on 
optimisation carried out in CHAPTER 2), and combing of DNA fragments will be 
discussed. This will be followed by detailed in silico generation and alignment of 
intensity profiles to test the effect of various experimental parameters and for 




3.2 Results and discussion 
3.2.1 Methyltransferase-directed labelling and deposition of genomic DNA 
A two-step labelling scheme is used for methyltransferase-directed labelling of DNA: 
first the DNA is transalkylated using M.TaqI and an AdoMet analogue (AdoHcy-azide); 
then the azide functionalised groups are coupled to a fluorophore using strain-promoted 
azide-alkyne cycloaddition (SPAAC). This method was optimised for pUC19 in CHAPTER 
2. 
A restriction assay can be used to show the concentration of M.TaqI required for 
complete labelling. Figure 3.5 shows a restriction assay for T7 bacteriophage genomic 
DNA (henceforth referred to as ‘T7’). pUC19 has one TaqI site every 672 bp, whilst T7 
has one TaqI site every 360 bp, therefore a higher concentration of M.TaqI is required to 
fully protect T7. This is also seen for bacterial genomic DNA which has on average one 
TaqI site every 325 bp (Supplementary Figure 7.5). A completely random genome will 





Figure 3.5  Restriction assay for T7 bacteriophage DNA. A) Map of T7 DNA. It is 
approximately 40kbp in length and contains 111 TaqI sites (1 every 
360bp). B) Restriction assay for M.TaqI labelling of T7 DNA with AdoHcy-
azide and without added cofactor. Lane 1, 2 log ladder; lanes 2-7, AdoHcy-
azide, 2x dilution of M.TaqI; lanes 8-13, no cofactor, 2x dilution of M.TaqI; 
lane 14, AdoMet control; lane 15, no cofactor control; lane 16, no M.TaqI 
control; lane 17, restricted pUC19; lane 18, unrestricted pUC19. 
DNA molecular combing was carried out as described by Deen et al57, with the exception 
that 100 mM sodium phosphate pH 5.7/5% DMSO was used as the buffer. The combing 
buffer was modified to include sodium cations, which have been shown to help combing 
efficiency56, whilst DMSO was added to improve dye solubility and prevent DNA 
secondary structure formation.  
Ideal deposition of DNA would leave uniformly-stretched, well-spaced, straight, 
individual molecules. A good example of experimental deposition is shown in Figure 3.6. 
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Molecules are uniformly-stretched to around 1.52 times the crystallographic length 
(Supplementary Figure 7.6) and only have a slight curve, which is only problematic 
when extracting intensity profiles of larger molecules. However, deposition of single 
DNA molecules at reasonable densities is not straightforward. This has not been tested 
systematically here, although the factors that affect deposition have been described in 
great detail elsewhere54–56.   
 
Figure 3.6 Typical DNA deposition. 100pg/µl M.TaqI-directed Atto647N-labelled T7 
DNA is combed at 20mm/min, in 100mM sodium phosphate pH 5.7/5% 
DMSO, onto zeonex-covered glass cover slips. A stitched image of several 
frames is shown along with a zoom that shows individual DNA molecules. In 
ideal combing experiments individual DNA molecules are well spaced, 
uniformly stretched, and straight. 
Most crucial is the concentration and deposition speed (the speed at which the meniscus 
is moved across the surface). High concentrations or slow deposition speeds can cause 
DNA fibre formation (Supplementary Figure 7.7 and Figure 3.7), which means individual 
molecules are difficult to extract. It can be impossible to distinguish overlapping DNA 
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molecules, which will prevent proper extraction of intensity profiles and affect 
subsequent alignment (Figure 3.7A). On the other hand, low deposition density will 
lower the throughput of the experiment (Figure 3.7C), so a balance must be struck 
(Figure 3.7B).  
 
Figure 3.7 Effect of concentration on DNA deposition. M.TaqI-directed Atto647N-
labelled T7 or lambda DNA is combed at 20mm/min, in 20mM MES pH5.7, 
2.7M NaCl, onto zeonex-covered glass cover slips. A stitched image of 
several frames is shown along with a zoom that shows individual DNA 
molecules. A) High density of deposition, ~1ng/µl labelled lambda DNA. 
DNA fibres form at high concentrations and overlapping DNA molecules 
make extracting individual intensity profiles impossible. B) Medium 
density of deposition, ~100pg/µl labelled T7 DNA. C) Low density of 
deposition. Unsuitable for high throughput extraction of intensity profiles. 
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The amount of salt is important (Supplementary Figure 7.8) as is the pH (Supplementary 
Figure 7.9). Further optimisation of the combing conditions is important to improve 
experimental data for alignment and this is perhaps the limiting step in this experiment. 
However, in general, combing at relatively low concentrations ~50-200 pg/µl and 
relatively fast speeds (20 mm/min) gave sufficiently good deposition for further analysis 
(Figure 3.6).  
Bleaching movies of deposited DNA molecules can be used to localise individual 
fluorophores, in a manner analogous to single molecule counting studies of pUC19 in 
CHAPTER 2. To do this with high throughput, molecules must be automatically extracted 
from the movies. For pUC19 this was achieved using the YOYO-1 intercalator. Since 
plasmids appeared as individual spots it was straightforward to use the Localizer 
plugin94 to localise the plasmid positions. However, in contrast to small plasmids, long 
DNA molecules that have been stretched appear as long, linear fragments. 
To allow automated single molecule counting for comparison with pUC19 the following 
procedure was developed and applied using custom Matlab code, for extraction of DNA 
from combing experiments. The procedure is shown in Figure 3.8, but in short, the steps 
are: 
1. Estimate direction of combing (theta) 
• Using Hough transform 
2. Smooth in that direction 
• Using convolution with Gabor filter in direction of theta 
3. Detect edges of DNA molecules 
• Using Sobel edge detection 
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4. Use edges to define intensity profiles 
• Image dilation in direction of theta to fill gaps 
• Group edges by connectivity (i.e. define each edge) 
• Extract ends of edges 
• Merge close ends to define lines along DNA molecules 
• Extract intensity along line 
• Also extract length and convert to estimate of number of base pairs 
5. Merge data for multiple images 
This procedure takes advantage of the directionality in individual images (Figure 3.8A) 
to extract lines. The Hough transform178 is a feature extraction technique that can be 
used to detect lines or shapes in images. Peaks in the Hough transform (Figure 3.8B) will 
correspond to lines in the image and here the median angle from the top ten features 
(theta) is used to give an estimate of the directionality of DNA molecules.  
The intensity profile is not uniform, which makes normal feature extraction (e.g. by 
thresholding) difficult. Therefore, the median angle (theta) is used to blur DNA 
molecules in that direction to make extraction of intensity profiles more 
straightforward. This also means an intercalator which uniformly stains along the length 
of a DNA molecule, e.g. YOYO-1, is not necessary for the extraction of intensity profiles. A 
Gabor filter with an angle set by the directionality (theta) is used (Figure 3.8C) and 




Figure 3.8 Automated extraction of intensity profiles. A) Typical combing image. B) 
Hough transform used to estimate direction of combing. 10 peaks are 
selected, and the median used to define theta. C) A Gabor filter in the 
direction of theta is created and a convolution with A) gives D). E) Edge 
detection on D) using the Sobel method and an automatically detected 
threshold. F) Edges are dilated, and connectivity used to define the ends of 
lines. When two pairs of end points are close a line is drawn between them. 
G) This line is shown in green, edges in red. H) This is done for many 
images and extracted intensity profiles are merged. 
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From this, the edges of DNA molecules are detected using the Sobel method and an 
automatically detected threshold, by a built-in Matlab function (Figure 3.8E). Edges are 
dilated to fill gaps and grouped by connectivity. If edges are short (i.e. <50 pixels) they 
are removed, and the ends of each edge are detected. When the ends of a pair of edges 
are close (within 15 pixels) they are paired (Figure 3.8F). The average position of a pair 
of ends is used to define the two ends of an individual DNA molecule and used to define 
a line along the DNA molecule (Figure 3.8G), from which the intensity profile and length 
of the molecule is extracted. This is repeated for many images to automatically extract 
the intensity profile along many DNA molecules (Figure 3.8H). 
The coordinates of extracted DNA molecules can be used to assign individual 
fluorophores to a given molecule. The assignment of these individual molecules can then 
be used for single molecule counting experiments (Figure 3.9). Bleaching movies are 
taken and individual fluorophore positions estimated using the Localizer plugin94 in 
IgorPro. Localisation coordinates are overlaid with DNA molecules extracted from the 
image (Figure 3.9B). Any localisations within close proximity (e.g. 5 pixels) of the line 
along the DNA molecule are assigned to it (Figure 3.9C). A ratio of the number of 
localisations and the length of the DNA fragment is used to calculate a labelling 
efficiency and is presented as a histogram. For example, for T7 DNA a label is expected 





Figure 3.9 Single molecule counting for combed DNA. The bleaching movie for the 
typical combing image of Figure 3.8 is used for localisation of individual 
fluorophores. A) Localisations (black) are overlaid with lines extracted by 
the process shown in Figure 3.8 (red). Note that coordinates have been 
flipped. B) Localisations are assigned to DNA fragments, each denoted by a 
different colour. 
Figure 3.10 shows that labelling efficiency for T7 is consistent with labelling of pUC19, 
though slightly reduced overall. The extent of non-specific labelling was not tested but is 
expected to be similar to the results for pUC19. When individual intensity profiles are 
examined this appears to be the case (Figure 3.11). Careful combing at low 
concentrations is required for reliable results or efficiency is overestimated due to 





Figure 3.10 Labelling efficiency of T7 DNA for different commercial dyes. T7 was 
labelled with M.TaqI and AdoHcy-azide and coupled post-transalkylation. 
A) Single molecule counting results for each dye. B) Labelling efficiencies 
for each dye. 
The labelling/combing procedure that has been used throughout the rest of this chapter 
is as follows: 
1. Run protection assay with AdoHcy-azide to confirm minimum amount of 
required M.TaqI 
2. Label 2 µg of DNA with AdoHcy-azide and M.TaqI. Mix the following and incubate 
at 50oC for 1 hour. 
All in µL  
Water 30.0 
10x CutSmart 4.0 
0.5mg/ml T7 4.0 
15mM AdoHcy-azide 2.0 
0.3mg/ml M.TaqI 2.0 
 
3. Add 2 µl proteinase K (18 mg/ml)/0.1% Triton X-100 and incubate at 50oC for 1 
hour. 
4. Purify by ethanol precipitation into 50 µl 1xPBS 
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5. Mix 2.5 µl 1xPBS, 1.5 µl 50 mM Atto647N NHS Ester and 1.0 µl and 20 mM DBCO-
amine. Incubate at 4oC for 1 hour. 
6. Add DBCO-Atto647N mixture and 5 µl DMSO to purified DNA. Incubate at room 
temperature overnight. 
7. Purify on silica columns into 200 µl elution buffer. Dilute in elution buffer to 
around 2 ng/µl. 
8. Mix 2 µl labelled DNA, 17 µl 100 mM sodium phosphate buffer (pH 5.7) and 1 µl 
DMSO. Comb 1.5 µl at 20 mm/min on zeonex-coated glass coverslips. 
9. Image using TIRF/widefield, 100/150X, 640 nm excitation. 
In Figure 3.11A an individual T7 molecule is shown that has been labelled and combed 
by this procedure.  The intensity profile is automatically extracted and is shown in 
Figure 3.11B. It has been aligned to a reference intensity profile and shows good visual 
agreement with the expected profile. The alignment procedure will be described in 





Figure 3.11 Individual labelled molecule of T7 DNA. M.TaqI-directed labelling with 
AdoHcy-azide is followed by post-transalkylation coupling with Atto 647N. 
DNA is then combed onto a coated glass coverslip and imaged by excitation 
at 640nm. A) A typical individual molecule, with a zoom showing the 
experimental intensity profile (scale bar = 10µm). B) The intensity profile 
is automatically extracted (red and bottom) and can be aligned to the 
reference intensity profile (red). 
3.2.2 Generation of DNA barcodes in silico 
The alignment of intensity profiles (henceforth referred to as DNA barcodes) can be 
tested fully in silico to inform the experimental and analytical techniques. The 
importance of experimental factors e.g. labelling efficiency, can be determined and 
alignment strategies developed and tested more easily. In particular, the alignment of a 
‘ground-truth’ can inform the development of alignment strategies for more complex 
experimental samples. 
For modelling in silico, a series of realistic DNA barcodes are generated. The 
imperfections of the barcodes that can be obtained experimentally are simulated by 
considering various experimental parameters: labelling efficiency; non-specific labelling; 
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variation in fluorescence intensity; fragment length and position in genome; non-
uniform stretch; camera pixel size; orientation of fragments; noise; and the effective PSF. 
These parameters are summarised in Table 3.1, along with typical estimated 
experimental values. 
Variables Description Typical 
values 
sequence  Genome sequence n/a 
data_no  No of fragments to be generated 100-
10000 
meth_efficiency  Labelling efficiency 30-60% 
false_methylation  Chance of non-specific labelling (per base pair) 0-0.001 
flu_intensity_var  Variation in fluorophore intensity 10-30% 
min_fragment_length  Minimum length of fragment (in base pairs) 30,000 
max_fragment_length  Maximum length of fragment (in base pairs) 50,000 
base_length_var  Variation in stretching 0-10% 
sample_freq_mean  Average pixel size (base pairs per pixel) 300-400 
sample_freq_distr  Variation in pixel size (will depend on 
direction) 
10-20% 
pixel_distr  Variation in pixel sampling (in base pairs) 20-60 
noise_mag  Magnitude of noise 10-20% 
PSF_ref  [sigma,size] for reference PSF (in base pairs) n/a 
PSF_frag [sigma] sigma for experimental PSF (in base pairs) 250-500 
PSF_frag [size] size for experimental PSF (in base pairs) n/a 
PSF_frag_var  Variation in experimental PSF 5-20% 
 
Table 3.1 Typical experimental parameters for in silico generation of experimental 
barcodes (procedure shown in Figure 3.13).  
The procedure for generating barcodes in silico is shown in Figure 3.13 and is as follows: 
1. Import labelled genome 
• Known sequence is imported from FASTA and converted to matrix form 
(A=1, C=2, G=3, T=4) 
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• Convert to labelled sequence. Labelled bases=2, unlabelled bases=0. E.g. 
for M.TaqI the A of TCGA=2, all other bases=0. 
2. Choose random fragment from genome 
• Random first fragmentation site 
• Second fragmentation site up to max fragment length away e.g. 50,000 bp 
• Only fragments larger than minimum fragment length e.g. 30,000 bp and 
within ends of genome are carried forward 
• Store size of fragment. Known size of fragment (in bases) altered by 
random variation in stretch e.g. ±10% 
3. Reduce labelling efficiency.  
• Each site gets two random numbers between 0 and 1. If number is greater 
than desired frequency e.g. 0.45 then label is removed. 
4. Add in non-specific labelling.  
• Each site gets a random number between 0 and 1 and if number is less 
than desired frequency e.g. 0.001 then methylation site is added 
5. Allow fluorescence intensity to vary e.g. ±20% 
6. Convolve labelled fragment with Gaussian filter 
• Define sigma and length of PSF e.g. 300 and 3000 bp 
• Allow for variation in sigma e.g. ±20% 
7. Sample intensity along fragment 
• Sample every e.g. 250 fragments, based on pixel size, with allowed 
variation e.g. 200 to 300 bp per pixel (since this will depend on 
orientation of molecule) 
• Don’t sample perfectly e.g. sample at 0, 245, 502, 746, etc. 
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8. Randomly flip fragment (i.e. 50% likelihood fragment is backwards) 
9. Add noise. E.g. Intensity varies by e.g. ±15% 
10. Repeat for desired number of fragments, merge data and display 
Examples of a generated barcode and an experimental barcode are shown in Figure 3.12 
and show differences between them that must be considered. In experimental barcodes 
there will be a background of fluorescence intensity, unless this is subtracted from the 
image. Also, in generated barcodes the intensity profile is abruptly terminated, whilst in 
experimental barcodes signal is extracted from slightly beyond the molecule. This will 
be taken into account during alignment of experimental barcodes. 
 
Figure 3.12 Examples of generated and experimental DNA barcodes. DNA is M.TaqI 
labelled. A) Barcode generated in silico using procedure and parameters 





Figure 3.13 Procedure for in silico generation of DNA barcodes. Full procedure is 
described in main text. 1) Import labelled genome, e.g. M.TaqI-labelled T7 
genome. 2) Choose random fragment from genome. 3) Reduce labelling 
efficiency. 4) Add in non-specific labelling. 5) Allow fluorescence intensity 
to vary. 6) Convolve labelled fragment with Gaussian filter. 7) Sample 
intensity along fragment. 8) Randomly flip fragment. 9) Add noise. 10) 
Alignment of generated barcode to reference 
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3.2.3 Alignment of DNA barcodes to a reference 
Fragments can be readily aligned to a known reference by maximising the cross-
correlation. Cross-correlation is a measure of similarity between two signals as a 
function of the displacement of one relative to the other. It is commonly used in signal 
processing, for example to calculate the delay between the same signal collected from 
different sensors179. This is a problem analogous to the alignment of DNA barcodes. The 
cross-correlation, xcorr, between two signals, x and y (e.g. Figure 3.14A), of length, N, at 
delay, d, is defined as: 
𝑥𝑐𝑜𝑟𝑟(𝑑) =  ∑ 𝑥(𝑖)𝑦(𝑖 − 𝑑)
𝑖
 
Where d=-N+1,-N+2,…,N-2,N-1. An example is shown in Figure 3.14B, which shows that 
the peak in cross-correlation correlation corresponds to a displacement of zero. 
However, this peak is not significantly higher than values of the cross-correlation at 
other displacements, since it also depends on the number of values overlapping between 
signals. 
To correct for this the cross-correlation can be normalised, so that for complete overlap 
between signals the cross-correlation is 1. An example of this is shown in Figure 3.14C. 
The mean is subtracted from each signal and each signal is divided by its standard 
deviation, before the final result is divided by the length of the signal: 
𝑥𝑐𝑜𝑟𝑟(𝑑) =  
1
𝑁
∑ (𝑥(𝑖) − ?̅?)(𝑦(𝑖 − 𝑑) − ?̅?)𝑖
√∑ (𝑥(𝑖) − ?̅?)2𝑖 √∑ (𝑦(𝑖) − ?̅?)2𝑖
 
Note how the peak cross-correlation is now largely unaffected by overlap and so can be 
more easily identified. Cross-correlation is equivalent to the convolution of 𝑥∗(−𝑖) and 
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𝑦(𝑖), which allows for exploitation of fast Fourier transform algorithms for efficient 
computation. This is what the built-in Matlab functions xcorr and xcorr2 use: 
𝑥𝑐𝑜𝑟𝑟(𝑥, 𝑦) = 𝑥∗(−𝑖) ∗ 𝑦(𝑖) 
𝐹𝑇(𝑥𝑐𝑜𝑟𝑟(𝑥, 𝑦)) = 𝐹𝑇(𝑥)∗. 𝐹𝑇(𝑦) 
Where FT denotes the Fourier transform, and 𝑥∗ the complex conjugate of x.  
 
Figure 3.14 Example of cross-correlation. A) Generated signals, x (blue) and y (red). x is 
randomly generated signal between 0-1, and y is with noise of 20%. B) 
Cross-correlation between x and y. The peak in cross-correlation is at a 
displacement of zero, which is when the signals are correctly aligned. C) 
Normalised cross correlation between x and y. The dependency on overlap 
is largely removed, making the peak cross-correlation more easily 
identified. 
For fitting fragments to larger genomes (e.g. E. coli) there will be a large difference in the 
length of signals. When signals are of different lengths zeros will be appended to the 
shorter signal to make the lengths equal (e.g. Figure 3.15A). However, if the global mean 
and standard deviation are used to normalise the reference signal then the alignment 
will be biased towards the most intense parts of the signal (Figure 3.15B). Since the 
absolute intensity of an individual barcode is not necessarily known this is undesirable, 
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the barcode should have an equal probability of fitting across the genome, independent 
of intensity. Normalisation using a rolling mean and standard deviation, from the same 
length as the shorter signal, removes most of the bias (Figure 3.15C). 
 
Figure 3.15 Example of cross-correlation between two signals of different length, x and 
y. A) Generated signals, x (blue) and y (red). The second half of x is twice 
the intensity as the first half of x. y is a region taken from the first half of x. 
Zeros are appended to y to make it the same length as x for cross-
correlation. B) Normalised cross-correlation between x and y (black). 
There is a clear bias towards the intense regions, which is undesirable. C) 
Normalised cross-correlation using a rolling mean and standard deviation 
of the length of y, between x and y (black). This removes most of the bias 
towards intense regions. D) Normalised cross correlation using rolling 
mean and standard deviation (blue) multiplied by percentage overlap (red) 
and the percentage overlap mask (black). For short barcodes when large 
amounts of overlap are expected this reduces spurious cross-correlation 
for partial overlap. 
Finally, to penalise cross-correlation when there is not complete overlap the normalised 
cross-correlation can be multiplied by the percentage overlap between signals, 
henceforth called the mask. This will be used for short genomes, e.g. T7/lambda, where 
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there should be significant overlap between DNA barcodes. Spurious cross-correlation 
for only very partial alignment is reduced (Figure 3.15D).  
Alignment of experimental DNA barcodes to known reference barcodes uses the cross-
correlation between them. Experimental barcodes are stretched to 90-110%, (in 
intervals of 1%), of the estimated length and the normalised cross-correlation calculated 
for each stretch and for both orientations (forward or reverse). The maximum value of 
the normalised cross-correlation is used to give the displacement, stretch and 
orientation of the experimental barcode and used for alignment to the reference 
barcode. The full procedure is outlined below: 
1. Generate reference barcode 
• Reference sequence is imported from FASTA and converted to matrix 
form (A=1, C=2, G=3, T=4) 
• Convert to labelled sequence. Labelled bases=2, unlabelled bases=0. E.g. 
for M.TaqI the A of TCGA=2, all other bases=0. 
• Convolution with PSF, select sigma from 250-400bp 
• Sample every N base pairs, where N is ‘sampling’ 
2. Stretch experimental barcode 
• Length of DNA fragment calculated based on pixel size. 
• Use crystallographic length of bp (0.34 nm) and estimated stretch (1.52) 
to estimated base pairs per nanometre = 1.93 bp/nm 
• Use estimated length in number of bases to estimate stretch required 
• Use interpolation to ‘stretch’ fragment to full length in base pairs 
• Sample every N base pairs, where N is ‘sampling density’ 
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• Include reverse of fragment 
3. Cross correlation with reference barcode to define best stretch 
• Use normalised cross correlation and test for 90%-110% of estimated 
stretch 
• Maximise normalised cross correlation to define best stretch and 
orientation 
4. Align fragment 
• Maximum normalised cross correlation gives corresponding displacement 
• Use displacement to align stretched and oriented fragment along 
reference genome 
5. Repeat for each fragment 
An example of the result of this procedure is shown in Figure 3.16A. 100 barcodes, 
randomly generated from the T7 genome (Figure 3.16B), can be aligned to the T7 
reference barcode (Figure 3.16C) in less than 1 second.  
 
Figure 3.16 Example of alignment procedure. A) T7 reference barcode (blue) and 
generated barcode (red), generated in silico from the T7 genome. The 
generated barcode has been stretched, oriented and aligned by maximising 
the normalised cross-correlation. B) 100 generated barcodes, generated in 
silico from the T7 genome. C) Alignment of generated barcodes to the 
reference barcode (bottom). 
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3.2.4 Sensitivity analysis and experimental parameters 
Using this alignment procedure in tandem with random generation of fragments in silico 
the sensitivity of alignment to each experimental parameter can be determined. This can 
inform the experimental protocol, for instance, what sort of labelling efficiency is 
required and what length of DNA fragment?  
Here Monte-Carlo simulations are used to assess the sensitivity towards each 
experimental parameter. In these simulations the parameters for in silico generation of 
barcodes are randomly varied, between reasonable experimental values, shown in Table 
3.2. 100 barcodes are generated for each of 5000 sets of parameters and aligned to the 
reference barcode. The position from which the barcode was generated is compared to 
the aligned position and where overlap between the generated and fitted position is 
greater than 98% the barcode is considered to be correctly aligned. This means for each 











Variable Description max min 
sequence  Genome sequence n/a n/a 
data_no  No of fragments to be generated 100 100 
meth_efficiency  Labelling efficiency 0.1 1 
false_methylation  Chance of non-specific labelling (per 
base pair) 
0 0.01 
flu_intensity_var  Variation in fluorophore intensity 0 1 
min_fragment_length  Minimum length of fragment (in 
base pairs) 
30000 10000 
max_fragment_length  Maximum length of fragment (in 
base pairs) 
min+10000 min+10000 
base_length_var  Variation in stretching 0 0.2 
sample_freq_mean  Average pixel size (base pairs per 
pixel) 
100 500 
sample_freq_distr  Variation in pixel size (will depend 
on direction) 
0 0.2 
pixel_distr  Variation in pixel sampling (in base 
pairs) 
0 0.2 
noise_mag  Magnitude of noise 0 1 
PSF_ref  [sigma,size] for reference PSF (in 
base pairs) 
n/a n/a 
PSF_frag [sigma] [sigma,size] for experimental PSF 
(in base pairs) 
250 500 
PSF_frag [sized] [sigma,size] for experimental PSF 
(in base pairs) 
n/a n/a 
PSF_frag_var  Variation in experimental PSF 0 0.5 
 





A 2D histogram can be produced for each parameter, plotting the number of correctly 
fitted fragments against the value of the parameter. An example is shown for the 
labelling efficiency parameter, in Figure 3.17A and B.  Each point in the scatter plot in 
Figure 3.17A represents a single Monte-Carlo run for a specific set of parameters, these 
are then used for a histogram for visualisation in Figure 3.17B (histograms for each 
parameter are shown in Supplementary Figure 7.11). The correlation between the 
parameter and the number of correctly fitted fragments can then be used to assess 
sensitivity of the alignment towards each parameter. For this the Spearman rank 
correlation coefficient is used (Figure 3.17C). This can be used to assess the dependence 
between the rankings of the two variables, where a value of 1 is perfect positive 
correlation, a value of -1 is perfect negative correlation and a value of 0 means there is 
no correlation. The line of best fit is shown (Figure 3.17A and B) and approximates the 
correlation of the parameter and the number of correctly fitted barcodes.  
The alignment of barcodes is most sensitive to the labelling efficiency, this is clear from 
both the Spearman rank correlation coefficient and the trend in the 2D histogram. Non-
specific labelling, the length of fragments and the amount of noise are also important to 
consider, however the alignment is less sensitive to other variables, such as fluctuations 
in fluorophore intensity or changes in the PSF.  
Conceptually these results make sense. The most important characteristic of a signal for 
cross-correlation is the position of peaks i.e. the position of labels, which is most affected 
by labelling efficiency and non-specific labelling. However, parameters that affect the 
intensity of the peaks are less important, for example variations in fluorophore intensity 
or noise. Also, the pixel size and PSF, within these ranges, do not significantly affect the 
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presence and location of peaks. Shorter signals are less likely to find a unique position 
along the reference barcode, but problems with non-uniform stretch are less important.  
 
Figure 3.17 Monte-Carlo simulation to test sensitivity of parameters. 5000 sets of 
parameters were run for 100 fragments each. Experimental barcodes were 
generated and aligned from/to the T7 genome. A) Example scatter plot for 
the labelling efficiency. Each point in the scatter plot in represents a single 
Monte-Carlo run for a specific set of parameters. B) These can be visualised 
as a 2D histogram. The line of best fit shows the sensitivity of each 
parameter on the number of correctly fitted barcodes. C) This can be 






Here the two parameters to which alignment was most sensitive, labelling efficiency and 
non-specific labelling, are investigated in more detail. This is especially useful as the 
parameters can be experimentally tested, for example labelling efficiency of T7 is shown 
in Figure 3.10. This was also optimised in CHAPTER 2, so knowledge of the required 
labelling efficiency can be used to assess the quality of methyltransferase-directed 
labelling. 
Each parameter is varied systematically, and barcodes generated and aligned to the 
reference barcode. Figure 3.18A shows a 2D histogram for T7. Each pixel represents a 
different labelling efficiency and amount of non-specific labelling, whilst the colour of 
each pixel reports on the proportion of generated barcodes that were correctly fitted. 
The average dependence on labelling efficiency (for all values of non-specific labelling) 
is shown in Figure 3.18B and the average dependence on non-specific labelling (for all 
values of labelling efficiency) is shown in Figure 3.18C.  
For T7 these results suggest that a labelling efficiency of around 50% should be 
sufficient for around 90% of fragments to be fitted, whilst non-specific labelling can 
approach around 1 label per 1000 bases, before there is a significant drop in correct 
alignment. Experimentally, M.TaqI-directed labelling of pUC19 with Atto647N achieved 
50% labelling efficiency, but a non-specific label around every 1500 base pairs (results 
in CHAPTER 2). For TAMRA labelling was around 30% efficient, but with no significant 
non-specific labelling. The proportion of correctly fitted barcodes for these regimes is 
93% and 97% respectively. Similar results should be expected for genomes of similar 




Figure 3.18 Simulating effect of labelling efficiency and non-specific labelling on 
alignment of DNA barcodes to/from T7 bacteriophage DNA. M.TaqI-
directed labelling is simulated, with parameters given in supplementary 
materials and methods. A) Simulation from 5-100% efficiency and non-
specific labelling of 0 to 1 in 100 base pairs. 100 barcodes are generated 
and aligned per pixel and colour indicates the proportion that was 
correctly aligned. B) Average number of barcodes correctly fitted against 
labelling efficiency. C) Average number of barcodes correctly fitted against 
the frequency of offsite labels. 
Figure 3.19 shows the same results for DNA barcodes aligned to and generated from the 
E. coli K-12 genome (4640 kbp). This genome is approximately 100 times longer than 
the T7 genome (40 kbp), so the search for correct alignment is more difficult. Now 
around 80% labelling efficiency is required for 90% of barcodes to be correctly aligned, 
though the effect of non-specific labelling is similar.  At 50% labelling efficiency and non-
specific labels around every 1500 base pairs the proportion of correctly aligned 
barcodes is reduced to 60%. There is also a reduction at 30% labelling efficiency (and no 




Figure 3.19 Simulating effect of labelling efficiency and non-specific labelling on 
alignment of DNA barcodes to/from E. coli K-12. M.TaqI-directed labelling 
is simulated, with parameters given in supplementary materials and 
methods. A) Simulation from 5-100% efficiency and non-specific labelling 
of 0 to 1 in 100 base pairs. 10 barcodes are generated and aligned per pixel 
and colour indicates the proportion that was correctly aligned. B) Average 
number of barcodes correctly fitted against labelling efficiency. C) Average 
number of barcodes correctly fitted against the frequency of offsite labels. 
For long genomes such as E. coli the computational time for alignment of barcodes 
becomes apparent, the generation of Figure 3.19 took 6 hours, whilst Figure 3.18 only 
took 15 minutes. This is because although cross-correlation is relatively fast, (since fast 
Fourier transform algorithms can be used), long signals still take a long time to process. 
In cross-correlation the two signals must have the same effective resolution, but if a 
single intensity value for each base pair is used the time of computation is prohibitive. 
However, in reality the number of base pairs per pixel is only 200-400, so this is 




To reduce the sampling each barcode is initially stretched to the estimated number of 
base pairs, by interpolation, then a reduced sampling rate is used, i.e. the intensity is 
taken every 100 base pairs. The same sampling rate is used for the reference genome 
and this is used for alignment by cross-correlation. The effect of different sampling rates 
on the time taken for alignment is shown in Figure 3.20A. Increasing the sampling rate 
from 100 base pairs to 1000 base pairs decreases the computation time by a factor of 
more than 10. However, the rate of sampling will also affect the quality of the alignment 
procedure. This is shown in Figure 3.20B, where the effect of labelling efficiency is tested 
for various sampling rates. The alignment begins to suffer at sampling rates above 
approximately twice the pixel size (400-600 base pairs). So, for the results in the rest of 
this chapter a sampling rate of 100-300 bp will be used 
 
Figure 3.20 Simulating the effect of sampling rate. Each DNA barcode is initially 
stretched to the estimated number of base pairs, by interpolation. Then 
sampling is used, i.e. the intensity is taken every 100 base-pairs. A) Time 
taken for alignment of 10 fragments to the T7 genome against the sampling 
rate. B) Histogram showing number of fragments correctly fitted to E. coli 
K-12, depending on the labelling efficiency and sampling rate. 
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3.2.5 Measures of alignment accuracy 
The normalised cross-correlation is used to align barcodes, as it is a rapid and reliable 
method to align signals. However, it is not always a good measure of alignment, i.e. 
whether a barcode is aligned correctly or not since maximising the cross-correlation is 
not a guarantee of good alignment, it might just be the best of a bad match. Ideally 
barcodes should be separated into correctly fitted barcodes (positive) and incorrectly 
fitted barcodes (negative, e.g. barcodes from a contaminating sample) with complete 
accuracy, for example using a threshold normalised cross-correlation of 0.7 (Figure 
3.21A). 
 
Figure 3.21 Normalised cross-correlation as a measure of alignment accuracy. A) Ideal 
separation by normalised cross correlation. Correctly fitted barcodes (red) 
will have a higher normalised cross correlation than incorrectly (blue). A 
threshold can be used to discriminate with 100% accuracy. B) Example for 
barcodes generated from and aligned to E. coli K-12, with 40% labelling 
efficiency. There is a large amount of overlap between correctly (red) and 
incorrectly (blue) fitted barcodes, making discrimination impossible from 
the total data (black). C) The accuracy of separation at different normalised 
cross-correlation thresholds, for data in B).  
However, for typical experimental parameters (e.g. 40% labelling efficiency) there is not 
complete separation between correctly and incorrectly fitted barcodes (Figure 3.21B). 
At any chosen threshold there will be correctly fitted barcodes that are falsely assigned 
as negative and/or incorrectly fitted barcodes that will be falsely assigned as positive. 
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The accuracy for any threshold gives the percentage of barcodes that are correctly 
assigned (i.e. as being incorrectly or correctly fitting) and can be calculated as: 
𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦 =
𝑡𝑟𝑢𝑒 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒𝑠 + 𝑡𝑟𝑢𝑒 𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒𝑠
𝑡𝑟𝑢𝑒 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒𝑠 + 𝑓𝑎𝑙𝑠𝑒 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒𝑠 + 𝑡𝑟𝑢𝑒 𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒𝑠 + 𝑓𝑎𝑙𝑠𝑒 𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒𝑠
 
This can be compared to other commonly used measures such as sensitivity and 
specificity. Sensitivity is the probability that a correctly fitted barcode will be identified 
as such, and specificity is the probability that an incorrectly fitted barcode will be 
identified as such. They can be calculated as: 
𝑆𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦 =
𝑡𝑟𝑢𝑒 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒𝑠




𝑓𝑎𝑙𝑠𝑒 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒𝑠 + 𝑡𝑟𝑢𝑒 𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒𝑠
 
A peak accuracy of 71% is reached for a normalised cross-correlation threshold of 0.66 
(Figure 3.21C), which is insufficient for reliable identification of a sample. Therefore, in 
addition to normalised cross-correlation other measures will be used to assess 
alignment.  
Conceptually the location and height of peaks and troughs is important to align 
barcodes, therefore two additional measures will be used: the mean difference in the 
intensities of the generated and reference barcode (Figure 3.22A), which primarily 
reports on the height of peaks; and the mean difference in the gradient of the intensities 
(Figure 3.22B), which will primarily report on the location of peaks and troughs. These 
are subtracted from 1 to give reasonable distributions, where 0=no alignment and 




Figure 3.22 Example intensity profile for DNA barcode generated from and aligned to E. 
coli K-12. A) Intensity profiles. Across the fragment the difference between 
intensities is divided by the average intensity of the two signals, and then 
the mean used. B) Gradient of the intensity profiles. Across the fragment 
the difference between intensities is averaged. 
The accuracy of these measures can be assessed as before (Figure 3.23A). Both 
measures are an improvement on using normalised cross-correlation: the difference of 
the intensities gives an accuracy of 76% at a threshold of 0.68; and the difference in 
gradients gives and accuracy of 80% at a threshold of 0.72. Combining the measures, 
using a mean, gives an overall accuracy of 81% at a threshold of 0.69, which is a 
significant improvement over using normalised cross-correlation alone.  
Another way to assess the accuracy of each measure is to record the sensitivity and 
specificity for each threshold and to plot a receiver operating characteristic (ROC) curve. 
This is shown for each measure in Figure 3.23B. If there was ideal separation (i.e. 100% 
accuracy) then both sensitivity and specificity would equal one and the area under the 
curve (AUC) would equal 1. If there was no separation, then the ROC curve would fall 
along the dashed line and the AUC would equal 0.5. Plots which are closer to the ideal 
case and have a larger AUC indicate a better measure of discrimination. As before, 
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combining measures is shown to be the most effective method of discrimination with an 
AUC equal to 0.88, which can be considered excellent for accurate separation. 
 
Figure 3.23 The accuracy of separation using alternative measures. A) Accuracy of 
separation. B) Receiver operating characteristic (ROC) curves. 10,000 
barcodes generated from and aligned to E. coli K-12, with 40% labelling 
efficiency. Correctly and incorrectly aligned barcodes are separated by 
several measures, using thresholds ranging from 0 (no alignment) to 1 
(perfect alignment). Measures include normalised cross-correlation (blue); 
difference in intensity (red); difference in gradients (yellow); and an 
average of all three measures (purple).  
The combination of normalised cross-correlation, difference of intensities and difference 
in gradients will henceforth be referred to as the alignment ‘weight’. It is important to 
note that this measure is only used to check barcode alignment. It is not used during the 
alignment procedure since an implementation would generally slow computation 
significantly; the reason cross-correlation is a popular method is because it is fast. 
However, an alignment procedure which used this measure, or similar, would likely 




3.2.6 Effect of labelling density and resolution 
All these simulations have been carried out with M.TaqI (labelling TCGA sites) since it 
proved to be the most effective and reliable methyltransferase for labelling (see 
CHAPTER 2). However, labelling by other methyltransferases can easily be simulated, to 
determine if the barcodes would also be effective for alignment. Here enzymes with 
varying labelling density are trialled: M.EcoRI (low density, GAATTC sites); M.HhaI 
(medium density, GCGC sites) and M.MpeI (high density, CG sites). 
 
Figure 3.24 Reference barcodes for lambda genome (48.5 kbp), labelled by alternative 
methyltransferases. Shown in black are the labelling sites, and in blue the 
reference barcode with a PSF of 250 bp. A) M.EcoRI-directed labelling 
(GAATTC sites). B) M.TaqI-directed labelling (TCGA sites). C) M.HhaI-
directed labelling (GCGC sites). D) M.MpeI-directed labelling (CG sites). 
These have different densities and highlight the difference in CG content 
across the lambda genome. 
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Figure 3.24 shows the reference barcodes generated by each methyltransferase-directed 
labelling reaction for lambda DNA (~48.5 kbp). There are only 5 EcoRI sites in the whole 
genome (Figure 3.24A), which is a density similar to traditional optical restriction 
mapping, whilst there are 121 TaqI sites and 157 HhaI sites, giving intermediate 
labelling densities, though different patterns. The lambda bacteriophage genome has a 
large difference in GC content across the genome, which is particularly visible in M.MpeI 
labelling, for which there are 3113 sites, giving an extremely high-density labelling, 
similar to the density seen for affinity labelling (since this typically uses GC content to 
generate the barcode).  
Figure 3.25 shows the alignment of generated barcodes generated using these 
methyltransferases, depending on labelling efficiency. Figure 3.25A shows results of 
simulations for barcodes generated from and aligned to the lambda genome. It shows 
that M.MpeI barcodes are aligned well to the genome, due to the difference in GC 
content. This also means M.HhaI performs better than M.TaqI. However M.EcoRI 
performs poorly, as the very low density of sites gives insufficient information for robust 
alignment which is the reason traditional optical restriction mapping has not been 
widely used for short genomes (Figure 3.1).  
Figure 3.25B shows the results for the T7 genome. Here there are no M.EcoRI sites, so 
the labelling fails completely for alignment. Now M.MpeI does not outperform the 
intermediate labelling densities (M.TaqI and M.HhaI), since there is less GC content 
variation across T7. Given the reference barcode we might expect it to perform even 
worse as the information content (i.e. number of and contrast between peaks and 
troughs) is rather low (Supplementary Figure 7.12).  
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If the simulations are run for the E. coli K-12 genome this is indeed what happens 
(Figure 3.25C). M.HhaI and M.TaqI perform as expected, however now M.MpeI-directed 
labelling is far poorer for alignment of barcodes. Even at 100% labelling efficiency only 
around 50% of barcodes are correctly aligned, compared to at least 90% for M.HhaI and 
M.TaqI-labelled barcodes. At 100% labelling efficiency even M.EcoRI-directed labelling 
is able to align 50% of barcodes correctly.  
 
Figure 3.25 Alignment of barcodes labelled by alternative methyltransferases. For 5-
100% labelling efficiency, 100 barcodes were generated from and aligned 
to: A) lambda genome, B) T7 genome, C) E. coli K-12 genome.  Barcodes 
were generated for different methyltransferases and non-specific labelling 
also varied: M.EcoRI, no non-specific labelling (purple, dash-dot); M.TaqI, 1 
per 10 kbp (yellow, dotted); M.HhaI, 1 per 10 kbp (red, dashed); M.MpeI, 1 
per 1 kbp (blue, solid). 
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In the literature, localisation procedures have been used to improve the resolution of 
optical mapping93. This is equivalent to reducing the size of the PSF and increasing 
fluorophore localisation precision. The effect of the size of the PSF, on the reference 
barcode of the T7 genome, is shown in Figure 3.26. Here the PSF is varied from 10 base 
pairs, where almost all individual fluorophores can be localised with a very high 
precision, to a PSF of 1000 base pairs, where most information is lost, and only very 
broad peaks or troughs remain. These extremes are analogous to results in literature, 
where localisation of labels has been used for alignment93 through to where barcodes 
are imaged in nanochannels, where thermal fluctuations reduce the effective PSF83, see 
for instance Figure 1.20C and D. 
For barcodes that are generated using typical experimental parameters (e.g. M.TaqI-
labelled, with 50% labelling efficiency) the number of correctly aligned barcodes does 
not increase as the PSF width is decreased below around 500 bp, for barcodes generated 
from the T7 genome (Figure 3.27A), and below around 200 bp for barcodes from the E. 
coli K-12 genome (Figure 3.27C). At values higher than this there is a decrease in the 
number of barcodes that are correctly aligned, as the detail of the features is lost. It is 
important to note that for imaging barcodes that have been combed onto a surface the 
PSF width is typically 300-500 bp, however for nanochannels the reported intensity 




Figure 3.26 Reference barcodes for T7 genome with various PSF widths. Sigma values 
of: A) 10, B) 50, C) 250 and D) 1000 base pairs. 
Below 200-500 bp there is still an advantage for increased localisation precision. The 
quality of alignment for correctly aligned barcodes improves significantly with increased 
localisation (Figure 3.27B and D). In effect the separation between correctly and 
incorrectly fitted barcodes is being increased (Figure 3.21A), which may improve the 
reliability of alignment overall.  
Although this is significant, there are still a number of drawbacks to increasing 
localisation beyond the diffraction limit (~300-500 bp in a typical combing experiment). 
For super-resolution localisation methods, many time points are needed, significantly 
increasing imaging time, in addition to the processing time after imaging. For example, if 
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1000 frames are needed rather than a single frame, the data acquisition will be 
inherently 1000 times slower. Also significant is the higher sampling rate that is 
necessary once intensity profiles are extracted. This should be typically of the order of 
the pixel size, so increased localisation will lead to a higher sampling rate, which 
significantly slows computational speed (Figure 3.20). These factors will significantly 
reduce throughput, without a significant decrease in correct alignment, therefore non-
localised, but combed, barcodes will be used.  
 
Figure 3.27 Effect of PSF on alignment of barcodes. For PSF sigma of 10-2000, 100 
barcodes, M.TaqI-labelled with 50% labelling efficiency, generated from 
and aligned to : A-B) T7 genome (dashed line at ~500bp), C-D) E. coli K-12 
genome (dashed line at ~200bp). A and C) No. of correctly aligned barcodes, 
depending on PSF. B and D) The mean alignment weight for correctly 
aligned barcodes, depending on PSF. Although the no. of correctly aligned 
barcodes does not increase at a PSF width below the dashed line, the 




In silico generation and alignment of DNA barcodes has been used to investigate many of 
the important experimental parameters of optical mapping and to inform development 
of the analytical procedures, in particular the alignment procedure. As well as 
considering the parameters for the experimental methods used in this research, for 
example the labelling efficiency, there have been some comparisons with alternative 
optical mapping techniques (Figure 3.1).  
In particular the main aspects to consider when comparing alternative techniques are 
the width of the PSF and the density of labelling sites. Typically, nanofluidic devices will 
have a relatively wide PSF (500-1000 bp), due to thermal fluctuations, whilst molecular 
combing can be easily used in tandem with localisation microscopy to achieve a very 
narrow PSF (down to around 20 bp). The density of sites varies, typically from around 1 
site every 10 kbp, for traditional optical restriction mapping, to a much higher density of 
labelling along the whole DNA molecule as affinity-based labelling is very dense (for 
example CG sites occur on average once every 16 bp). The techniques used in this 
research have intermediate resolution (PSF width of 300-500 bp) and labelling density 
(around 1 label every 500 bp). 
These regimes are compared in Figure 3.28. Genomes 5 Mbp in length, are generated 
with densities varying from 1 label every 10 bp (10-1 labels per base), to 1 label every 10 
kbp (10-4 labels per base). From these genomes, barcodes are generated and aligned, 
with PSF widths ranging from 50 to 1000 bp. This confirms that for the identification of 
microorganisms (e.g. bacteria) alignment is poor at low effective resolutions as well as 
high or low labelling densities. Alignment is best at very high resolutions, but obtaining 
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this data reduces the throughput significantly. Therefore a ‘sweet spot’ lies in the 
intermediate range of values, at the labelling densities and resolution obtained for 
M.TaqI-directed labelling, molecular combing, and typical widefield microscopy. This 
confirms that the primary advantage of using the combination of these techniques is for 
the rapid identification of microorganisms. 
 
Figure 3.28 Comparison of optical mapping techniques based on labelling density and 
PSF width. Random 5Mbp genomes with labelling densities of between 10-4 
and 10-1 per base were generated. 40 barcodes with a PSF width of between 
50 and 1000 bp, and 80% labelling efficiency, were generated from, and 
aligned to, each genome. The colour of the pixel represents the proportion 
of barcodes that were correctly aligned. Various experimental regimes are 
shown. The best alignment is at intermediate labelling densities (10-1.6 to 
10-3 labels per base) and high resolution (PSF width of <200 bp). However, 
obtaining this resolution significantly reduces throughput, therefore an 
intermediate resolution (PSF width of 300-500 bp) is preferred. This is the 
‘sweet-spot’ that methyltransferase-directed labelling and molecular 
combing (with no localisation) occupies. 
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In CHAPTER 4 this knowledge will be applied to experimental samples and will show the 
applicability of methyltransferase-directed labelling, molecular combing and alignment 




3.4 Materials and Methods 
3.4.1 Genomic DNA restriction assay (Figure 3.5) 
The following were mixed and incubated at 50oC for 1 hour. 
 
0.5µl R.TaqI was added to samples 1-16 and all samples incubated at 65oC for 1 hour, 
before adding 0.5µl 18mg/ml proteinase K /0.1% Triton X-100 to all samples and 
incubation at 50oC for 1 hour. DNA was analysed by gel electrophoresis. 
3.4.2 Labelling of genomic DNA 
A 200µl solution containing 1x CutSmart (NEB), 10µg T7 DNA (NEB), 0.9µg M.TaqI 
(Ashleigh Rushton) and 750µM AdoHcy-azide (Andrew Wilkinson) was incubated at 
50oC for 1 hour. 5µl 18mg/ml proteinase K (NEB)/0.1% Triton X-100 (Sigma-Aldrich) is 
added and incubated at 50oC for 1 hour, before purification by GenElute Bacterial 
Genomic DNA kit (Sigma-Aldrich) and elution into 200µl 1xTE (Sigma-Aldrich). 
Meanwhile a 20µl solution containing 0.5x PBS/50% DMSO, 1mM DBCO-amine (Sigma-
Aldrich) and 12.5mM Atto647N (Sigma-Aldrich) was incubated at 4oC for 1 hour. The 
DNA sample was split into 30µl aliquots and either 10µl of the NHS Ester mix was added 
or 5µl DMSO, 5µl 1x PBS and 2.5µl 50mM TAMRA or Texas Red DBCO (Jena Bioscience) 
was added and incubated at room temperature overnight, before purification by 
GenElute Bacterial Genomic DNA kit and elution into 50µl 1xTE. 
All in µL 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Water 7.5 7.5 7.5 7.5 7.5 7.5 8.0 8.0 8.0 8.0 8.0 8.0 8.0 8.0 7.5 8.0 8.0
10x CutSmart 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
0.5mg/ml T7 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
15mM AdoMet-azide 0.5 0.5 0.5 0.5 0.5 0.5 0.5




3.4.3 Molecular combing 
Molecular combing of DNA based on procedure described by Deen et al.57 
To prepare Zeonex-coated coverslips: Glass coverslips (20x20 mm, BRAND, no. 1) were 
cleaned to remove any fluorescent contaminants by incubation in a furnace oven at 
450oC for 24 h prior to coating. A few drops of Zeonex solution (Zeon Chemicals, 1.5% 
w/v solution in chlorobenzene) was deposited onto a stationary coverslip and 
subsequently spun at 3000 rpm for 90s. Zeonex-coated coverslips were allowed to dry 
at room temperature overnight and stored in a desiccator. 
For molecular combing: mix 2µl Atto647N-labelled DNA (2ng/μl in 1xTE), 17µl 100mM 
sodium phosphate buffer (pH 5.7) and 1µl DMSO. Deposit 1.5µl droplet on surface of 
Zeonex-coated coverslip, lower a pipette tip to contact the droplet and drag at 
20mm/min across the coverslip. Image using TIRF/widefield, 100/150X, 640 nm 
excitation. 
3.4.4 Automated extraction, in silico generation of barcodes and alignment 
procedures 
Custom code was written using Matlab 2016b for automated extraction, in silico 
generation of barcodes and alignment procedures. Unless otherwise stated, barcodes 
were generated using parameters in Supplementary Table 7.1. Copy of the code is 




CHAPTER 4 OPTICAL MAPPING FOR IDENTIFICATION OF 
COMPLEX MIXTURES OF VIRAL AND BACTERIAL DNA – 
EXPERIMENTAL SAMPLES 
Robert K. Neely and Iain B. Styles provided supervision and guidance for the research 
undertaken in this chapter. Nathaniel O. Wand (the author) designed, performed and 
analysed all labelling experiments including optical mapping experiments.  Nathaniel O. 
Wand (the author) also developed and performed all extraction and alignment 
procedures unless otherwise stated. 
4.1 Introduction 
In CHAPTER 3 barcodes were generated in silico to test the various experimental 
parameters and inform analytical procedures.  
In terms of optical mapping techniques, M.TaqI-directed labelling and molecular 
combing provide the ‘sweet spot’ of labelling density and resolution. It was shown that 
labelling efficiency is the most important parameter for alignment. A labelling efficiency 
of 50% is sufficient to align around 80% of barcodes to the T7 genome which is at the 
upper end of the experimental labelling efficiency (20-50%). In addition, it was shown 
that the maximum non-specific labelling seen experimentally (1 label per 1500 bp) will 
not significantly affect alignment, whilst barcodes of the experimentally obtained length 
(20-50 kbp) are sufficient for alignment. Therefore, it is likely the limiting factor for this 
optical mapping technique may be the molecular combing and the extraction of 
experimental barcodes. 
In silico results informed development of a straightforward alignment procedure based 
on normalised cross-correlation. For this alignment procedure, a sampling rate of 100-
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500 bp can be used to reduced computation time and the alignment weight, (an average 
of the normalised cross-correlation, the difference in barcode intensities and the 
difference in the gradient of barcodes), gives good alignment accuracy. 
In CHAPTER 4 barcodes extracted from experimental samples of DNA will be aligned to 
short reference genomes (10 kbp to 10 Mbp). In addition to straightforward alignment, 
de novo alignment will be used, for simple and more complex mixtures. Together with 
CHAPTER 3, these results will show the applicability of methyltransferase-directed 
labelling, molecular combing and alignment of intensity profiles for rapid identification 
of microorganisms.  
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4.2 Results and discussion 
4.2.1 Alignment of experimental barcodes to short reference genomes 
Ideal molecular combing of DNA molecules would produce optical images with distinct 
and uniformly stretched individual molecules, from which individual barcodes could be 
extracted. However, in practice ideal molecular combing is difficult to achieve and the 
automated extraction of individual DNA barcodes remains challenging.  
Consequently, before the barcodes extracted from experimental samples can be aligned, 
it is important to clean-up the data, to exclude barcodes which did not represent 
individual, correctly extracted barcodes. This is done in several steps. 
The first step is to select barcodes based on size. The longer a barcode is, the better the 
alignment (3.2.4) and the maximum size may be known based on the sample. For 
example, for lambda DNA (~50 kbp) barcodes that are 35 kbp to 55 kbp can be selected 
(Figure 4.1A). A few kbp are extracted at either end of the barcode, so an allowance of 5-
10 kbp is used. Once these barcodes are selected they are also selected by average 
intensity (e.g. 5000-30000 for a 16-bit image, Figure 4.1B). Dim barcodes are likely to be 
artefacts from the extraction procedure (i.e. background rather than a labelled DNA 




Figure 4.1 Selecting DNA barcodes based on length and average intensity. An example 
here is given for Atto647N-labelled lambda DNA. A) Length of barcodes. 
Barcodes 35-55 kbp in length are selected. B) After selection by length, the 
average intensity of barcodes. Barcodes with mean intensities between 
5000 and 30000 are selected. 
The next step is to select barcodes based on the intensity profile. The barcode is cut at 
the ends, to remove the extra 5-10 kbp (noted previously, see Figure 3.12). Next, 
barcodes with very bright and/or very dim regions should be discarded, as they are 
likely artefacts from the extraction procedure or due to overlapping DNA molecules 
(Figure 4.2A and B). A rolling mean, a fifth of the size of the barcode, is calculated along 
the barcode. When the ratio of the minimum to the maximum rolling intensity is very 
small this typically indicates very bright or very dim regions along the intensity profile, 
and so the DNA is discarded (e.g. ratio minimum:maximum of 0.2, Figure 4.2C).  
Finally, DNA fragments which have saturated the detector are discarded. This is 




Figure 4.2 Selecting DNA barcodes are based on the intensity profile. An example here 
is given for Atto647N-labelled lambda DNA. A, B) Examples of discarded 
fragments based on the intensity profile. A) This barcode is dim for much of 
its length, probably as it is not extracted properly. B) This fragment has 
both very bright and very dim regions, meaning overlapping DNA 
molecules have probably been extracted. C) A rolling mean of the barcode, 
a fifth of the size of the barcode, is calculated. The ratio of the 
minimum:maximum rolling mean is calculated and used to select barcodes 
(e.g. with a rolling intensity ratio >0.2). 
Using the alignment procedure developed for barcodes generated in silico, it is now 
possible to align extracted and cleaned barcodes to a known reference sequence. For 
short genomes, i.e. <100kb, 1000 fragments take around 30 seconds to align. The 
combined alignment weight can then be used to extract those fragments that have 
aligned well. A cut-off value of 0.7 is used, since this gave a good level of accuracy 




Here the extraction and alignment procedures have been used for samples of lambda 
and T7 DNA labelled using M.TaqI. Figure 4.3 shows typical results for a pure sample of 
lambda DNA. Around 38,000 raw barcodes (approximately 200 Megabases) are 
extracted from around 1,000 images of combed DNA, from which 1077 cleaned barcodes 
are finally extracted (Figure 4.3A). Each of these is aligned, in turn, to the experimental 
barcode, with a PSF of 300 bp. An example of a barcode that aligns well (i.e. has a high 
alignment weight) is shown in Figure 4.3B and a histogram of alignment weights for all 
1077 barcodes is shown in Figure 4.3C. A threshold of 0.7 is used to filter 368 well-
aligned molecules, which are shown in Figure 4.3D. The mean intensity of these is 
calculated and shown at the bottom of Figure 4.3D and in Figure 4.3E. The background 
from this can be removed by using a ‘rolling ball’ with a suitable diameter (e.g. 50 




Figure 4.3 Alignment of pure experimental sample of lambda DNA. Lambda DNA was 
labelled using M.TaqI with Atto647N, combed and imaged. 38,000 raw 
barcodes were extracted from the images. A) After cleaning 1077 barcodes 
are extracted. B) An example of an experimental barcode (red) that aligns 
well to the reference barcode (blue). C) Alignment weight of all 
experimental barcodes, with a threshold of 0.7 shown (black). D) 
Alignment of 368 barcodes with alignment weight greater than threshold. 
At the bottom of the image is shown the mean experimental barcode, the 
mean with the background removed and the reference barcode (top to 
bottom). E) Plot of mean experimental barcode (red) against the reference 






The same results for a pure sample of T7 DNA are shown in Figure 4.4. Here 1166 
barcodes are extracted from the sample, of which 174 (15%) have an alignment weight 
greater than 0.7.  
 
Figure 4.4 Alignment of pure experimental sample of T7 DNA. T7 DNA was labelled 
using M.TaqI with Atto647N, combed and imaged. A) After cleaning 1166 
barcodes are extracted. B) An example of an experimental barcode (red) 
that aligns well to the reference barcode (blue). C) Alignment weight of all 
experimental barcodes, with a threshold of 0.7 shown (black). D) 
Alignment of 174 barcodes with alignment weight greater than threshold. 
At the bottom of the image is shown the mean experimental barcode, the 
mean with the background removed and the reference barcode (top to 
bottom). E) Plot of mean experimental barcode (red) against the reference 





From the simulations in CHAPTER 4, and the experimental labelling efficiency we would 
expect greater than 90% of barcodes to be correctly aligned. It is unlikely that large 
numbers of correctly aligned barcodes are excluded based on the alignment weight 
threshold, therefore it appears that there are a larger than expected number of barcodes 
that cannot be aligned well to the reference barcode, for both samples. These will be 
described henceforth as ‘junk’ barcodes. 
One source of these ‘junk’ barcodes will be the molecular combing and extraction 
procedures. Ideal molecular combing is difficult and consequently automated extraction 
of individual barcodes remains challenging, as discussed above. The artefacts of 
molecular combing that are retained during barcode extraction, for instance overlapping 
DNA molecules, may thus be one source of barcodes that do not align to the reference. 
Another possible source of ‘junk’ barcodes is contamination, for instance during the 
labelling and purification procedure. Even a handful of cells would be capable of 
introducing foreign DNA to the sample and is a known problem in DNA sequencing for 
which tools have been developed, for example to discard sequences obtained from 
contaminating DNA180. Contamination may be reduced if greater care is taken during 
DNA preparation and labelling, for instance by ensuring all reagents, columns and tubes 





4.2.2 Identification of mixtures by alignment to short reference genomes 
For many samples this simple alignment is not applicable, since it requires a single 
known reference, which all experimental barcodes are aligned to. In contrast, the 
identification of microorganisms would require all experimental barcodes to be aligned 
to a library of reference barcodes. In reality, a DNA sample will also often contain a 
mixture of genomes. However, if the alignment of DNA barcodes is reliable, then 
individual barcodes should align well enough to a library of reference genomes to 
identify a mixture of DNA.  
Here this simple procedure will be applied on a mixed sample containing T7 and lambda 
DNA. If the data from Figure 4.3 and Figure 4.4 is combined then we have an effective 
ground-truth, since the source of each barcode is known. When each barcode is aligned 
to both T7 and lambda reference barcodes we can examine the results.  
The alignment weights for each barcode, aligned to both references, are displayed as a 
joint scatter and histogram in Figure 4.5. There is separation between the samples, 
although the separation is not complete (due to the issues discussed in Figure 3.21). 
However, an alignment weight threshold of around 0.65 would be sufficient to separate 
most molecules successfully, in other words an alignment weight above 0.65 means the 




Figure 4.5 Alignment of artificially combined samples of pure lambda and pure T7 
DNA. DNA was labelled using M.TaqI with Atto647N, combed and imaged.  
A) Scatter plot showing weight of each molecule for alignment to both the 
T7 and lambda reference barcodes. Molecules from the pure lambda 
sample (black) and from the pure T7 sample (red) can clearly be separated. 
B) Joint histogram showing the same information. 
If a real mixture of DNA is used, i.e. a 1:1 mixture of T7 and lambda DNA then the 
following results can be obtained which agree well with the artificial mixture (Figure 
4.6). 1756 barcodes are extracted (Figure 4.6A), of which 136 align well to lambda 
(Figure 4.6B) and 161 align well to T7 (Figure 4.6C). The distribution of alignment 




Figure 4.6 Alignment of experimental sample of mixed T7/lambda DNA. DNA was 
labelled using M.TaqI with Atto647N, combed and imaged. A) After cleaning 
1756 barcodes are extracted. B-C) Alignment of barcodes with alignment 
weight greater than threshold. At the bottom of the image is shown the 
mean experimental barcode, the mean with the background removed and 
the reference barcode (top to bottom). B) For lambda reference 136 
barcodes are fitted. C) For T7 reference 161 barcodes are fitted.  D) 
Alignment weight to lambda(red) and T7 (blue) of all experimental 
barcodes, with a threshold of 0.7 shown (black). E) Joint histogram for 
weight of each barcode for alignment to both the T7 and lambda reference 
barcodes. 
These methods can be extended to identify bacteriophage DNA. If the barcodes are 
aligned to a library of reference barcodes, then the genome from which the DNA 
originated should be identified. This has already been used on a small number of DNA 
barcodes labelled using M.TaqI,  against a small library of bacteriophages by Grunwald 
et al83.  
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Grunwald et al. used nanochannels to stretch DNA labelled using M.TaqI labelled with 
TAMRA, from which intensity profiles were extracted. This method is inherently lower-
throughput than DNA combing, since the molecules are moving and a time-lapse must be 
recorded, therefore only 85 barcodes were aligned. Extracted barcodes were aligned by 
cross-correlation and assigned to the genome for which the maximum cross-correlation 
was obtained. The results are shown below in Figure 4.7. Barcodes were either from a 
sample of pure lambda DNA (red), of from pure T7 DNA (black), which are clearly 
identified. A similar procedure has also been reported for resistance plasmids, affinity-
labelled and mapped in nanochannels61. 
 
Figure 4.7 Identification of bacteriophage DNA, adapted from Grunwald et al. 
Experimental barcodes from 35 lambda molecules (red) and 50 T7 
molecules (black), labelled using M.TaqI and TAMRA, were aligned, using 
normalised cross-correlation, to 20 different phage reference genomes. 
Each experimental barcode was assigned to the phage to which its 
alignment yielded the highest normalised cross-correlation. The histogram 




This type of analysis can be carried out on the samples which were aligned previously 
(Figure 4.8). In Figure 4.8A similar results are shown, but for over ten times more 
molecules and using the combined weight measure instead of normalised cross-
correlation.  
The T7 sample in particular has many barcodes which are assigned to other genomes. 
This is presumably because molecular combing has introduced the problems mentioned 
previously: artefacts in barcode extraction and overlapping DNA molecules. Therefore, 
there are many ‘junk’ barcodes, which will either be assigned to a reference barcode 
which happens to share the same pattern, or more generally to a reference barcode with 
a particularly intense region (since normalised cross-correlation is biased towards 
bright regions). It is unlikely that the other viruses are present in the sample, therefore 
barcodes which are assigned to other barcodes are likely to be junk barcodes. Examples 
of junk barcodes which are assigned to other genomes are shown in Figure 4.9. 
 
Figure 4.8 Identification of bacteriophage DNA from pure samples. 1098 experimental 
barcodes from pure lambda sample (red) and 752 from pure T7 sample 
(black) aligned and assigned to 20 different phage genomes. A) Each 
experimental barcode was assigned to the phage to which its alignment 
yielded the highest alignment weight. B) The number of fragments fitting to 
each genome with an alignment weight greater than 0.7 
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Using a threshold (e.g. alignment weight>0.7) to remove junk barcodes improves the 
results (Figure 4.8B), the identity of the sample is clear from the alignment of the 
barcodes. However, a notable feature of this analysis is that the greater the number of 
phage genomes, the more experimental barcodes are needed, as they become assigned 
to different genomes by chance. 
 
Figure 4.9 Examples of fragments assigned to genomes other than T7/lambda. 848 
experimental barcodes (red) from a mixed T7/lambda sample were aligned 
to 20 bacteriophage genomes (reference barcodes, blue). Examples of 
fragments assigned to genomes other than T7/lambda are shown. Aligned 




This has also been tested with the T7/lambda experimental mixture (Figure 4.10), 
which further highlights the problems with this approach for this type of data. From the 
approach Grunwald et al. used (Figure 4.10A) it is very difficult to identify the mixture, 
although it is easier when the approach of using thresholds is used (Figure 4.10B). This 
is because there will always be some good alignment to genomes which the DNA is not 
derived from, particularly for junk DNA. For more complex mixtures the problem would 
be exacerbated further. 
A still more fundamental issue exists with this procedure. It takes around 10 seconds to 
align 1000 experimental barcodes against each reference, therefore the total analysis 
takes around 10N seconds in total, where N is the number of genomes in the reference 
library. For running against a library of 2000 genomes this means the procedure takes 
around 5 hours. If the DNA is not in the library, then such an analysis fails to produce the 
correct match.  
 
Figure 4.10 Identification of bacteriophage DNA in a mixed sample. 1756 experimental 
barcodes from a mixed T7/lambda sample. A) Each experimental barcode 
was assigned to the phage to which its alignment yielded the highest 
alignment weight. Note that lambda and T7 cannot be readily identified. B) 
The number of experimental barcodes aligned to each reference genome 




4.2.3 Applications of simple alignment procedure 
Although the simple alignment procedure described above has severe limitations when 
used to identify DNA in a reference library, it is useful for checking the quality, 
methylation state, or sequence of short genomic DNA, for instance from a sample of 
known viral DNA. The number of barcodes that align well to the genome is indicative of 
the quality, whilst the mean alignment may show any discrepancies between the 
experimental barcode and reference barcode. An example of this is shown in Figure 
4.11. Dam methylation (5’-GATC-3’) is known to block restriction by R.TaqI (the sister 
endonuclease to M.TaqI ) at 5’-TCGATC-3’ sites181. This is also expected to block M.TaqI-
directed labelling, since the adenine in the 5’-TCGA-3’ is methylated, however the 
reverse strand reads 5’-GATCGA-3’. Whether this M.TaqI site is labelled is not known. 
This can be tested by optical mapping using M.TaqI-directed labelling. If all 5’-TCGATC-
3’ and 5’-GATCGA-3’ sites are blocked by dam methylation the expected reference 
barcode is shown in Figure 4.11A. There are only 8 such sites, giving very subtle changes 
in the overall intensity profile, shown by the difference in the dam-methylated and un-
unmethylated reference genomes.  
In Figure 4.11B the fragments from Figure 4.3 (dam-negative lambda) are aligned to the 
dam-methylated reference barcode. Apart from a poorer alignment weight overall (290 
barcodes have an alignment weight greater than 0.7 compared to 368 previously), the 
mean experimental barcode can be compared to the reference and the difference 
calculated. When plotted with the expected difference (Figure 4.11C), the known 
discrepancies between the two are clear. When this analysis is repeated for dam-
methylated lambda, similar results are seen (Figure 4.11D). This shows that it is unlikely 
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that M.TaqI-directed labelling is significantly blocked by dam methylation. This result is 
confirmed by results using the de novo alignment which is described later in this chapter 
and is shown in Supplementary Figure 7.13. 
 
Figure 4.11 Effect of dam methylation on M.TaqI-directed labelling. Dam methylation 
occurs at 5’-GATC-3’ sites and M.TaqI-labelling at 5’-TCGA-3’ sites. 
Therefore, for dam-methylated DNA 5’-TCGATC-3’ sites will be unlabelled, 
although the effect on 5’-GATCGA-3’ sites is not obvious. A) The reference 
barcode for lambda DNA if dam-methylation blocks M.TaqI-labelling (red) 
or not (blue) and the difference (black). B) Dam-negative DNA, labelled 
using M.TaqI, is aligned to the dam-blocked reference genome (red). The 
mean alignment is shown (red) and the difference (black). C) The 
difference between the expected and experimental results for dam-
negative lambda DNA. Good agreement is seen, showing the expected 
discrepancies. D) The difference between the expected and experimental 
results for dam-methylated lambda DNA. Similar results are seen to C), 
suggesting dam-methylation does not block M.TaqI-labelling. 
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Another application for this type of alignment is for alignment of a second colour of 
interest, for example bound fluorescently-tagged proteins (e.g. Kim et al.95) or 
incorporated synthetic nucleotides. Here this has been applied to lambda DNA that has 
been affinity-labelled, in addition to M.TaqI-labelling, to demonstrate the procedure. 
Lambda DNA is labelled using M.TaqI with Atto647N as usual, however prior to combing 
the labelled DNA is incubated with YOYO-1 and netropsin. YOYO-1 is a DNA intercalator 
which will normally bind uniformly along the DNA (Supplementary Figure 7.14), 
however netropsin will competitively bind to AT rich regions, therefore generating a 
barcode which represents the underlying GC:AT ratio59. This is combed onto a surface 
and both the M.TaqI-labelling and affinity barcodes are imaged. A typical field of view is 
shown in Figure 4.12. For nanofluidic devices affinity-based labelling works well, 
however for molecular combing there are a number of issues. Ideal combing is difficult, 
there was a large number of overlapping molecules and very few long individual 
molecules could be extracted. Additionally, YOYO-1 binding is difficult to maintain 
during combing, perhaps because the DNA is being stretched, whilst YOYO-1 appears to 








Figure 4.12 Dual colour imaging of lambda DNA labelled using YOYO-1 and M.TaqI-
directed labelling. A typical region is shown for lambda DNA that is labelled 
using M.TaqI with Atto647N, then affinity-labelled using YOYO-1 and 
netropsin. A) Atto647N, B) YOYO-1, C) Overlay of Atto647N (red) and YOYO-
1 (green). Note that there are a large number of overlapping DNA 
molecules, and the YOYO-1 and Atto647N are not as bright or uniform as is 
typical in other experiments. 
Despite these challenges, because of the high-throughput nature of the experiment a 
significant number of experimental barcodes can be extracted, using the M.TaqI-barcode 
as normal (Figure 4.13A and B). The M.TaqI-barcode can then be used for alignment to 
the reference genome. Figure 4.13C shows an individual molecule, in which the 
experimental M.TaqI-barcode is well-aligned. The YOYO-1 intensity does not appear to 
have the affinity-based labelling expected, as there is no difference between GC and AT-
rich regions. However, when many barcodes are aligned (Figure 4.13D) the average 
affinity pattern can be calculated to investigate the ensemble of individual molecules. 
The results for this are shown in Figure 4.13E and F, with and without background 
subtraction. From these results the expected affinity barcode appears to be obtained.  
As well as aligning the second colour using the M.TaqI-barcode, it can be foreseen that 
using two colours for the alignment could improve overall reliability of alignment, 
although this has not been explored here. Conceptually the alignment of both barcodes 




Figure 4.13 Alignment of a second colour using M.TaqI-directed labelling. Lambda DNA 
is labelled using M.TaqI with Atto647N, then affinity-labelled using YOYO-1 
and netropsin. A) M.TaqI-barcodes extracted as normal. B) The M.TaqI-
barcode is used to extract the second colour, YOYO-1. C) An example of an 
individual barcode. The M.TaqI-barcode (red) is used for alignment to the 
reference barcode (blue), and for alignment of the affinity-barcode (green). 
D) Barcodes with an alignment weight greater than 0.65 are used to 
calculate a mean M.TaqI-barcode (red), which aligns well to the reference 
barcode (blue). E) The mean affinity-barcode (red) is calculated and aligns 
to the expected barcode (blue) – generated by CG labelling. F) The 
background is removed from the mean affinity-barcode (red) and aligns to 






4.2.4 De novo separation, alignment and identification of short genomes in 
complex mixtures 
The severe limitations with simple alignment procedures, when applied to identify 
complex mixtures, have been demonstrated previously. Here an alternative method to 
separate and then identify short (e.g. viral) genomes will be demonstrated.  
The first step in this procedure (after line extraction and cleaning) is to separate the 
mixture. If different genomes can be separated at this step this can lead to more rapid 
and reliable identification, since if a consensus barcode can be derived for each genome 
then that can be used for identification, rather than unreliable individual barcodes. 
Separation will be achieved by treating barcodes as a network and detecting 
communities of similar DNA barcodes from within this network. When constructing the 
network, the ‘affinity’ of experimental barcodes will be used to define the edges of the 
network, with the barcodes themselves defining the nodes. This will be assessed by the 
alignment weight. 
Consider for instance a simple network of four overlapping DNA barcodes (Figure 
4.14A). An affinity matrix (Figure 4.14B) comparing all experimental barcodes is 
generated, by aligning all barcodes to all other barcodes and using alignment weight. 
Overlapping barcodes will, in general, have a higher alignment weight than non-
overlapping barcodes. This is converted into an adjacency matrix (Figure 4.14C) using a 
simple threshold, for instance the two most similar edges for each node are retained 
above a certain alignment weight. Finally, this network can be refined (Figure 4.14D) by 
removing edges between nodes that don’t share many connections or by adding in edges 
between nodes that share many connections. These networks can then be visualised as 
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graphs and the communities and the order of DNA barcodes (for instance from a long 
genome) should be generated. 
 
Figure 4.14 Representation of the principles for generating a network from 
experimental DNA barcodes. A) Consider four overlapping DNA barcodes. 
B) An affinity matrix is calculated by calculating the similarity (alignment 
weight) between each barcode. C) This is converted to a simple adjacency 
matrix by using a threshold. D) Edges can be removed or added based on 
how many neighbours are shared between nodes, to produce a final 
adjacency matrix. 
A process known as t-Distributed Stochastic Neighbour Embedding (t-SNE)182 is used to 
visualise these networks. t-SNE is a machine learning algorithm for dimensionality 
reduction, particularly suited to visualising high-dimensional datasets. It models each 
high-dimensional object as a two or three-dimensional point, in which similar objects 
are modelled as nearby points and dissimilar objects as distant points. This is a good 
method to view the results from generating the network. An example of this is shown in 
Figure 4.15, in which the affinity matrix is calculated by two-dimensional normalised 
cross correlation. Images that are similar (i.e. have a high maximum normalised cross-
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correlation) are clustered together in two-dimensional space, since they will have 
formed a community within the network. 
 
Figure 4.15 Example of t-Distributed Stochastic Neighbour Embedding (t-SNE) for 
visualisation of networks. 10 images of members of the Neely group are 
used to generate 100 noisy and cropped images (padded to the same size 
with appended zeros). Two-dimensional normalised cross correlation 
between every image is used to calculate an affinity matrix. t-SNE is used 
for visualisation of the communities within the network defined by this 
affinity matrix. 
An example of this process applied to DNA barcodes is shown in Figure 4.16. 
Experimental barcodes can be generated in silico from the 20 bacteriophage genomes in 
the reference library and the affinity (i.e. alignment weight) between barcodes 
calculated. For 1000 barcodes this takes approximately 1 minute and will scale with the 
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square of the number of barcodes. This will therefore become prohibitive if large 
numbers of barcodes are to be aligned, but for example 1000 barcodes is sufficient to 
give around ten times coverage of an E. coli genome. This can then be used to generate 
an affinity matrix (Figure 4.16A) and an adjacency matrix (Figure 4.16B, refined in 
Figure 4.16C). The results can be visualised by using t-SNE (Figure 4.16D) and barcodes 
generated from the same genome are clearly clustered together.  
 
Figure 4.16 Example of network generation and visualisation for barcodes generated in 
silico. 50 barcodes are generated for 20 phage genomes, with 100% 
labelling efficiency. A) Affinity matrix. The generated barcodes are ordered, 
and the diagonal clusters are clear. B) Adjacency matrix. An alignment 
weight threshold of 0.65 and 10 edges per node is used. C) Refined 
adjacency matrix. Edges between nodes that share fewer than 3 neighbours 
are removed. D) t-SNE visualisation. Each point represents a single barcode 




To detect clusters of barcodes that are generated from the same genome a community 
detection algorithm can be used. There are many algorithms available which can detect 
communities within networks, based on the adjacency matrix. A fast greedy modularity 
maximization method (by Erwan Le Martelot)183, which has a Matlab implementation, 
has been selected for speed, and good unsupervised clustering. The results of this are 
shown for a realistic simulation in Figure 4.17.  
Between 50 and 430 barcodes were generated with 50% labelling efficiency and 
realistic experimental parameters for each genome (see Supplementary Table 7.1). An 
adjacency matrix was calculated and a t-SNE visualisation of the results is shown in 
Figure 4.17B. The communities that are detected are shown in Figure 4.17B and cluster 
validation gives a Jaccard index of 0.8599 and Rand index of 0.9927. The Jaccard and 
Rand indexes are measures of clustering defined as: 
𝐽𝑎𝑐𝑐𝑎𝑟𝑑 𝑖𝑛𝑑𝑒𝑥 =
𝑀11




𝑀01 + 𝑀10 + 𝑀11 + 𝑀00
  
Where:  
𝑀11= barcodes that are clustered in both ground truth and community detection;      
𝑀00= barcodes that are not clustered in either ground truth or community detection; 
𝑀10= barcodes that are clustered in ground truth but not community detection;         
𝑀01= barcodes that are not clustered in ground truth but are in community detection. 
The number of clusters gives a good indication of how much faster this method will be 
for identification of the mixture. For instance, if 1000 fragments are reduced to only 10 
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clusters, then only 10 barcodes (derived from the clusters) need to be identified. This 
will equate to a 100-fold decrease in the number of fragments that must be aligned 
against the reference library and a corresponding decrease in computation time. 
 
Figure 4.17 Community detection for barcodes generated in silico. 50 to 430 barcodes 
are generated for 20 phage genomes, with 50% labelling efficiency. A) t-
SNE visualisation of network generated from adjacency matrix. Each colour 
represents a different genome. B) Community detection. Each colour 
represents a community that has been detected. 
Once barcodes are separated and clustered, the next step is to align the clusters to 
produce a consensus barcode, from which the genome can be identified. A method for 
generation of consensus barcodes has been described previously by Reisner et al53 and a 
hierarchical method was used by Nyberg et al61 which could be applied to mixtures. The 
main drawback with these approaches is that barcodes are combined one at a time, 
which is problematic due to the presence of junk barcodes and for large datasets. By 
chance barcodes which are not from the original genome (i.e. the genome most of the 
cluster are from) can be incorporated to the consensus barcodes. As they are 
incorporated the consensus barcode will be significantly affected, meaning mis-
incorporation of another barcode is even more likely in the next step and effectively 
amplifying the problem. 
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Here an alternative procedure is described that produces a global alignment of barcodes 
in one step. Barcodes are aligned to each other to give a value of the normalised cross-
correlation at each displacement and for both orientations. The optimum consensus 
barcode will give a maximum for the overall cross-correlation between barcodes, i.e. a 
maximum global fit. Finding this optimum is not a trivial problem, since for even 100 
barcodes there will be 198 parameters to optimise (99 displacements and 99 
orientations). Therefore, to enable rapid alignment only 100 possible combinations of 
parameters will be tested, by fixing each barcode in turn and maximising the cross-
correlation for each other barcode to the fixed barcode. The global fit can be calculated 
for each fixed barcode and the maximum global fit gives a reasonable consensus 
barcode. The whole procedure is as follows: 
1. Prepare barcodes for normalised cross-correlation 
• Stretch all barcodes using same estimated stretch 
• Store both orientations (forward and reverse) 
2. Normalised cross-correlation calculated 
• Calculated for every fragment aligned to every other fragment (forward 
and reverse) 
• Store value at every displacement and orientation 
3. In turn, fix each barcode and use to align every other barcode 
• Position (and orient) every barcode based on maximum normalised cross-
correlation to fixed barcode 
• Calculate global fit, i.e. sum normalised cross-correlation for all barcodes 
4. Use maximum global fit to align barcodes 
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• Average to generate consensus barcode 
This procedure can be tested on barcodes which are known to fit well to a reference 
barcode, for instance for experimental data for T7 (Figure 4.4). The top 36 well-aligned 
barcodes (Figure 4.18A) can be used and give remarkably good results. The de novo 
alignment is shown in Figure 4.18B and can be compared to the known alignment in 
Figure 4.18C, which shows that 32 out of 36 barcodes are well aligned. The final 
consensus barcode is shown in Figure 4.18D and is recognisable as the T7 reference 
barcode. 
 
Figure 4.18 De novo alignment results for experimental T7 data. T7 DNA was labelled 
using M.TaqI with Atto647N, experimental barcodes extracted and aligned 
to the T7 reference genome. A) 36 barcodes are chosen that aligned well 
(alignment weight>0.72) to the reference genome. Their alignment 
position is known and displayed. B) De novo alignment of the 36 barcodes, 
without a known reference. C) Known alignment (black) against de novo 
alignment (red). Relative displacement is indicated for each barcode and 
the orientation is indicated by the size of each point. D) Consensus barcode 





The consensus barcode can be aligned against the reference library as normal to identify 
the genome (Figure 4.19). At this stage the ends are cut, background can be removed, 
and the consensus barcode can be discarded based on similar criteria to individual 
barcodes (e.g. length, brightness etc.), as well as how good the global fit is. Importantly 
as well as being many times quicker, the alignment weight is generally higher than for 
individual barcodes, making for more reliable identification. Also, if the barcode is not in 
the reference library, or has discrepancies (e.g. insertions, deletions, rearrangements, 
mutations) then this will be evident. 
 
Figure 4.19 Alignment of consensus barcode to library of bacteriophages for 
identification. A) The ends of the consensus barcode from Figure 4.18 and 
background are removed.  The consensus barcode (red) aligns well to the 
T7 reference barcode (blue). B) Consensus barcode is aligned to 20 phages 
and can be clearly identified by the alignment weight. 
This procedure can now be applied to the complex simulated mixture of 20 viral 
genomes. Barcodes are generated in silico and clusters identified as shown in Figure 
4.17. A consensus barcode for each cluster is calculated prior to identification from a 
large reference library. For 4800 DNA barcodes, grouped into 23 clusters and aligned 
against a library of 2000 phage genomes this whole process takes around 1 hour. By 
comparison the alignment of every barcode takes around 24 hours. The final 
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identification is shown in Figure 4.20, which shows how successful this procedure has 
been at rapidly identifying and quantifying the complex mixture. 
 
Figure 4.20 Identification and quantification of complex mixture of phages, generated 
in silico. 50 to 430 barcodes are generated for 20 phage genomes, with 50% 
labelling efficiency. Clustering was shown in Figure 4.17. A consensus 
barcode was generated for each cluster, aligned to a library of 2000 phages 
and assigned to the phage for which the maximum alignment weight was 
obtained. A) Quantification of the result. For each genome the number of 
barcodes generated in silico is shown as well as the number of barcodes 
contributing to consensus barcodes that were subsequently assigned. B) A 
plot of these results is shown, showing quantification is good. 
The consensuses barcodes and alignment results can be interrogated by either the 
clusters or genomes to check results. The number and size of clusters is shown in Figure 
4.21A. In this example all clusters are used for alignment to the reference library, 
however in reality clusters which have been discarded (i.e. clusters composed of junk 
barcodes) can be highlighted at this point. Each cluster can be investigated in more 
detail, for instance the alignment to the consensus barcode for cluster 8 is shown in 
Figure 4.21B. This consensus barcode correctly identifies BarrelRoll, but also identifies a 
number of other genomes which share a high sequence identity, alignments to which are 
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shown in Figure 4.21C-E. This illustrates the power of this technique, since even when 
the reference barcode is not present similar genomes would be identified and the 
differences can be explored. 
 
Figure 4.21 Alignment results for de novo alignment of mixture generated in silico, by 
cluster. 50 to 430 barcodes were generated for 20 phage genomes, with 
50% labelling efficiency. Clustering is shown in Figure 4.17 and the 
numbers of barcodes in each cluster is quantified in A). B) Alignment 
results for consensus barcode generated from cluster 8. The best match 
(i.e. highest alignment weight) is for the correct phage, BarrelRoll. Also 
identified are genomes which share significant sequence identity: CrimD, 
Angelica and Murucutumbu. C-E) Alignment results are shown for 
consensus barcode (red) to reference barcode (blue) for: C) BarrelRoll, D) 





Another way to interrogate the mixture is by genome (Figure 4.22). Each cluster is 
assigned to the genome for which the maximum alignment weight is obtained, and the 
resulting identification of the mixture is shown in Figure 4.22A. An example of the 
alignments to phiMAM1 is shown in Figure 4.22B. There are two clusters which have 
very high alignment weights, which are shown in Figure 4.22C and D. These show that 
two clusters were identified, for barcodes generated from either end of the genome.  
This also demonstrates that for many genomes it is difficult to use this procedure to 
obtain de novo barcodes covering the whole genome. If the genome is significantly 
longer then the experimental barcodes, then the procedure is not sophisticated enough 
to obtain the full-length barcode. This may be for instance due to are regions of 
relatively low-density information (i.e. few peaks and troughs) or regions for which 





Figure 4.22 Alignment results for de novo alignment of mixture generated in silico, by 
genome. 50 to 430 barcodes were generated for 20 phage genomes, with 
50% labelling efficiency. Clustering is shown in Figure 4.17. Consensus 
barcodes are generated for each cluster and aligned to a library of 
reference genomes. A) They are assigned to the genome which has the 
greatest alignment weight allowing for quantified identification of the 
mixture. B) Example results for phiMAM1 genome. Cluster 15 and cluster 
22 align well to the genome. C-D) Alignment to phiMAM1 reference barcode 
(blue) of consensus barcode (red) generated from C) Cluster 15, D) Cluster 
22. 
This procedure can be applied to experimental mixed data. Clustering and t-SNE results 
for a known mixture of T7/lambda (see Figure 4.5) are shown in Figure 4.22. This takes 
around 2 minutes for 1500 fragments. Here we can note that the different genomes are 
separated, but not as well as in simulations (e.g. Figure 4.17), seemingly producing a 
rather poor clustering result overall. This is likely due to the junk barcodes that have 




Figure 4.23 Community detection for known mixture of lambda and T7 barcodes. DNA 
was with Atto647N, combed and imaged. A) t-SNE visualisation of network 
generated from adjacency matrix. Barcodes are from lambda (blue) and T7 
(yellow) samples. B) Community detection. Each colour represents a 
community that has been detected. 
Despite this, consensus barcodes can be derived for each cluster. Clusters are discarded 
which have poor de novo alignments or by the criteria used previously (Figure 4.24A). 
When the cleaned clusters are aligned to the library of 2000 phage genomes the results 
in Figure 4.24B are obtained. T7 and lambda are clearly identified within the sample and 
further interrogation can be used to show the alignment of consensus barcodes (Figure 
4.24C and D). Only clusters 5, 8 and 9 do not align well to either genome, therefore are 
likely constructed from junk barcodes, however these can be discarded for 





Figure 4.24 Alignment results for lambda/T7 mixture using de novo alignment and 
assignment of consensus barcodes. A) Experimental barcodes (Figure 4.6A) 
are separated into 9 clusters and aligned de novo to generate consensus 
barcodes. 7 consensus barcodes are used for assignment of the mixture 
(highlighted with red boxes), based on global alignment, length and 
intensity. B) Assignment of consensus barcodes to phage genomes. 
Consensus barcodes are aligned to a library of 2000 phages and assigned to 
the genome with the greatest alignment weight. C) Results for lambda 
reference. Four consensus barcodes align very well to the genome, and the 
top two alignments are displayed. D) Results for T7 reference. Two 
consensus barcodes align very well to the genome and are displayed. 
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These results can be compared to the previous alignment procedure (Figure 4.8). 920 
out of 1850 barcodes are identified as lambda and 462 as T7, compared to 328 and 188, 
respectively, previously. The previous procedure also identifies many other genomes 
during the analysis whilst using de novo alignment identification is more reliable. These 
results are for a library that is 100 times larger but only takes twice as long to compute 
(16 minutes for 2000 genomes against 8 minutes for 20 genomes). 
The only issue with the results is that it appears that one cluster has been misidentified 
as HK630. This is investigated further in Figure 4.25, which shows the consensus 
barcode also aligns well to lambda. HK630 (and HK629) share a large amount of 
sequence identity with lambda, meaning the reference barcodes are very similar, hence 
the apparent misidentification. 
 
Figure 4.25 Alignment results for consensus barcode from cluster 3 of lambda/T7 
mixture of Figure 4.24. Cluster is assigned to HK630, which shares 99% 




Results for the pure samples of lambda and T7 (Figure 4.3 and Figure 4.4), and a mixed 
sample (Figure 4.6) are shown in Supplementary Figure 7.15, Figure 7.16 and Figure 
7.17. A summary and comparison of the alignment procedures for these samples is 
shown in Table 4.1. The improved alignment procedure is both more rapid for 
assignment against a large reference library and more reliable for identification. 
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barcode to every genome in reference 
library (20 phages) 
Separation, de novo alignment and 
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*181 barcodes assigned to HK630 and 45 barcodes to HK629, which both share 99% sequence identity with 
lambda 
**Consensus barcodes are discarded based on global alignment of experimental barcodes, length and intensity. 
Table 4.1 Summary and comparison of alignment procedure for samples of lambda 








4.2.5 Identification of Adenovirus A 
To illustrate these procedures on a more realistic sample they were applied to identify a 
sample of Adenovirus A. DNA was extracted from Adenovirus A-infected human cells 72 
hours post-infection. Gel electrophoresis of DNA extracted pre-infection and after 48 
hours showed that most of the long fragments were viral DNA (Supplementary Figure 
7.18). DNA was labelled with Atto647N, combed and imaged as normal.  
Around 2000 barcodes were extracted from the sample and were aligned to a reference 
library of 128 vertebrate viruses, in turn, which took approximately one hour. The 
results are shown in Figure 4.26A. 276 out of 1986 barcodes (14%) are assigned to 
Human adenovirus, however a very large number of barcodes are assigned to other 
viruses, so the sample cannot be reliably identified. For instance, 82 (4%) of barcodes 





Figure 4.26 Assignment of Adenovirus A DNA sample by alignment of each barcode to 
each reference genome. 1986 experimental barcodes were extracted and 
aligned to 128 reference barcodes from a library of vertebrate viruses. A) 
Barcodes are assigned to the genome with the maximum alignment weight 
(with a threshold of 0.7). 276 of 1986 barcodes are assigned to Adenovirus 
A. B-D) Examples of alignments of experimental barcodes to: B) Human 
adenovirus A; C) Fowl adenovirus A; D) Simian adenovirus 20. 
By using clustering and de novo alignment to produce consensus barcodes, more reliable 
identification of the sample is possible. Results are obtained in 10 minutes and are 
shown in Figure 4.27. 669 (34%) barcodes are assigned to Human Adenovirus A and 
consensus barcodes show very high similarity to the reference barcode (Figure 4.27B 
and C). No other references are assigned as all other consensus barcodes are discarded 





Figure 4.27  Assignment of Adenovirus A DNA sample by separation, de novo alignment 
and assignment of consensus barcode to reference library. 1986 
experimental barcodes were extracted and produced 21 consensus 
barcodes for alignment to 128 reference barcodes from a library of 
vertebrate viruses. 669 of 1986 barcodes are assigned to Adenovirus A. A-
B) Examples of alignment of consensus barcodes. 
4.2.6 Separation and identification of viral DNA for complex genomic 
mixtures 
The results for Adenovirus A highlight another aspect of de novo separation and 
alignment of barcodes. As well as junk DNA there will be human genomic DNA present in 
the sample. In other words, the sample is not pure, but a mixture of viral and genomic 
DNA. By using separation and clustering it is possible to identify the viral DNA if the 
copy number is sufficiently high, therefore it is possible that this procedure may also be 
extended to identify resistance plasmids.  
To test this a simple model system was used: DNA was extracted from E. coli, with 
Atto647N as usual and mixed in a ratio of 4:1 with labelled bacteriophage DNA, for 
example lambda DNA. The bacterial genome is around 100 times longer than the viral 
DNA, so this is equivalent to a copy number of around 20. More barcodes must be 
imaged to enable reliable identification (5000 compared to around 1000 before), which 
will make rapid alignment more important. 
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A 4:1 mixture of genomic DNA from E. coli strain C2566 (henceforth referred to as NEB 
‘T7 Express’) and lambda DNA was imaged, and 5114 barcodes extracted and aligned to 
the lambda reference barcode. Results are shown in Figure 4.28A and B; 195 (4%) 
barcodes are assigned to the lambda reference genome (alignment weight greater than 
0.7), compared to 368 out of 1077 (34%) in the pure sample.  
 
Figure 4.28 Identification of bacteriophage DNA in genomic mixture by alignment of 
experimental barcodes to reference barcodes. DNA is with Atto647N and a 
4:1 mixture of E. coli:lambda is combed and imaged. 5114 barcodes are 
extracted from the images. A) 195 (4%) of barcodes aligned with 
weight>0.7 to lambda reference barcode. B) Alignment weight of all 
experimental barcodes to lambda reference. C-D) Identification of barcodes 
against a library of 20 phage genomes. C) Each barcode is assigned to the 
genome for which the largest alignment weight was obtained. D) The 
number of barcodes assigned to each genome with an alignment weight 
greater than a threshold (0.7, 0.75 and 0.8). 
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If the sample is known, then short genomes can be identified and relatively easily 
extracted by simple alignment like this. However, it is very difficult to identify a complex 
sample if the DNA is not known. To obtain suitable coverage, around five times the 
number of fragments are aligned to the reference library, slowing the procedure by the 
same amount. In addition, there is a much greater chance that barcodes will be assigned 
incorrectly, since as well as junk barcodes there are barcodes derived from the genomic 
DNA, which may, by chance, align well to a reference barcode. Results are shown in 
Figure 4.28C, for assignment of each barcode to the genome with the maximum 
alignment weight, and in Figure 4.28D for the assignment of barcodes to genomes based 
on thresholds of alignment weight. Lambda can be identified in the sample, but not 
reliably. 
In contrast when de novo separation and alignment of the sample is carried out lambda 
is reliably identified (Figure 4.29). The adjacency matrix and clustering is visualised by 
t-SNE in Figure 4.29A and B. Barcodes that fit well to lambda form a clear cluster which 
is identified during community detection. When consensus barcodes are derived for 
each cluster, only two are selected (based on global alignment, length and intensity), 
which both align well to lambda (Figure 4.29C-E). When compared to the procedure in 
Figure 4.28 it is clear that de novo separation and alignment can be used to give more 
reliable results. Previously it was difficult to identify lambda against the background of 
junk and genomic barcodes, however separation and generation of a consensus barcode 





Figure 4.29 Identification of bacteriophage DNA in genomic mixture by de novo 
separation and alignment of experimental barcodes. A) t-SNE visualisation 
of network generated from adjacency matrix. Colour is given by alignment 
weight to lambda reference genome. B) Community detection. Each colour 
represents a community that has been detected. C-D) Examples of 
alignment of consensus barcodes. Barcodes are assigned to the genome 





In addition, results have also been obtained for a 4:1 mixture of E. coli and T7 
(Supplementary Figure 7.19 and Figure 7.20) and for a 4:1:1 mixture of E. coli, lambda 
and T7 (Supplementary Figure 7.21 and Figure 7.22). The results are summarised in 
Table 4.2, once again highlighting the improvements when using de novo alignment, in 
particular note the number of other genomes to which barcodes are assigned, which 
make reliable identification problematic. 
 Alignment of each experimental 
barcode to every genome in reference 
library (20 phages) 
Separation, de novo alignment and 
assignment of consensus barcode to 
reference library (2000 phages) 









No. of barcodes assigned to: Comput-
ation 
time 
lambda T7 Other 
genomes 

















































*Consensus barcodes are discarded based on global alignment of experimental barcodes, length and intensity. 
Table 4.2 Summary and comparison of alignment procedures for samples of E. coli 




4.2.7 Separation and identification of resistance plasmids in complex 
genomic mixtures 
Given the reliable results for experimental mixtures of viral DNA and E. coli genomic 
DNA it should be possible to extend these approaches to mixtures of resistance plasmids 
and genomic DNA. The isolation and purification of large, low copy number, plasmids 
(such as resistance plasmids) is generally time-consuming and difficult, so if it can be 
avoided then it would aid with rapid diagnosis. Several reference plasmid/bacteria 
systems will be used experimentally here to test this separation and identification: pCT 
(94 kbp) in E. coli strain EC958 (5,249 kbp); pNDM (89 kbp) in E. coli strain DH10B 
(4,686 kbp); and pKpQIL (114 kbp) in K. pneumoniae strain Ecl8 (5,325 kbp).  
There are several important differences when considering these samples. The copy 
number of the resistance plasmids is likely to be very low, perhaps only 1-5 copies per 
cell, compared to around 20 for the artificial lambda/T7 mixtures. These plasmids will 
also be circular, rather than the linear viral DNA that has been used to this point. These 






Figure 4.30 Identification of resistance plasmids by alignment of DNA barcodes, copy 
number=5. 5000 barcodes were generated in silico for a pCT:E. coli mixture, 
in a ratio of 11:1 (copy number of 5). A) Simple alignment of barcodes to 
pCT reference barcode. i) pCT is circular, so a linear reference barcode 
(red) is unsuitable for alignment. A region of the barcode, of the length of 
the largest experimental barcode, is appended to the end to simulate a 
circular reference (blue). ii) The alignment weight of all fragments is 
shown and shows that simulating a circular reference improves the 
alignment results. B) De novo separation of barcodes. t-SNE is used to 
visualise the network generated from the adjacency matrix. i) Barcodes 
generated from pCT (yellow) and E. coli (blue) reference genomes. ii) 
Weight of alignment to pCT reference genome in A). iii) Community 
detection. C) De novo alignment of barcodes to generate consensus 
barcodes (red). The three clusters are shown that align well (weight>0.85) 





5000 barcodes were generated in silico, from the reference genomes for E. coli strain and 
pCT, in a ratio which reflects a copy number of 5 (~11:1, E. coli:pCT). These were 
generated with typical experimental parameter values, for example a labelling efficiency 
of 50%. From the simple alignment of all barcodes to the pCT reference genome 377 
barcodes align with a weight greater than 0.7 when the circularity of plasmids is not 
considered (Figure 4.30A). However, this can be simply altered by appending a copy of 
the reference genome, of the length of the maximum barcode, to the end of the linear 
reference. Now 503 barcodes align with a weight greater than 0.7 (Figure 4.30A). In 
experimental samples, it is likely that the natural shearing of DNA during simple DNA 
extraction procedures is sufficient to linearise most plasmid molecules. An example 
restriction assay for an experimental sample is shown in Supplementary Figure 7.5 and 
shows that the majority of fragments are 30-50 kbp in length, despite no explicit step to 
shear genomic DNA. 
De novo separation and alignment of barcodes can also be carried out (Figure 4.30B-C). 
There is a clear cluster formed by barcodes generated from the pCT reference genome, 
which can be separated automatically into several clusters. The consensus barcodes 
from these clusters aligns well to the reference genome and can be used to reliably 
identify the resistance plasmid in the sample. 
Despite these results the identification of resistance plasmids in experimental samples 
was unsuccessful (data not shown). This could be for a number of experimental reasons, 
however perhaps the most likely reason is that the copy number is very low, perhaps 
only 1-2 per cell. This may have been reduced further during purification, since a 
commercial genomic DNA extraction kit was used, which may have caused the loss of 
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most plasmids from the sample or if plasmids have not sheared they will not bind to the 
surface during molecular combing. A copy number of one plasmid per cell (~55:1 E. 
coli:pCT) is simulated in Figure 4.31 to test this; 90 barcodes out of 5000 are generated 
from pCT. When compared to a copy number of 5 in Figure 4.30 the results are striking 
and similar to the experimental results. 
Few molecules are reliably identified by alignment weight (Figure 4.31A), but perhaps 
more importantly the de novo separation and clustering of barcodes fails to produce any 
significant cluster of barcodes generated from the pCT reference (Figure 4.31B). This 
means there is no possibility to generate a consensus barcode that can be reliably 
identified. The top three consensus barcode alignments to the pCT reference are shown 
in Figure 4.31C. These results demonstrate the propensity of cross-correlation to align 
barcodes to bright regions of the reference genome. This leads to 211 barcodes aligned 
to the reference genome with a weight greater than 0.7, of which 123 were generated 
from the E. coli reference and only 88 from the pCT reference. The alignment to the 
bright region is also clear in Figure 4.31Aii.  
These results demonstrate the challenges for alignment of barcodes, particularly in 
complex mixtures. Good experimental data and a relatively high copy number are 
necessary to reliably identify small DNA fragments from a mixture. To ensure good 
experimental data both optimisation of the methyltransferase-directed labelling (as in 
CHAPTER 2) and careful imaging of individual labelled DNA molecules are required. In 
particular, the molecular combing employed in this research appears to introduce many 
junk molecules that make identification difficult. Therefore, further development of 
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imaging techniques (including nanochannels) would improve the reliability of 
identification. 
 
Figure 4.31 Identification of resistance plasmids by alignment of DNA barcodes, copy 
number=1. 5000 barcodes were generated in silico for a pCT:E. coli mixture, 
in a ratio of 55:1 (copy number of 1). A) Simple alignment of barcodes to 
pCT reference barcode. i) The alignment weight of all fragments. 211 
barcodes align with a weight greater than 0.7, but only 88 of these are 
originally generated from pCT. ii) The mean alignment of 211 barcodes 
with alignment weight greater than 0.7. B) De novo separation of barcodes. 
t-SNE is used to visualise the network generated from the adjacency matrix. 
i) Barcodes generated from pCT (yellow) and E. coli (blue) reference 
genomes. ii) Weight of alignment to pCT reference genome in A). iii) 
Community detection. C) De novo alignment of barcodes to generate 
consensus barcodes (red). Three clusters are shown aligned to the pCT 




4.2.8 Identification of bacterial species and strains 
In this final section these procedures are applied to the identification of bacterial species 
and strains. This is a more challenging problem than the identification of short genomes, 
since previously the experimental barcodes were around the same size as viral genomes 
but are now around 100 times shorter than bacterial genomes. Consequently, to get the 
same coverage 100 times more fragments are required, which slows computation speed, 
whist in addition the alignment to the correct region of the genome is 100 times more 
difficult. Despite these challenges, identification of genomes by using affinity labelling 
has been demonstrated by Nilsson et al.63 It was shown previously that a lower density 
of labelling improves alignment to bacterial genomes (see 3.2.6), therefore using M.TaqI-
directed labelling should allow for more reliable identification. 
To test this, fragments were generated in silico from the E. coli strain EC958, with 50% 
labelling efficiency, and aligned to a library of bacterial genomes. This simple 
identification procedure is conceptually the same as that applied for bacteriophage 
genomes (e.g. Figure 4.10), however now alignment is 100 times slower (since the 
reference genomes are 100 times longer). The results for this alignment are shown in 
Figure 4.32 and Figure 4.33, and show that the strain can clearly be identified. Barcodes 
are either assigned to reference genomes based on the maximum alignment weight 
(Figure 4.32A) or by an alignment weight threshold (Figure 4.32B). In this simulated 
data the threshold does not identify the species/strain as clearly as the assignment to 
the maximum alignment weight. This is in contrast to short genomes (e.g. Figure 4.8), 
since there is now a much greater chance that a fragment will align well, by chance, to a 
bacterial genome, since there are many more possible sites of alignment. 
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First, the barcodes are aligned to a library of 23 bacterial genomes that represent a wide 
range of bacterial species, this is shown in Figure 4.32. Since strains of the same 
bacterial species will have similar genome sequences this can be used to identify the 
species before identifying the strain, for example in this case E. coli K-12 is clearly 
identified.  
This allows for the barcodes to be aligned to a refined library of E. coli genomes for more 
accurate identification, the results of alignment to 10 E. coli genomes is shown in Figure 
4.33. E. coli strain EC958 is rapidly (~1 hour) and clearly identified based on the 
generated barcodes. Also evident is the similarity of genomes, which can make it difficult 
to resolve genomes which share regions of largely identical sequences. For example, 
JJ1886 is most closely related to EC958 and SE15 is slightly more distantly related, but 
all three belong to the ST131 specific lineage184. CFT073 and 536 strains belong to the 
same B2 phylogroup, so also share a large amount of sequence similarity, however other 




Figure 4.32 Identification of in silico barcodes generated from E. coli strain EC958, by 
species. 100 barcodes were generated in silico from the E. coli strain EC958, 
with 50% labelling efficiency. A) Each barcode was assigned to the species 
to which its alignment yielded the highest alignment weight. B) The 
number of barcodes aligned to each reference genome with an alignment 




Figure 4.33 Identification of in silico barcodes generated from E. coli strain EC958, by 
strain. 100 barcodes were generated in silico from the E. coli strain EC958, 
with 50% labelling efficiency. A) Each barcode was assigned to the strain to 
which its alignment yielded the highest alignment weight. B) The number 
of barcodes aligned to each reference genome with an alignment weight 




For experimental barcodes this type of identification is not as reliable. Results are 
shown for an experimental sample of E. coli strain DH10B in Figure 4.34 and Figure 4.35. 
E. coli is identified from the library of bacteria (Figure 4.34), but not as clearly as before 
since a higher proportion of barcodes also align well to other genomes. These are either 
junk barcodes that have been discussed previously, or experimental barcodes which do 
not align as well as those generated in silico because of poorer experimental parameters 
such as labelling efficiency.  Regardless, DH10B is also the genome that is identified 
when the barcodes are run against the library of E. coli genomes (Figure 4.35).  
Note that although fewer than 1000 barcodes are used for this alignment, giving 
relatively poor coverage of the genome, the identification is robust. A relatively low 
coverage must be used to reduce computation time and therefore fragments can be 
filtered thoroughly (based on length and the intensity profile). Consequently, the 
fragments that remain are of high quality and identification appears to be reliable. The 
number of fragments assigned to E. coli is over double any other species, and E. coli is 
the only species with a significant number of fragments that have an alignment weight of 




Figure 4.34 Identification of E. coli strain DH10B, by species. Identification of bacterial 
DNA by species. A sample of E. coli strain DH10B was labelled using M.TaqI 
with Atto47N, combed and images as normal. A) Each barcode was assigned 
to the species to which its alignment yielded the highest alignment weight. 
B) The number of barcodes aligned to each reference genome with an 




Figure 4.35 Identification of E. coli strain DH10B, by strain. A sample of E. coli strain 
DH10B was labelled using M.TaqI with Atto47N, combed and images as 
normal. A) Each barcode was assigned to the strain to which its alignment 
yielded the highest alignment weight. B) The number of barcodes aligned 
to each reference genome with an alignment weight greater than 0.7 (blue), 





This has also been used to identify the three samples which contained resistance 
plasmids, and which were from: E. coli strain DH10B; E. coli strain EC958 and K. 
pneumoniae strain Ecl8. The species can be identified by assigning barcodes to the strain 
with which the highest alignment weight is obtained (Figure 4.36A). Only a draft 
complete genome sequence is available for EcI8, however the E. coli strains can be 
identified from a library of E. coli genomes (Figure 4.36B). Here barcodes are assigned to 
a genome if a threshold of 0.75 is reached for the alignment weight. DH10B is clearly 




Figure 4.36 Identification of E. coli strain DH10B; E. coli strain EC958 and K. 
pneumoniae strain Ecl8. DNA from E. coli strain DH10B; E. coli strain EC958 
and K. pneumoniae strain Ecl8 was extracted, labelled using M.TaqI with 
Atto647N, combed and imaged as normal. Between 100 and 1000 
experimental barcodes were used from each sample for alignment. A) Each 
barcode was assigned to the species to which its alignment yielded the 
highest alignment weight. DH10B (cyan) and EC958 (yellow) are both 
identified as E. coli and Ecl8 (blue) as K. pneumoniae. B) The number of 
barcodes aligned to each E. coli reference genome with an alignment weight 




As well as identifying bacteria this type of simple alignment can be used if a strain is 
already known to confirm the genome identity. For example, if barcodes which are 
generated in silico from the DH10B strain are aligned to the reference genome of the 
same strain then the alignment weight and number of barcodes fitting across the 
genome is consistent (Figure 4.37A). However, if the same barcodes are aligned to the 
closely-related strain W3110 then there are several regions where barcodes align poorly 
(Figure 4.37B).  A BLAST analysis can be carried out to compare the genomes and show 
the regions of difference (larger than 5 kbp). These appear to line up with the regions 
where poor alignment is occurring. This type of analysis therefore shows the regions in 
which the genome sequences differ and can be used to trace evolutionary history or to 
check sequence alignment. Experimental results are shown in Figure 4.37C and D, 
however the results are not as clear, presumably as a result of junk barcodes but may 
also be due to other experimental factors which limit correct alignment (e.g. labelling 
efficiency). Note how there are several regions where alignment is preferred, these are 




Figure 4.37 Examination of alignment across reference genome sequences. 5000 
fragments were generated in silico from the DH10B genome, with 50% 
labelling efficiency for analysis in A) and B). For C) and D) around 5000 
fragments were extracted from an experimental sample of DH10B genomic 
DNA. A and C) The alignment of fragments across the DH10B reference 
barcode. The no. of barcodes aligned across the reference (blue) and the 
mean alignment weight across the reference (red) is shown. The alignment 
across the reference is consistent. B and D) The alignment of DH10B 
fragments across the W3110 reference barcode. Now the number of 
barcodes aligning (blue) and the mean alignment weight (red) shows 
regions of poor alignment. These regions correlate with differences in the 
genomes which can be shown by BLAST alignment. 
As well as this simple alignment procedure for identification and confirmation, the 
procedure for de novo separation and alignment can be used. As before, this provides the 
advantage of drastically reducing the time for alignment to large reference libraries. In 
this case since each reference is 100 times larger than a viral genome this is even more 
important. However, this procedure fails for experimental samples. Cross-correlation for 
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this experimental data (i.e. at this level of coverage and with this quality) isn’t sufficient 
to identify tight clusters. Therefore, consensus barcodes cannot be used for 
identification (Supplementary Figure 7.23).  
Despite this, to test the validity of this approach, barcodes have been generated in silico 
from the three strains described (E. coli DH10B and EC958 and K. pneumoniae blaDNM-
1), with 60% labelling efficiency and an average length of 40 kbp. An affinity matrix and 
adjacency matrix are generated as normal and the results are visualised by t-SNE in 
Figure 4.38. Each genome is shown by a different colour in Figure 4.38A and the cluster 
detection in Figure 4.38B. It is clear that regions from each genome can be clustered 
together to derive many reliable consensus barcodes. 
 
Figure 4.38 Community detection for barcodes generated in silico from bacterial 
genomes. 1500-2500 barcodes are generated for DH10B, EC958 and 
blaDNM-1 genomes, with 60% labelling efficiency. A) t-SNE visualisation of 
network generated from adjacency matrix. Each colour represents a 
different genome: DH10B (blue), EC958 (cyan) and blaDNM-1 (yellow) B) 





The consensus barcodes are aligned in turn to a library of approximately 500 bacterial 
genomes (complete enterobacteria genomes with lengths between 4.5 Mbp and 5.5 
Mbp) and the results are shown in Figure 4.39. The identification of the three strains is 
clear and reliable, similar to the results for complex mixtures of bacteriophages (Figure 
4.22) and the number of barcodes assigned to each genome is similar to the number of 
generated barcodes (Figure 4.39B).  
The difference when compared to bacteriophages is that a large number of very similar 
strains are now identified, the top 19 strains, for which at least 50 barcodes were 
assigned, are shown in Figure 4.39A. This is because that even if large regions of the 
genomes are different, the bacterial strains can share 100 kbp regions (i.e. the size of the 
consensus barcodes) that are identical, so other K. pneumoniae and E. coli strains are 
identified. The barcodes are not being mis-assigned (examples of aligned consensus 
barcodes are shown in Figure 4.39C-E), the genomes themselves are nearly identical, 
which can make the exact determination of the sample difficult. However, if unique 
regions (i.e. sequences) can be identified for each genome then these can be used as a 
reference to identify the exact strain. 
The results in Figure 4.38 also suggest a possible route to de novo alignment of whole 
bacteria genomes. It is clear from the shape of clusters that long regions of the genome 
are being identified, in other words one end of the cluster will contain barcodes from 
many kbps away from barcodes contained in the other end of the cluster. If the 
adjacency matrix was perfectly formed then these fragments would form a circle in the 
t-SNE visualisation of the network (Figure 4.40A), which would represent the ordering 
of all fragments along the genome. This could be used to generate the whole bacteria 
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genome de novo, although not by the procedure described in this research, since this is 
optimised for alignment of barcodes which completely overlap. 
 
Figure 4.39 Identification and quantification of complex mixture of bacteria, generated 
in silico. 1500-2500 barcodes are generated for DH10B, EC958 and blaDNM-
1 genomes, with 60% labelling efficiency. Clustering was shown in Figure 
4.38. A consensus barcode was generated for each cluster, aligned to a 
library of around 500 enterobacteria and assigned to the strain for which 
the maximum alignment weight was obtained. A) The overall result by 
genome. A relatively large number of genomes are identified, but all share 
a large amount of homology (shown by the BLAST query coverage) with one 
of the genomes from which barcodes were generated. B) Quantification of 
the result. For each genome, the number of barcodes generated in silico is 
shown as well as the number of barcodes contributing to consensus 
barcodes that were assigned, based on an alignment threshold of 0.8. C-E) 
An example alignment for each genome: C) blaDNM-1; D) EC958 and E) 
DH10B. 
A more realistic t-SNE visualisation of barcodes generated from a single genome is 
shown in Figure 4.40B, which shows that a circular genome would be difficult to obtain. 
Very large clusters can be formed, which represent fragments from regions hundreds of 
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kbp in length, however these are separated when, by chance, two adjacent barcodes are 
not well-aligned, which removes the edges from the network. However, the possibility 
remains that despite isolated clusters being formed, these could be connected by 
considering the network formed from the affinity if enough edges can be identified to 
join clusters together. 
 
Figure 4.40 t-SNE visualisations for experimental barcodes generated in silico from a 
bacterial genome. 5000 barcodes are generated for genomes, with 60% 
labelling efficiency. A) Ideal t-SNE if adjacency matrix connected all 
overlapping barcodes. The colour represents the position of the barcode in 
the genome. A circle is formed which orders all fragments and could be 
used for de novo alignment of a whole bacterial genome. B) t-SNE results if 
adjacency matrix is used, based on alignment of all barcodes to each other. 
Long clusters are formed which represent regions of the circle, but these 




An optical mapping method using methyltransferase-directed labelling of DNA, 
molecular combing and widefield microscopy has been developed and demonstrated for 
the identification of microorganisms. This exploits the unique pattern generated by 
fluorescent labelling at specific sequences, to identify DNA fragments. In CHAPTER 3 it 
was shown that this combination of experimental techniques is the ‘sweet spot’ for 
accuracy and speed of identification of microorganisms. In CHAPTER 4 a new rapid 
procedure for separation, de novo alignment and identification of microorganisms has 
been described to exploit the barcodes which are extracted. 
These procedures have been applied to identify DNA in a number of systems ranging in 
the size of genomic DNA and the complexity of the sample. A summary of these 
applications is shown in Figure 4.41. This shows both the types of samples for which 
identification has been demonstrated, but also those to which this optical mapping 
procedure has not yet been applied. At the boundaries of these, barcodes generated in 
silico have been used to demonstrate the applicability of these procedures, but these 
have not yet been confirmed experimentally. 
The easiest samples to identify are pure samples of short genomes, and simple and de 
novo alignment has been applied to reliably identify experimental samples of lambda, T7 
and Adenovirus A viral DNA. More complex mixtures increase the challenge of 
identification, however experimental mixtures of lambda, T7 and E. coli genomic DNA 
have been reliably identified, as have resistance plasmids from mixtures generated in 
silico. These procedures have been pushed to the limit for very complex in silico samples 
containing twenty phages. Apart from increasing the complexity of the mixture, 
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increasing the size of the genomic DNA makes identification more challenging. Pure 
experimental samples of E. coli and K. pneumoniae have been identified and this has 
been extended to mixtures of bacterial strains in silico. As well as identification these 
methods have been applied to check the DNA sample (e.g. M.TaqI-labelling of dam-
methylated lambda DNA) and to enable two-colour mapping of an alternative label (e.g. 
YOYO-1 affinity labelling).  
 
Figure 4.41 Overview of samples identified in this research. As the size of the DNA and 
the complexity of the sample increases the identification of the sample by 
optical mapping becomes more challenging. M.TaqI-directed labelling, 
molecular combing and widefield microscopy have been applied in this 
research to relatively small genomes and simple mixtures. Examples from 
this chapter are shown and italics are used to highlight samples that were 




The main issues that appear to be holding back this technique are junk barcodes 
(artefacts in barcode extraction and/or overlapping DNA molecules). These are 
primarily due to poor labelling efficiency and difficulties obtaining ideal molecular 
combing of molecules. Further optimisation of the labelling strategy (described in 
CHAPTER 2) in tandem with improved molecular combing would reduce these 
problems, and may therefore allow these procedures to be applied beyond the bounds of 
this research, towards complex environmental samples, and possibly toward larger 





4.4 Materials and Methods 
4.4.1 Source and extraction of genomic DNA 
Adenovirus A sample was kindly provided by Roger Grant. Overnights of pCT in E. coli 
strain EC958; pNDM in E. coli strain DH10B; and pKpQIL in K. pneumoniae strain Ecl8 
were provided by Michelle Buckner and DNA was obtained by extraction using a 
GenElute Bacterial Genomic DNA kit (Sigma-Aldrich).  
4.4.2 In silico generation of barcodes and de novo alignment procedures 
Custom code was written using Matlab 2016b for automated extraction, in silico 
generation of barcodes and alignment procedures. Unless otherwise stated, barcodes 
were generated using parameters in Supplementary Table 7.1. Copy of the code is 




CHAPTER 5 LOCALISATION AND DYNAMICS OF SINGLE 
PLASMID MOLECULES IN E. COLI 
Robert K. Neely and Stephen J. W. Busby provided supervision and guidance for the 
research undertaken in this chapter. Nathaniel O. Wand (the author) designed and 
analysed all labelling experiments, transformations and imaging experiments.  Lara 
Horne performed all labelling experiments, transformations and imaging experiments 
under the supervision of Nathaniel O. Wand (the author). Nathaniel O. Wand (the 
author) also developed and performed all image analysis procedures unless otherwise 
stated. 
5.1 Introduction  
5.1.1 Plasmid function and maintenance 
Plasmids are small extrachromosomal pieces of DNA that are found naturally in bacteria 
and have essential roles in metabolism185, pathogenesis186 and resistance187. They are 
usually circular, ranging in size from 1 to 100kbp and have copy numbers ranging from a 
single copy to hundreds103. The genes plasmids carry include those which promote 
replication, maintenance and proliferation of the plasmid, but also genes that help the 
host to adapt to the environment. These include genes for antibiotic resistance, one of 
the greatest public health threats we face109. However, recombinant plasmids can also 
carry genes that can be manipulated for industrial processes, such as the production of 
human insulin188. Understanding the mechanisms of plasmid maintenance would allow 





Figure 5.1 Overview of plasmid maintenance and transfer in bacteria. A) Replication 
regulation. There are two main mechanisms: antisense RNA and iteron-
binding. In antisense at high copy numbers the antisense RNA will 
hybridise to an RNA which is essential for replication, whilst at low copy 
numbers less antisense RNA is transcribed and replication can proceed. In 
iteron-binding mechanisms a protein, RepA, binds to a specific site on the 
plasmid, the iteron. When the plasmid is replicated RepA couples the newly 
replicated plasmids, preventing further replication until RepA is diluted. B) 
Post-segregational killing. When copies of the plasmid are present a short-
lived antitoxin is produced that prevents a longer-lived toxin from killing 
the cell. However, if during cell division the plasmid is no longer present, 
the toxin leads to cell death. C) Multimer resolution. During replication and 
recombination plasmids can form dimers, which are resolved by multimer 
resolution systems. D) Active partitioning. Several types of active 
partitioning system exist in bacteria, to ensure proper segregation of low 
copy number plasmids. The two most common are Type I and II, which both 
use adaptor proteins to bind to specific regions on the plasmid, known as 
centromeres. Motor proteins can bind to the adaptor and either ‘push’ or 
‘pull’ the plasmids to the cell poles. E) Random segregation. For high copy 
number plasmids, it is thought that plasmids randomly segregate during 
division, since there is a low probability of daughter cells having no copies 




Several mechanisms are used by bacteria to ensure plasmids are maintained in a stable 
copy number189 and transferred to daughter cells113,190. These mechanisms are shown in 
Figure 5.1 and include regulation of replication, partition mechanisms, multimer 
resolution and post-segregational killing. Active partitioning mechanisms are used for 
low copy number plasmids, to ensure proper segregation and transfer to daughter cells. 
However, it is thought that no such active partition mechanisms are involved for higher 
copy number plasmids. Instead, it is believed they are randomly segregated during 
division, meaning by chance each daughter cell should retain at least a single copy114. 
There is some debate about this mechanism, as microscopy of fluorescently-labelled 
plasmids has shown them clustering, despite the absence of any known active 
partitioning systems115. 
5.1.2 Plasmid localisation and dynamics in bacteria 
It was first shown that high copy number plasmids cluster at specific locations by using 
DAPI, a nuclear stain, to visualise derivatives of the high copy number plasmids R100 
(60kbp, 10-15 copies per cell) and pBR322 (8kbp, 40-60 copies per cell)191. This used a 
non-specific stain to visualise DNA in fixed cells, and showed that the R100 derivative 
was evenly spaced throughout the cell (Figure 5.2A), whilst the pBR322 derivative was 
localised to cell poles (Figure 5.2B). The main drawback with this approach is that the 
staining is non-specific. The nucleoid is stained as well as plasmids, so cannot be 
differentiated except by location. If, for instance, individual plasmids are residing within 




Figure 5.2 Clustering of high copy number plasmids, by staining with DAPI. Adapted 
from Eliasson et al191. A comparison is shown between intracellular 
distribution of derivatives of A) R100 and B) pRB322. The R100 derivative 
is evenly spaced throughout the cell, while the pBR322 derivative is 
localised to cell poles. Note how the DAPI stain is non-specific and has 
labelled the nucleoid (large, bright region in the centre of cells) as well as 
plasmids (small spots).  
An alternative approach for fixed cells is to use fluorescent in situ hybridisation (FISH, 
Figure 5.6A), which allows for specific sequences to be fluorescently tagged. In this 
method short DNA or RNA probes are designed to bind to unique complementary DNA 
sequences. When these are fluorescently labelled they can be used for visualising the 
location of plasmids, which contain the unique sequence. This must be done on fixed and 
permeabilised cells, since cellular uptake of probes is poor, and probes can be unstable. 
This method has been used since the late 1990s to visualise low copy number plasmids 
and investigate their subcellular distribution during active partitioning115,192,193. For 
example, the low copy number plasmid R1 (95kbp, 4-5 copies per cell), is known to be 
segregated by an active partition mechanism. However, microscopy showed that there 
were fewer plasmid foci in cells than plasmid copies, suggesting clustering occurs. These 
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results were confirmed by a copy number mutant, which contained the same number of 
foci as before but now two to three times more plasmids per cell193. 
More recently FISH has been used, in combination with localisation microscopy, to study 
the distribution of high copy number plasmids118. Here a ColE1-like plasmid, pBluescript 
(3kbp, >300 copies per cell), containing an array of 256 LacO repeats and 96 TetO 
repeats (~14kbp) was used, and visualised by a 20bp Atto 532-labelled probe that 
targeted the LacO repeats. The plasmids were shown to aggregate into large clusters, 
however most plasmids were observed to be located randomly throughout the cell 
(although excluded by chromosomal DNA). The number of plasmids in each cluster 
could also be quantified, however the movement of plasmids and changes in distribution 
cannot be studied using fixed cells. 
 
Figure 5.3 Fluorescent in situ hybridisation (FISH) for quantitative localisation of high 
copy number plasmids. Taken from Wang et al118, scale bar = 500 nm. A-B) 
The location of derivatives of pBluescript plasmid within a single E. coli 
bacterium. A) Pixel brightness indicates the density of individual plasmid 
localisations, which are shown in B). Two dense clusters are highlighted 
(green and orange rings). The number of plasmids in each cluster can be 
estimated based on the hybridisation efficiency of the probe. 
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The distribution and dynamics of plasmids in living cells has generally been studied 
using fluorescent repressor operator systems (FROS, Figure 5.6B). These were used in 
the late 1990s to visualise low copy number plasmids194–196, and the first report of FROS 
to visualise clustering of a high copy number plasmid was by Pogliano et al. in 2001 
(Figure 5.4)115. FISH was used as a comparison. Two FROS systems in common use are 
the tetracycline (Tet) and the lactose (Lac) operator/repressor systems, which both rely 
on bacterial repressors fused to a fluorescent protein. The fusion protein is expressed 
within the cell and subsequently binds to its respective operator system which can be 
inserted as a tandem array within the plasmid of interest. 
Pogliano et al. inserted a large tandem repeat of Lac operators (10kbp, ~256 copies) 
into RK2 (60kbp, 5-8 copies per cell) and pUC19 (2.7kbp, 40-250 copies per cell) 
derivatives115. A GFP-LacI fusion protein was expressed by cells from the arabinose 
promoter on a compatible plasmid and used to visualise plasmids. The majority of cells 
containing RK2 had one or two clusters visible with either a single focus localised near 
the mid-cell, or two foci near the ¼ and ¾ cell positions (Figure 5.4A-C). Cells containing 
pUC19 also had un-clustered plasmids and plasmids that appeared to be rapidly 
diffusing through the whole cell (Figure 5.4D-F). The distribution of RK2 clusters was 
shown to change during cell growth, as time lapse images showed a single focus could 
split rapidly into multiple foci and the number of clusters was dependent on the cell 
length. The clustering of RK2 is conserved across bacterial species197 and similar 
behaviour has been observed for ColE1 (6.6kbp, 10-15 copies per cell)116. ColE1 was 
found to cluster at cell poles, but also movement to the mid-cell was observed. There is 
also evidence that as well as replication197,198, transcription and translation of plasmids 
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can drive their clustering119,199, although it is not clear these processes are always 
required for clustering200. 
 
Figure 5.4 Clustering of high copy number plasmids, using fluorescent repressor 
operator system (FROS). Adapted from Pogliano et al115, scale bar = 1µm. A 
comparison is shown between intracellular distribution of derivatives of A-
C) RK2 and D-F) pUC19. Cell membranes are stained with FM 4-64 (red), 
plasmids tagged with LacI-GFP (green) and DNA stained with DAPI (blue). 
A-C) The RK2 derivative forms one or two clusters, with either a single 
focus localised near the mid-cell, or two foci near the ¼ and ¾ cell 
positions D-F) The pUC19 derivative: i) with one focus, ii) with two foci, iii) 
during division, iv) with multiple foci. 
There remains some debate about the likely explanation for this clustering of 
plasmids113,201. Importantly, multimer formation is unlikely to cause the clustering 
effect, since, for example, RK2 encodes a potent multimer-resolution system115. Reyes-
Lamothe et al. attributed localisation to displacement of plasmids by the nucleoid117. A 
TetO operator array (24, 48 or 96 copies) was inserted into the ColE1-type plasmid, 
pJHCMW1 (11kbp, 20-30 copies per cell) and a fluorescent TetR expressed from the 
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chromosome. They described how individual plasmids were highly mobile, but tended 
to be excluded from the nucleoid, therefore localised at cell poles, only occasionally 
moving along the long axis of the cell.  
 
Figure 5.5 Exclusion of plasmids from the nucleoid, using FROS. Taken from Reyes-
Lamothe et al117, using the ColE1-type plasmid, pJHCMW1. A) Typical 
localisation of pJHCMW1 (green) and nucleoid (red). B) Ten example, 
normalised, traces of the variation in plasmid (green) and nucleoid (red) 
signal, across the long cell axis. C) Average of the normalised traces for 329 
examples. This shows that plasmids are clustered and localised to the poles 
of the cells and therefore tend to be excluded from the nucleoid. 
Studying individual plasmids, using either FISH or FROS, remains challenging. 
Quantitative localisation microscopy using FISH has been demonstrated only on fixed 
cells and therefore nothing about the plasmid dynamics, particularly during cell division, 
can be inferred. However, studying kinetics in live cells experiments using FROS is 
challenging, since the density of plasmids will be high. One method to overcome this has 
been to effectively dilute out the plasmid by preventing replication117. As bacteria divide 
the distribution of plasmids will become uneven, with some bacteria having none or 
very few plasmids. Individual spots can then be assumed to be individual plasmids, 
although this cannot be definitive.  
This reduction in copy number may alter the behaviour of plasmids, as might increasing 
the size of plasmids several times, by the insertion of tandem arrays. The binding of 
many repressor molecules may also have an effect, for example GFP is known to form 
236 
 
inclusion bodies (insoluble aggregates of misfolded proteins) at high concentrations202. 
Therefore, it is important to develop other labelling techniques for visualisation of 
plasmids. 
5.1.3 Fluorescent labelling of plasmids 
There are a number of strategies for fluorescent labelling of plasmids for live cell 
imaging (Figure 5.6), an excellent review of these is given by Rombouts et al97. These 
broadly fit in to two categories, non-specific and sequence-specific labelling. Non-
specific and non-covalent labelling can be achieved by using DNA-binding dyes (Figure 
5.6C) that include groove-binding dyes (e.g. DAPI) and intercalators (e.g. YOYO-1). These 
can be used for staining DNA in live cells, depending primarily on cell permeability and 
their effect on the structure of DNA203. However, their non-specific and non-covalent 
nature means that staining plasmids with sequence specificity is not feasible. 
Non-specific, but covalent attachment can be used to overcome this drawback, since the 
labelling will be irreversible (Figure 5.6D). Plasmids can be labelled in vitro before 
transfection back in to cells. There are a number of commercial labelling kits available 
for covalent attachment of fluorophores204–206 One example is the use of reagents with 
an aromatic nitrogen mustard, which can be used to covalently alkylate DNA, primarily 
at the N7 of guanine bases204. This can be used to enable the direct coupling of 
fluorophores (e.g. Cy3, CX rhodamine) to plasmid DNA, prior to transfection and these 
kits have been used extensively to study plasmids in living mammalian cells. The 
plasmid DNA is still replicated and transcribed, however high labelling densities or 
bulky fluorophores can begin to effect the behaviour of the DNA207,208.  
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Fluorophores are generally hydrophobic and will increase steric hindrance, whilst 
cationic dyes will begin to lower the overall negative charge of plasmids. Therefore, the 
minimum number of fluorophores, should be used to try to prevent this behaviour, 
however this can be difficult to control with non-specific labelling. The minimum 
number of fluorophores that can be used will be determined by the nature of the 
fluorophore and the detection system. For reliable detection a large signal to noise ratio 
is required, so bright fluorophores and sensitive detectors will require fewer 
fluorophores than dim fluorophores with insensitive detection. 
Specific, covalent labelling of plasmids can be used to control labelling density, as well as 
label location. Methyltransferase-directed labelling is like some of the non-specific 
covalent labelling approaches, since organic dyes can be covalently attached to the DNA 
bases, but in contrast to non-specific approaches labelling is now directed to specific 
sequences. DNA methyltransferases are naturally occurring enzymes which covalently 
methylate cytosine or adenine bases. Methylation occurs within a specific DNA target, 
typically consisting of a palindromic sequence, 2 to 8 base pairs in length. In nature all 
known classes of DNA methyltransferases use the cofactor S-adenosyl-L-methionine 
(AdoMet) as the methyl donor, but it has been demonstrated that synthetic AdoMet 
analogues can also be used to catalyse the transfer of more complex chemical groups. 
Fluorophores and other modifications can be targeted to specific sites in a DNA 
sequence, efficiently and non-destructively86, as shown in CHAPTER 2. 
Other labelling strategies include the incorporation of modified bases209, DNA-binding 
by small molecules210, as well as by DNA hybridisation (e.g. FISH) and DNA-binding by 




Figure 5.6 Overview of methods for visualisation of plasmids in bacteria. A) DNA 
hybridisation methods, e.g. FISH. Short, fluorescent, DNA or RNA probes are 
designed to bind to unique complementary DNA sequences on the plasmid. 
Bacteria are fixed and permeabilised, the probe added and allowed to 
hybridise to the target DNA for visualisation. B) DNA-binding protein 
methods, e.g. FROS. A tandem array of a specific protein-binding site (e.g. 
LacO) is inserted into the plasmid. A fusion protein, composed of a 
repressor that binds to the array (e.g. LacI) and a fluorescent protein (e.g. 
GFP), is expressed within the cell and subsequently binds to the plasmid for 
visualisation. C) Non-specific DNA binding, e.g. intercalators. Small 
fluorescent molecules that bind to DNA, e.g. DAPI, YOYO-1, are added to the 
cell. These bind to the DNA non-specifically allowing visualisation. D) Non-
specific covalent DNA labelling. Plasmids are fluorescently-labelled 
covalently, e.g. by an aromatic nitrogen mustard. Labelled plasmids are 





5.1.4 Overview and objectives 
There are many complex mechanisms that bacteria use to maintain and transfer 
plasmids. In particular, there remains debate about the mechanisms of segregation of 
high copy number plasmids, since clustering of plasmids is found in bacteria, but the 
current methods of fluorescently-labelling plasmids are unsuited to studying these 
mechanisms. DNA hybridisation techniques such as FISH are most easily used on fixed 
and permealised samples, so are unsuitable to study plasmid movement. On the other 
hand, FROS is ideally suited to live cells, but suffers from difficulties in visualising and 
quantifying individual plasmids, against the dense background of fluorescent proteins.  
Covalently labelling plasmids prior to transformation can overcome these drawbacks. 
Individual plasmids are easily tracked, and the technique can be used on live cells. 
Methyltransferase-directed labelling is well suited to covalently-labelling plasmids since 
it provides easy control of labelling density. In addition, the target sequence could be 
inserted into distinct locations on DNA, to label specific positions. However, the main 
drawback with this approach is that there is no commercially available kit. The 
optimisation of plasmid labelling with methyltransferases was undertaken in CHAPTER 
2. 
The plasmids labelled in CHAPTER 2 will be used to transform E. coli which will 
subsequently be grown on agarose pads. Ampicillin selection and expression of a 
fluorescent protein will be used to identify E. coli that contain a copy of the plasmid, 




5.2 Results and discussion 
5.2.1 Plasmids and strains 
Two approaches were used to select for transformed E. coli: ampicillin resistance and 
the expression of a fluorescent protein. Selection is important since only around 0.1-1% 
of bacteria are typically transformed when chemical transformation is used211, therefore 
identifying these bacteria, i.e. those that contain the fluorescently-labelled plasmid, is 
not straightforward.  
Expression of genes encoded by the plasmid can be used to select bacteria that contain a 
copy of it. β-lactam antibiotics, such as ampicillin, are used to kill bacteria, since they 
inhibit cross-linking of the peptidoglycan in the bacterial cell wall. Eventually this leads 
to a weakening of the cell wall, particularly during cell growth, which can no longer 
compensate for the osmotic pressure and will effectively burst, causing cell death. The 
effect of ampicillin can be seen in Figure 5.7 and is dependent on concentration and time 
of growth. Ampicillin resistance is conferred to bacteria by a gene that encodes for β-
lactamase, which hydrolyses β-lactams. 
Alternatively, a gene that encodes for a fluorescent protein, e.g. GFP, was used. As the 
fluorescent protein is expressed, the fluorescence it produces will effectively light-up 
bacteria that contain a copy of the plasmid. In practice this is often under the control of 
an inducible promoter (Figure 5.8A). For example, the GFP gene can be inserted after a 
T7 promoter, therefore only when T7 RNA polymerase is present will the gene be 
transcribed and the GFP be expressed. The expression of T7 RNA polymerase, from a 
gene on the bacterial chromosome, can be controlled by the lac operator. The Lac 
repressor will bind to the lac operator, preventing expression of T7 RNA polymerase 
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unless lactose (or a structural isomer, e.g. IPTG) is present. Therefore, addition of IPTG 
should induce expression of the fluorescent protein, although a basal level of ‘leaky’ 
expression is likely, since the T7 RNA polymerase will be expressed at a low level, 
despite the Lac repressor. The expression of GFP is seen in Figure 5.8B, which shows 
how much brighter bacteria become when they contain a copy of the plasmid and GFP 
expression is induced. 
 
Figure 5.7 Effect of ampicillin on E. coli during growth. Ampicillin inhibits cell wall 
formation, so during cell division osmotic pressure cannot be compensated 
and cells will ‘burst’. A) Effect of ampicillin concentration. RLG221 strain 
was grown on agarose pads containing varying concentrations of 
ampicillin, at 37oC for four hours. As the concentration increased bacteria 
become stressed and elongated, before bursting at high concentrations. B) 
Effect of time. RLG221 strain was grown on agarose pads containing 0.1 
mg/ml ampicillin overnight. Most bacteria burst within 1 hour, although 




Figure 5.8 Expression of fluorescent proteins in bacteria. A) Inducible expression 
system. Lac repressor is expressed from a gene on the bacterial 
chromosome and usually prevents expression of T7 RNA polymerase. When 
IPTG is added the Lac repressor falls off the DNA and T7 RNA polymerase is 
expressed. This is then free to express GFP, the gene for which is present on 
a plasmid, downstream of the strong T7 promoter. B) Expression of EGFP in 
E. coli. The same image is shown in different contrasts, to show the 
difference between bacteria that aren’t expressing EGFP and those two in 
the middle of the image that are. Those that are expressing EGFP must 
contain a copy of the plasmid. 
To take advantage of these selection mechanisms two separate systems were used. The 
first used ampicillin selection and pUC19, a common, engineered, high copy number 
plasmid, the distribution of which has been studied previously (Figure 5.4 D-F)115. A 
map of pUC19 is shown in Figure 5.9A. It is 2.7 kbp in size, has a copy number of 40-250, 
depending on the strain, and contains an origin of replication (ori) and genes encoding 
β-lactamase (AmpR) and an N-terminal fragment of β-galactosidase (lacZα). The AmpR 
gene is for ampicillin selection, whilst the multiple cloning site is within the lacZα gene, 
so the activity of β-galactosidase reports on whether foreign DNA has been inserted. 
This activity is tested when transformed colonies are grown on IPTG and X-gal, since β-




pUC19 has four target sites for the TaqI RM system and can therefore be labelled with up 
to eight fluorophores by DNA methyltransferase M.TaqI, using the methyltransferase-
directed labelling methods described in CHAPTER 2. Here pUC19 has been labelled with 
an amine AdoMet analogue, AdoHcy-amine, which was coupled pre-transalkylation to 
Atto 647N NHS ester. This has a maximum absorbance at 646 nm and maximum 
emission at 664 nm, which is well suited to detection within bacteria, where 
autofluorescence is a problem for excitation at below around 500 nm212,213. Single 
molecule counting results are shown in Figure 5.9B and representative images of 
labelled plasmids in Figure 5.9C. There are at least 2.6 fluorophores per plasmid on 
average, with only 2.8% of plasmids having no fluorophores visible. This means 
plasmids are bright and suitable for localisation experiments. 
This was transformed into E. coli K-12 strain RLG221. K-12 is a common laboratory 
strain first isolated in 1922214 which has been extensively studied and thousands of 
mutants produced. RLG221 is one such mutant that contains a deletion of the lac gene 
and the recA gene, to reduce plasmid recombination. 
The second system studied exploits expression of a fluorescent protein for detection. 
Enhanced GFP (EGFP) is a mutant of the original GFP that exhibits 100-fold greater 
fluorescence intensity215 and is now in widespread usage. Here the protein will be 
expressed from a pRSET B derivative, for which the key features are shown in Figure 
5.10A. It is 3.6 kbp, contains a gene encoding β-lactamase (AmpR), and will be present in 
a high copy number due to the pUC19 derived origin of replication (ori). The F1 origin of 
replication (f1 ori) is phage derived and allows for replication of pRSET B into single-
stranded DNA.  The gene encoding EGFP has been inserted in the multiple cloning site, 
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downstream of the T7 promoter. This ensures that when T7 RNA polymerase is induced 
and the plasmid is present, EGFP will be expressed. 
 
Figure 5.9 pUC19 plasmid map and labelling. A) Map of pUC19. pUC19 is 2.7 kbp and 
contains an origin of replication (ori) and genes encoding β-lactamase 
(AmpR) and an N-terminal fragment of β-galactosidase (lacZα). It contains 
four TaqI sites and therefore can have a maximum of eight fluorescent 
labels. B) Single molecule counting results. pUC19 was labelled by M.TaqI 
with AdoHcy-amine, coupled pre-transalkylation to Atto 647N. There are 
2.6 fluorophores per plasmid on average. C) Representative images of 
labelled pUC19. i) YOYO-1 labelled plasmids, ii) Atto 647N label, iii) 
overlay: YOYO-1 (green) and Atto 647N (red). 
pRSET B-EGFP has ten target sites for the TaqI RM enzymes (5’-TCGA-3’), however one 
site overlaps with the site for Dam methyltransferase (5’-GATC-3’), present in many E. 
coli strains, which may block labelling. pRSET B-EGFP  was labelled by M.TaqI with Atto 
647N, similarly to pUC19 and there was an average of at least 4.1 fluorophores per 
plasmid. Single molecule counting results are shown in Figure 5.10B and representative 
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images of labelled plasmids in Figure 5.10C. A restriction assay is shown in 
Supplementary Figure 7.24. 
The strain used with this plasmid was T7 Express, purchased commercially from NEB. 
This is an enhanced BL21 derivative, in which T7 RNA polymerase is expressed from the 
chromosome under control of the Lac operator, making it a suitable strain for induced 
expression of EGFP (Figure 5.8A). 
 
Figure 5.10 pRSET B-EGFP plasmid map and labelling. A) Map of pRSET B-EGFP. pRSET 
B-EGFP is 3.6 kbp and contains two origins of replication (ori and f1 ori) 
and genes encoding β-lactamase (AmpR) and EGFP, under the control of a 
T7 promoter. It contains 10 TaqI sites, although one overlaps with Dam 
methylation (*) and therefore can have a maximum of eighteen or twenty 
fluorescent labels. B) Single molecule counting results. pRSET B-EGFP was 
labelled by M.TaqI with AdoHcy-amine, coupled pre-transalkylation to Atto 
647N. There are 4.1 fluorophores per plasmid on average. C) 
Representative images of labelled pRSET B-EGFP. i) YOYO-1 labelled 




5.2.2 Optimising transformations and imaging 
Transformation efficiency was tested by a standard transformation protocol. Chemically 
competent cells were mixed with plasmid DNA, on ice, for 30 minutes. This was followed 
by heat shock at 42oC, a recovery period and growth overnight, at 37oC, on LB agar 
plates which contained ampicillin. Bacteria which have been transformed by the plasmid 
DNA and can replicate and transcribe the plasmid will divide and form visible colonies, 
whilst bacteria that haven’t been transformed will be killed by the ampicillin. Both 
plasmid/strain systems were tested with labelled and un-labelled plasmids and typical 
results are shown in Figure 5.11. In both systems there is no significant difference 
between labelled and un-labelled plasmids, which was expected, as similarly covalently 
modified DNA has previously been shown to be transcribed and replicated in eukaryotic 
cells204. 
LB agar plates like these are unsuitable for fluorescence microscopy. The sheer size of 
them makes them unsuitable for most microscopes and they do not typically have a 
glass bottom. However more problematic is the background autofluorescence 
introduced by the rich media. This contains many compounds which will absorb visible 
light and make imaging problematic213. One solution is to adsorb bacteria to poly-L-
lysine-coated slides and wash away the media. However there is evidence that using 
these highly charged surfaces, especially in thick layers, can affect the behaviour of 
bacteria216–218. Indeed such surfaces are known to have anti-bacterial properties219 and 




Figure 5.11 Transformation efficiency of labelled and un-labelled plasmids. Typical 
ampicillin-containing LB agar plates are shown for: A) pUC19/RLG221 and 
B) pRSET B-EGFP/T7 Express. When no plasmid is transformed no colonies 
are visible as ampicillin kills all bacteria. When Atto647N-labelled or 
unlabelled plasmid transforms bacteria colonies grow, as the plasmids 
contain a gene that expresses β-lactamase. There is no significant 
difference between labelled and un-labelled plasmids. 
Therefore, an alternative method was used in which bacteria are immobilised in agarose 
pads, which are similar to LB agar plates but composed of a minimal media, to prevent 
background fluorescence. This method was based on that developed by Young et al220, 
which is shown in Figure 5.12. In short, bacteria are loaded on small agarose pads and 
placed onto sealed glass-bottomed dishes for imaging. It is critical to prepare pads 
without scratches and to dry pads completely to prevent issues during imaging. Samples 





Figure 5.12 Preparation of agarose pads for immobilising and imaging bacteria, taken 
from Young et al220. 1) Melted agarose is pipetted onto a coverslip and 2) 
sandwiched with another coverslip. 3) Smaller agarose pads are cut from 
the larger pad and 4) bacteria loaded on top. 5) After drying pads are 
flipped onto a glass-bottomed dish, 6) many can be loaded onto a single 
dish. 7) The dish is sealed with parafilm and 8) can be imaged. 
Agarose pads can be used to test the difference in transformation efficiency of labelled 
and un-labelled plasmids in much the same way agar plates are used. Examples are 
shown in Figure 5.13 for labelled and un-labelled pUC19, transformed into T7 Express. 
This is used rather than RLG221 since it grows faster and at lower temperatures 
(particularly on minimal media), which is more suitable to prevent pads drying out over 
24 hours. Individual colonies are clearly visible and again there is no significant 




Figure 5.13 Transformation efficiency of labelled and un-labelled plasmids on agarose 
pads. Typical ampicillin-containing agarose pads are shown for: A) 
unlabelled pUC19/T7 Express and B) Atto 647N-labelled pUC19/T7 
Express. 100ng of DNA was used and pads were incubated overnight at 
30oC. There is no significant difference between labelled and un-labelled 
plasmids. 
For imaging labelled plasmids, it is important to optimise the experimental conditions, 
to ensure a reasonable number of transformed bacteria are present. Too many bacteria 
on the surface can make imaging individual bacteria impossible, whilst if there are too 
few transformed bacteria on the pad then they will be impossible to find for imaging (“a 
needle in a haystack”). Therefore, the correct dilution of the bacterial suspension must 
be used to place on the pad (typically a 10-100x dilution of an aliquot of competent 
cells), but also the transformation efficiency must be optimised to make visualisation of 
the plasmid possible. 
The transformation efficiency, for example, is dependent on the concentration of DNA 
used211, which is typically between 100 pg and 100 ng for an aliquot of chemically-
competent cells. Here the amount of DNA for transformations should be kept to a 
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minimum, since labelling large quantities of DNA consumes a large amount of cofactor, 
methyltransferase and dye. Figure 5.14 shows that 10-100 ng of plasmid DNA was 
sufficient to produce a large number of colonies. 
 
Figure 5.14 Effect of DNA concentration on transformation efficiency. T7 Express was 
transformed with varying amounts of unlabelled pUC19 and grown on 
agarose pads, overnight at 30oC. As the amount of DNA used to transform 
bacteria is increased so does the number of colonies. Between 10 and 100 
ng of pUC19 gives a reasonable number of colonies. 
Another important factor to optimise was the recovery period, for which results are 
shown in Figure 5.15. This is the period after heat-shocking but before plating the 
bacteria when the bacteria should be incubated at 37oC, to promote cell recovery after 
the heat-shock, but also to promote the expression of β-lactamase. No colonies are seen 
when there is no recovery period, possibly because the cell membrane will be 
destabilised during heat-shock, although relatively little is known about the mechanisms 
controlling this221. It is important to use the minimum recovery period possible, since as 
the bacteria divide the labelled plasmid will be diluted, i.e. will not be present in 
daughter cells. The buffer the bacteria are stored in (freeze-thaw buffer) was tested but 
found to give very few colonies for both plasmid/strain systems. Rich LB broth was 
suitable to give a reasonable number of colonies, within 20-40 minutes. Any longer and 
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too many divisions are possible, especially for the T7 Express strain. M9 minimal media 
gives similar results and is preferred, since this is the medium used for the agarose pads. 
 
Figure 5.15 Effect of recovery period and recovery buffer on transformation efficiency. 
T7 Express and RLG221 were transformed with 100ng of unlabelled pRSET 
B-EGFP or pUC19 respectively. This was followed by a recovery period, and 
growth on agarose pads, overnight at 30oC. The recovery period was 0, 10, 
20, 40 or 60 minutes and was carried out in freeze-thaw buffer, LB broth or 
M9 minimal media at 37oC . Generally the longer the recovery period the 
higher the apparent transformation efficiency, however for long periods 
cell division is possible. Freeze-thaw buffer was a poor recovery media, 
whilst LB broth and M9 minimal media gave high apparent transformation 
efficiency. 
The number of washes was also considered, to ensure DNA that isn’t transformed into 
cells is removed from the background. The final optimised procedure is given in the 
252 
 
methods but in summary, 50 μl aliquots of bacteria were transformed with 50 ng of 
plasmid DNA. After heat-shocking 0.5 ml of M9 minimal media was added and bacteria 
incubated at 37oC for 20 minutes. Bacteria were pelleted and washed with 0.5 ml M9 
minimal media, four times, before final resuspension in M9 minimal media (volume 
dependent on dilution required, typically 10-100x). 5 μl of bacterial suspension was 
placed on agarose pads, allowed to dry and sealed in a glass-bottomed dish for imaging. 
5.2.3 pUC19 localisation and dynamics 
The optimised procedure for transformations and imaging was applied over two 
different time periods: a short growth period and a long growth period. After a short 
growth period of around 1 hour at 30oC, on agarose pads which contain ampicillin, 
transformed bacteria are visible. Transformed bacteria will be resistant to ampicillin 
and begin micro-colony growth, whilst bacteria which have no copies of the plasmid will 
lyse (Figure 5.7). Therefore, during imaging, after a short growth period, any small 
micro-colonies are indicative of bacteria that originally contained the labelled plasmid. 
T7 Express was used for these experiments, since it had a faster growth rate than 
RLG221, making identification of micro-colonies easier.  
Results are shown in Figure 5.16A-C, for Atto647N-labelled pUC19, transformed into T7 
Express and grown at 30oC for 1 hour. Micro-colonies are clearly seen, although they 
were not straightforward to find (Figure 5.16 i). There are foci within the micro-colonies 
that are likely single plasmids (Figure 5.16 ii), however there are also a large number of 
plasmid or dye aggregates in the background. Washing the labelled plasmid away 
completely is difficult, even after multiple washes. The behaviour of the plasmids can 
help address whether they are single, transformed, plasmids or likely not. 15 second 
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time traces were taken of each micro-colony, allowing the number of bleaching steps for 
the plasmid to be compared to the expected number of labels (Figure 5.9). The results 
are consistent with well-labelled plasmids. The tracking of plasmids over time is also 
shown (Figure 5.16 iii), which allows the diffusion of plasmids to be investigated. For 
example, the plasmids in Figure 5.16A and C are less confined than most background 
plasmids, which behave more typically like the plasmid identified in Figure 5.16B. 
 
Figure 5.16 Localisation and dynamics of pUC19 after short term growth. T7 Express 
(green) was transformed with Atto 647N-labelled pUC19 (red) and grown 
on agarose pads for 1 hour at 30oC. A-C) Examples of single plasmid 
molecules. i) Microcolony growth can be used to identify transformed 
bacteria. ii) Zoom of microcolonies highlighted by white box in i). Plasmids 
are indicated by a white arrow. iii) Single plasmid tracking (red), in region 
highlighted in white box in ii), over 15 seconds, each step is 0.6s. iv) 
Intensity profiles for plasmids highlighted by arrow in ii). The number of 
bleaching steps is consistent with plasmid labelling (Figure 5.9) 
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Whether plasmids are inside bacteria or diffusing over the surface is still difficult to 
prove, although since these bacteria are transformed they must contain copies of the 
plasmid. E. coli cells are only around 1μm thick, so it was not possible experimentally to 
take a z-stack to laterally localise the plasmid. 
An alternative experiment to this is to image bacteria over long time scales and in large 
scans. This allows plasmids to be followed during cell growth and division, for example 
whether plasmids are transmitted during micro-colony growth. An example of this is 
shown in Figure 5.17. Here RLG221 was transformed with Atto 647N-labelled pUC19 
and imaged overnight at room temperature. The slow growth of RLG221 at room 
temperature allows for large scans to be taken (10x10 grid), since images can be taken 
every 5 minutes, without excessive growth. The growth of colonies is clear over the 9 
hours of imaging. At the centre of each colony a single transformed bacterium is 
expected, however in most cases there was no overlapping signal from labelled plasmids 
with these bacteria. 
An example of overlap between plasmid and a bacterium is shown in Figure 5.18 (region 
highlighted in Figure 5.17). Here there is a plasmid located between two dividing 
bacteria, which appears to be retained by a single bacterium after division. The plasmid 
can be followed over the course of 9 hours as the colony grows, and a time trace is 
shown. After initial drift of the sample (due to drying of the agarose pad), the plasmid 
moves a small amount for several hours, before moving rapidly across the image in the 
last hour of imaging, likely as the bacterium is moved within the colony as cells continue 
to divide (although the individual bacterium is no longer visible). Although there were 
no more examples of this type of behaviour, this time lapse highlights the advantage of 
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following single plasmids over long timescales. For instance, this technique could be 
used to follow resistance plasmids, to investigate transmission mechanisms. 
 
Figure 5.17 Localisation and dynamics of pUC19 during long term growth. RLG221 
(green) was transformed with Atto 647N-labelled pUC19 (red) and grown 
on agarose pads for 9 hours at room temperature. The growth of colonies is 
clearly visible. These can be traced back to an individual bacterium that 





Figure 5.18 Localisation and dynamics of pUC19 during long term growth, zoom. 
RLG221 (green) was transformed with Atto 647N-labelled pUC19 (red) and 
grown on agarose pads for 9 hours at room temperature. This is a zoom of a 
section in Figure 5.17. A single transformed bacterium grows into a colony 
over 9 hours. Highlighted with an arrow is a single plasmid. A trace of the 
location of the plasmid is also shown.  
The main drawback with identifying transformants by ampicillin resistance alone is that 
identifying micro-colonies is difficult. Large areas of the agarose pad must be scanned, 
but identification is difficult to automate since micro-colonies are not well-defined 
against the background of dead bacteria. Few examples could be imaged and there were 
many examples of micro-colonies with no labelled plasmids visible. Automated methods 
for extracting bacteria which overlap with plasmids will be discussed later in this 
chapter. 
5.2.4 pRSET-B localisation and dynamics 
One method to overcome some of the experimental challenges, without resorting to 
automation, is to use expression of a fluorescent protein, as well as ampicillin resistance. 
This can be used again after a short growth period, for example 1 hour at 30oC. Bacteria 
transformed with pRSET B-EGFP will not only be resistant to ampicillin and grow 
microcolonies as before but will also begin to express EGFP if expression is induced by 
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addition of IPTG to the agarose pads. Bacteria will effectively ‘light-up’ and make 
searching for transformants far more straightforward. 
Results are shown in Figure 5.19, for T7 Express transformed with Atto 647N-labelled 
pRSET B-EGFP. Transformants are now easily visualised and short time lapses (~15 
seconds) can be recorded to follow plasmid diffusion and bleaching. Examples of likely 
transformed plasmids are shown in Figure 5.19A and B. These have the correct number 
of bleaching steps for single, well-labelled plasmids (see Figure 5.10) and clearly diffuse 
over several pixels across the course of the time lapse. This contrasts with more 
confined plasmids, which are generally in the background, an example that overlaps an 
EGFP-expressing bacterium is shown in Figure 5.19C. The difference in behaviour 
between confined and more freely diffusing plasmids lends further evidence that the 





Figure 5.19 Localisation and dynamics of pRSET B-EGFP after short term growth. T7 
Express (green) was transformed with Atto 647N-labelled pRSET B-EGFP 
(red) and grown on agarose pads (with IPTG) for 1 hour at 30oC. A-D) 
Examples of single plasmid molecules. i) Expression of EGFP can be used to 
identify transformed bacteria. ii) Zoom of bacteria highlighted by white box 
in i). Plasmids are indicated by a white arrow. iii) Single plasmid tracking 
(red), in region highlighted in white box in ii), over 15 seconds, each step is 
0.6s. iv) Intensity profiles for plasmids highlighted by arrow in ii). The 




Overnight time lapses can also be used for this plasmid/strain system. An example is 
shown in Figure 5.20, for T7 Express incubated at room temperature, overnight, on 
agarose pads containing ampicillin and IPTG. There is no growth of microcolonies seen, 
in contrast to results with pUC19, and some bacteria that express EGFP die, though 
others continue to get brighter as EGFP expression is continuing. It seems likely that 
EGFP expression is preventing normal growth. Normally during protein expression 
bacteria are grown to maximum density, before induction of the protein, in other words 
cell division is not necessary, so the effect of protein expression on cell growth is not 
normally an issue. 
 
Figure 5.20 Localisation and dynamics of pRSET B-EGFP during long term growth. T7 
Express (green) was transformed with Atto 647N-labelled pRSET B-EGFP 
(red) and grown on agarose pads (with IPTG) for 12 hours at room 
temperature. Individual transformants are clearly visible by EGFP 
expression, however microcolonies do not grow, likely due to the stress of 




When IPTG is removed from pads there is still leaky expression of EGFP, allowing 
transformants to be identified, however microcolonies now grow allowing for plasmid 
dynamics to be followed as before. An example is shown in Supplementary Figure 7.25. 
The main issue remains however, that very few bacteria, which apparently contain a 
copy of the plasmid, have overlapping signal from labelled plasmids. Possible 
explanations for this will be discussed in the conclusion to this chapter.  
5.2.5 Image segmentation 
If many transformants (with overlapping signal from labelled plasmids) were present, 
then another difficulty would present itself. Imaging individual bacteria would be 
possible (as has been shown here e.g. Figure 5.19), but statistics to describe the 
behaviour of plasmids in the whole bacterial population would be difficult to obtain. 
High-throughput imaging analysis is necessary to rapidly identify transformants and to 
obtain statistics for the whole population. To allow this custom Matlab code has been 
used to segment bacteria and visualise those of interest (e.g. with overlapping signal 
from labelled plasmids). 
Image segmentation is a classic image processing problem, for which many different 
strategies exist222. The most effective strategy is one that will identify and segment the 
objects of interest within an image, with the highest possible accuracy. However, there is 
no general solution to image segmentation problems, so in practice the experimental 
images must be carefully considered, and custom code is often used to generate the best 
practical solution. 
For segmentation of E. coli on agarose pads there are a number of software packages 
available220,223–225, however these are generally unsuited to the images obtained here, 
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since they are applied to brightfield images rather than using the autofluorescence of the 
bacteria. This means that the contrast in the images is generally better, particularly the 
edges between bacteria within clumps or microcolonies, which makes for an easier 
image segmentation problem. 
An example region from a large scan is shown in Figure 5.21A. Note how the contrast 
between individual bacteria or clumps of bacteria, and the background is generally good. 
This means a simple threshold can be used to segment bacteria from the background, 
seen in Figure 5.21B. The size of regions identified by a threshold can then be used to 
identify individual bacteria, for example small regions (e.g. <40 pixels in area) can be 
removed (Figure 5.21C) and remaining regions can be separated between individual 
bacteria (e.g. <120 pixels in area, Figure 5.21D) and clumps (e.g. >=120 pixels in area, 
Figure 5.21E). The final results for this first stage of segmentation are shown in Figure 
5.21F. 
The next stage is to detect individual bacteria within clumps (shown in Figure 5.22A), 
first the contrast between bacteria must be improved. For this a contrast filter was used, 
the “magic contrast filter” used by the SuperSegger software package225. At each pixel 
the minimum intensity of pixels within a radius of interest (e.g. 3 pixels) is subtracted 
from the pixel. This will mean pixels located at the edges of bacteria, but within clumps, 







Figure 5.21 Image segmentation procedure. A) Typical raw image of E. coli from a large 
scan of an agarose pad. Individual bacteria and clumps of bacteria are both 
visible, but contrast is low. B) A thresold can be used to segment most 
bacteria from the background. C) Small regions (e.g. <40 pixels) are 
removed from the threshold image. D) Medium regions (e.g. 
40<pixels<120) are segmented as individual bacteria. E) Large regions (e.g. 
>120 pixels) are segmented as clumps of bacteria. F) Overlay showing 
segmentation of image into indivudal bacteria (red) and clumps (green). 
This can be used to generate a new threshold image, now of the clumps of bacteria, 
which should largely separate individual bacteria (Figure 5.22C). After image dilations 
and erosions and selection by size again many individual bacteria can be successfully 
segmented (Figure 5.22D). The segmentation is not perfect, particularly in clumps, 
however this is sufficient to identify large numbers of bacteria and therefore should be 
sufficient to generate good population statistics. The raw microscopy image is shown in 
Figure 5.22E and the segmentation and overlap with plasmids (selected by thresholding 




Figure 5.22 Image segmentation procedure for segmentation of clumps of bacteria. A) 
Clumps segmented from Figure 5.21. B) A contrast filter is used to increase 
the edge contrast between bacteria. C) Thresholding can be used to identify 
bacteria. D) Regions which contain a suitable number of pixels can be 
identified as individual bactera. E) Original overlay of bacteria (green) and 
plasmids (red). F) Overlay of segmented bacteria (green) and segmented 
plasmids (red). 
When this segmentation is carried out on hundreds of images from large scans, simple 
statistics can be generated, for example the number of bacteria on the surface and the 
number with overlapping plasmids. For example, for the RLG221/pUC19 image in 
Figure 5.17 there are 982 individual bacteria found, of which 99 overlap with labelled 
plasmids. A montage of these is shown in Figure 5.23. In this each overlap between an 
individual bacterium and a plasmid is displayed, so if there are multiple bacteria for a 
single plasmid, or vice versa, the same regions may be shown several times, centred on 




Figure 5.23 Bacteria of interest automatically identified by image segmentation. 
Regions of overlap between bacteria (green) and plamsids (red) are 
identified by image segmentation (Figure 5.22F). Areas are around each 
plasmid are extracted. Highlighted regions i-iv are shown in Figure 5.23. 
Furthermore, this montage can be used to follow plasmids throughout the whole time-
lapse. Four regions from Figure 5.23 have been selected to highlight this. The first region 
(i) is the same region that was identified in Figure 5.18, but here it has been 
automatically extracted. Other behaviours are also shown, including: bacteria that grow 
initially but then stop (ii); bacteria that do not grow normally (iii); and bacteria that 




Figure 5.24 Time lapses of regions of interest identified in Figure 5.23. Regions are 
automatically identified, and time lapses extracted for each. i) Region 
identified in Figure 5.18, showing colony growth from a transformant. ii) 
Bacterium that grow initially but then stops. iii) Bacterium that does not 
grow normally. iv) Bacterium that divides but does not appear to initially 
contain the plasmid. 
These examples show how powerful this type of image analysis can be for automatically 
selecting features of interest, for further investigation and the generation of statistics for 
the population as a whole. However, here they have only been used sparingly, since 







Several methods have been developed which should prove valuable for investigating the 
localisation and dynamics of single plasmids in bacteria. The preliminary results 
presented are also the first known example of the transformation and imaging of 
bacteria using plasmids, which have been fluorescently-labelled, covalently, in vitro 
(previous studies have either used eukaryotic cells or small oligonucleotides221). Using 
methyltransferase-directed labelling, plasmids can be fluorescently labelled, with 
controlled densities, at specific sites. Labelling efficiencies of around 30% are typical 
and only a small proportion of plasmids have no fluorescent labels visible (<5%).  
Labelled plasmids can be used for transformation of E. coli strains and the labelling does 
not affect transformation efficiency. Similar results have been observed previously for 
non-specifically labelled plasmids, transfected into mouse liver cells204, in which there 
was minimal difference in gene expression between labelled and un-labelled plasmids. 
Either labels have no effect on transcription (i.e. the RNA polymerase can read DNA 
regardless of the covalent labels) or alternatively repair of modified bases could be 
taking place (i.e. nuclear excision repair). 
In these experiments individual transformants were identified by either resistance to 
ampicillin and/or expression of EGFP. However, in general, very few of the transformed 
bacteria had overlapping fluorescent foci that could be attributed to labelled plasmids. 
Since there is no difference in transformation efficiency, but at least 95% of plasmids are 
fluorescently labelled, then most transformants should have been originally transformed 
by labelled plasmids. Cell division has not occurred more than 1-2 times before placing 
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bacteria on agarose pads, due to the short recovery period, so this also does not explain 
this observation. 
Atto 647N is unlikely to be quenched, (Atto 647N-labelled oligonucleotides have been 
imaged in cells221), and the amide coupling is also unlikely to be hydrolysed. However, to 
test the factors TAMRA-labelled plasmids, using DBCO coupling were also tested, but 
showed the same behaviour (results not shown). Also, higher labelling densities using 
M.MpeI-labelled plasmids did not yield more fluorescent foci (results not shown). 
Therefore it seems likely that the fluorescent label is being removed, for instance by 
nucleotide excision repair 226. In E. coli repair is carried out by the UvrABC system, 
which recognises a wide range of DNA damage, including alkylation. Therefore, for 
future work it is advised that strains containing a knock-out of this system should be 
used, since although they may be ‘sick’, it is expected that the fluorescent labels would 




5.4 Materials and Methods 
5.4.1 Plasmid labelling and single molecule counting (Figure 5.9 and Figure 
5.10) 
For plasmid labelling, a 10 μl solution containing 2x PBS, 3 mM AdoHcy-amine and 10 
mM Atto647N NHS Ester is incubated at 4oC for 1 hour. Next a 40 µl solution containing 
1x MES CutSmart, pH 5.75, 1 µg pUC19 (NEB) or pRSET B-EGFP (engineered by 
Muhammed Rassul), 0.6 µg M.TaqI and 4 μl of the AdoHcy-Atto647N mixture is 
incubated at 50oC for 1 hour. 1 µl 20 mg/ml proteinase K is added and incubated at 50oC 
for 1 hour, before purification by GenElute PCR Clean-up kit (Sigma-Aldrich) and elution 
into 50 µl 1xTE (Sigma-Aldrich).  
For imaging, a 50μl mixture of 50% DMSO, 0.5xTE, 0.2 μM YOYO-1 and ~5 ng DNA was 
incubated at 37oC for 30 minutes. 450 μl 1xTE was added and 100 μl was placed on poly-
l-lysine coated coverslips for ~30 seconds. Subsequently, the sample was washed with 3 
ml molecular grade water and dried. Samples were imaged using an Olympus IX81 
inverted widefield/epifluorescent/TIRF microscope equipped with 491, 560, 640 lasers, 
and a Hamamatsu CCD camera (Orca R2). All images were analysed using the Localizer 
plugin for IgorPro94 and custom Matlab software141. 
5.4.2 Preparation of competent cells 
Strains: RLG221, E. coli K-12 Δlac ΔrecA, R. Gourse, supplied by Rita Godfrey. T7 Express, 
enhanced BL21 derivative, New England Biolabs. 
Strains were grown in 20 ml LB broth overnight at 37°C, shaking. 50 ml of fresh LB broth 
was inoculated with 0.5 ml of overnight culture and grown at 37oC, shaking, until mid-
exponential phase (OD650 = 0.3-0.5). Cells were harvested by centrifugation, ~3700g, for 
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15 minutes, at 4oC and the cell pellet resuspended in 20 ml ice cold 50 mM calcium 
chloride and left on ice for 20 minutes. Cells were harvested by centrifugation (~3700g, 
15 minutes, 4oC) and the cell pellet resuspended in 5 ml ice cold freeze-thaw buffer (100 
mM calcium chloride, 15% glycerol) and left on ice overnight. 50 μl aliquots were stored 
at -80oC. 
5.4.3 Transformations on agar plates 
50μl aliquots of competent cells were thawed on ice. 10-100 ng of DNA was added, and 
cells incubated on ice for 30 minutes. Cells were heat-shocked at 42oC for 2 minutes, 
then placed back on ice for 2 minutes. 0.5 ml LB broth was added, and cells incubated at 
37oC for 1 hour. Cells were harvested by centrifugation (>6000g, 2 minutes) and 
resuspended in 50 μl LB broth. Culture was spread on agar plates, containing 100 μg/ml 
ampicillin (Sigma-Aldrich) and grown overnight at 37oC. 
5.4.4 Preparation of agarose pads 
50 ml M9 minimal media: mix 25 ml 2x M9 salts (Thermofisher), 1 ml 20% glucose, 1 ml 
0.1 M magnesium sulfate, 0.1 ml 50 mM calcium chloride, 0.5 ml 10 mg/ml thiamine 
hydrochloride, 0.5 ml 10 mg/ml biotin, 2.5 ml 20 mg/ml casamino acids, 50 μl trace 
elements (Sigma-Aldrich) and top up with molecular grade water. 
0.15 g low melting point agarose was mixed in 10 ml M9 minimal media and dissolved 
by microwave. 0.1 ml 100 mg/ml ampicillin and 0.1 ml 100 mM IPTG (as necessary) was 
added to agarose mix. 1 ml of solution was pipetted onto glass coverslip, sandwiched by 
another coverslip and left to set. Small pads (approx. 0.5x0.5 cm) were cut out. 
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5.4.5 Typical transformation onto agarose pads 
50 μl aliquots of competent cells were thawed on ice. 100 ng of unlabelled plasmid was 
added, and cells incubated on ice for 30 minutes. Cells were heat-shocked at 42oC for 2 
minutes, then placed back on ice for 2 minutes. Nothing 0.5 ml M9 minimal media was 
added and cells incubated at 37oC for 20 minutes. Cells were harvested by centrifugation 
(>6000g, 2 minutes) and washed with 0.5 ml M9 minimal media 3 times. The final 
resuspension was in 0.5 ml M9 minimal media. 5 μl of suspension was placed on agarose 
pads and allowed to dry for 15 minutes. Agarose pads were place into glass-bottomed 
dishes, sealed with parafilm and incubated at 30oC. 
For short term growth samples were incubated for 1 hour and imaged using an Olympus 
IX81 inverted widefield/epifluorescent/TIRF microscope equipped with 491, 560, 640 
lasers, and two Hamamatsu CCD cameras (Orca R2 and high-speed ImageEm). Images 
were analysed using Fiji and the Localizer plugin for IgorPro. 
For long term growth samples were incubated at room temperature overnight and 
imaged on a custom inverted widefield/epifluorescent/TIRF microscope, equipped with 




CHAPTER 6 CONCLUSIONS AND FUTURE PERSPECTIVE 
6.1 Conclusion 
In this doctoral thesis methyltransferase-directed labelling of DNA has been optimised 
and investigated, in particular with the methyltransferase M.TaqI and fluorescent 
organic dyes (CHAPTER 2). This has enabled robust and reproducible labelling of DNA at 
intermediate labelling densities, which has been applied for the identification and 
visualisation of DNA. 
The identification of resistance plasmids, bacterial populations and other complex 
mixtures of DNA remain challenging, despite the emergence and development of a 
variety of DNA sequencing technologies (CHAPTER 3 and CHAPTER 4). Similarly, the 
identification of specific DNA fragments (e.g. plasmids) in live cells remains technically 
challenging (CHAPTER 5). The unique properties and advantages of methyltransferase-
directed labelling have enabled the development and application of new methods to 
address these challenges. 
6.2 Future Perspectives 
It is important to consider the future perspectives of methyltransferase-directed 
labelling in light of the unique advantages it provides over alternative technologies. I 
consider that there are three primary properties that methyltransferase-directed 
labelling has, which will continue to lend it advantages over other emerging 
technologies: low resolution information content; multi-channel information; and 
targeting of DNA specifically, efficiently and with no damage. 
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6.2.1 Advantage one: lower resolution information content 
For rapid identification of bacterial populations or individual human genome sequences 
DNA nanopores are a particularly exciting emerging technology that is perhaps most 
comparable to the methods of DNA identification described in this thesis. For example, 
both methods effectively read the sequence of native DNA, without the need to 
synthesise DNA, unlike traditional sequencing technologies. Indeed the intensity traces 
which are derived by both techniques bear a striking similarity227 (Figure 6.1). 
 
Figure 6.1 Comparison of intensity traces obtained from optical mapping of DNA 
barcodes and nanopore sequencing. A) Typical intensity trace for optical 
mapping using M.TaqI-directed labelling. Theoretical intensity trace for E. 
coli K-12, labelled with M.TaqI and with a PSF width of 250 nm. B) Typical 
intensity trace for nanopore sequencing using a MinION. Raw current trace 
for the passage of the single 48 kbp lambda DNA molecule (adapted from 
Jain et al.227). 
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The primary difference between the two traces is resolution. For optically mapped DNA 
the intensity profile records a signal at every pixel, approximately every 250 bp (Figure 
6.1A), whilst the Oxford Nanopore MinION (Figure 6.1B), can record the current across 
the nanopore at many time points for even a single base pair. Similarly, the labels that 
are being detected in DNA labelled by M.TaqI (5’-TCGA-3’) are on average every 256 bp, 
whilst the MinION detects every base pair. 
One of the main challenges associated with sequencing DNA in nanochannels is the 
requirement to achieve single base pair resolution228. However, this resolution is not 
necessary for a simple identification of DNA, as has been shown in this thesis. An 
intermediate resolution of 100-1000 bp is sufficient to give unique signals for DNA 
identification, and therefore the challenge of resolution is effectively bypassed entirely. 
The challenge is simply to obtain high quality signals as rapidly as possible. In addition, 
lower resolution data is far easier to handle than the incredibly large and unwieldy 
datasets that are generated using current nanopore technology. 
The main limitations with the methods used in this thesis appear to be with the optical 
mapping procedure. It is difficult to parallelise the detection methods to achieve rapid 
identification. For molecular combing a single snapshot only contains around 1 Mbp of 
DNA and takes around 100 ms to acquire. For nanochannels this imaging is even less 
rapid since kymographs must be recorded. Molecular combing has also proved difficult 
to apply in practice, and there appears to be a large amount of junk data, due to 
overlapping DNA molecules. 
To overcome these limitations, it may be possible to exploit nanopores, in combination 
with methyltransferase-directed labelling. Rather than labelling DNA with fluorophores 
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for optical mapping, labels can be attached to DNA, at sequence-specific sites, which 
affect the current across a nanopore as the DNA is translocated. This would effectively 
scale-up the optical mapping procedure described in this thesis and perhaps provide 
more robust data, given the limitations of optical mapping. The methods applied in 
CHAPTER 4 could then be used reliably, since this would generate the same type of data 
as optical mapping. This would allow extremely rapid and robust identification of DNA 
samples, without the need for single-base resolution. 
6.2.2 Advantage two: multi-channel information 
The other advantage over current nanopore technology is that methyltransferase-
directed labelling allows multiple channels of information. In nanopores only a single 
channel of information is obtained, the electrical current. However, for 
methyltransferase-directed labels there is the possibility to use multiple 
methyltransferases with multiple different dyes which can allow multiplexing of 
information. 
Most obviously this can be applied to ensure that the identification of DNA is as robust 
as possible. If DNA fragments are labelled with two independent barcodes, then both can 
be used to maximise the cross-correlation. This would increase the robustness of fit 
many times since it is less likely the dual barcode will fit accidentally to a different 
region of the genome. Although this has not been considered in detail in this thesis, an 
example is shown in Figure 6.2.  
In Figure 6.2 two barcodes are simulated for the same stretch of DNA (bases 5,001 to 
35,000 of T7). The barcode shown is Figure 6.2A is generated using M.TaqI-directed 
labelling and the barcode in Figure 6.2B is generated using M.MpeI-directed labelling, 
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both with only 10% labelling efficiency. On their own, neither barcode can be used to 
reliably align the fragment to the reference barcode. A displacement of 350 (i.e. 35,000 
bp / sampling of 100 bp) is expected, however, the maximum normalised cross-
correlation is 0.36 at a displacement of 354 and 0.31 at a displacement of 347 for the 
M.TaqI-labelled and M.MpeI-labelled fragments respectively (Figure 6.2C). This is rather 
unreliable alignment (and identification), and is consistent with the results obtained in 
Figure 3.25, in which these labelling efficiencies would give correct alignment only 
around a third of the time. 
In contrast, when the product of the cross-correlations is used the correct displacement 
is more reliably obtained (Figure 6.2D); even for only 10% labelling a displacement of 
351 is obtained. This simple example demonstrates the advantage for identification and 
alignment that using two barcodes could provide over using single barcodes only. Of 
course, using even more channels is possible in theory and would provide robust 
identification of small fragments from even very large genomes, such as the human 
genome. 
Perhaps a more exciting application is to use other channels to provide a completely 
new layer of information. It has proved possible to use nanopores to investigate 
methylation and protein binding sites on DNA228. However, this still uses a single 
channel, the current, and therefore will never be as inherently reliable as using an 




Figure 6.2  Using two channels for DNA identification.  A-B) Simulated barcodes (red) 
generated from 5,001 to 35,000 bp of reference T7 genome (blue) with 
10% labelling efficiency for channels obtained by: A) M.TaqI-directed 
labelling and B) M.MpeI directed labelling. C) The normalised cross-
correlation as a function of displacement for both channels: M.TaqI-
labelled (blue) and M.MpeI-labelled (red). This is used to align the 
simulated fragments, but the results obtained are unreliable. D) The 
product of the normalised cross-correlation for both channels gives a more 
reliable alignment result. 
DNA methylation is an intriguing target for epigenetic sequencing. DNA methylation is 
involved in genome regulation in eukaryotes but in prokaryotes is thought to primarily 
associated with the restriction-modification system, for protection of native DNA and 
destruction of foreign DNA. However, there is emerging evidence that DNA methylation 
in prokaryotes may also have further roles, including control of gene expression229. 
Therefore, the study of the methylation state of prokaryotic genomes, in particular in 
response to environmental changes, is a growing area of study. Methyltransferase-
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directed labelling of DNA could be applied to allow rapid identification of methylation 
patterns. 
For example, one methyltransferase (e.g. M.TaqI) could be used to label the DNA for 
identification as described in CHAPTER 4. However, a second methyltransferase could 
be used to label possible methylation sites e.g. Dam methyltransferase. Where sites have 
been methylated a fluorescent label will not be transferred. A fluorescent signal will only 
be seen when a site has not been methylated in the bacteria and the methylation pattern 
could therefore be readily identified. This would allow rapid screening for different 
environmental conditions, to investigate the role methylation plays in prokaryotic gene 
regulation. 
An alternative is to use the second channel to target DNA-binding proteins. Again, one 
methyltransferase (e.g. M.TaqI) could be used to label the DNA for identification as 
described in CHAPTER 4. Now, the second channel is associated with a fluorescently-
tagged DNA-binding protein. This kind of method has already been described by Kim et 
al.95 This could be used to give a static snapshot of bound DNA proteins, similar to 
current techniques such as ChIP-Seq. However perhaps a more intriguing possibility is 
to use the DNA barcode in tandem with techniques which investigate the diffusion of 
DNA-binding proteins. 
DNA binding proteins that bind to specific regions of DNA do so with remarkable 
accuracy and speed, which forms the foundation for all genetic processes, including 
transcriptional regulation. This is illustrated by the classic lac operon system in which 
the LacI repressor prevents the transcription of genes required for lactose metabolism 
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whilst lactose is not present230. To be effective it must do so in a timely and accurate 
manner. 
In fact, DNA binding proteins are able to bind far more rapidly to their target sequences 
than predicted by random diffusion alone231. Hence the search for the target sequence is 
said to proceed by ‘facilitated diffusion’, where the protein binds randomly to a non-
specific site on the DNA and then uses the DNA to direct its subsequent search. The 
facilitated diffusion of DNA binding proteins has been well characterised from a 
theoretical perspective, but many aspects are yet to be examined experimentally. There 
is also some debate whether the rapidity of diffusion is primarily due to electrostatic 
interactions and not the reduction in dimensionality introduced by facilitated 
diffusion232. 
Single molecule techniques provide an ideal way to examine the diffusion of DNA 
binding proteins and address these questions. Techniques such as ‘DNA curtains’233 and 
‘DNA tightropes’234 have been used to image protein diffusion along DNA, but only along 
short, known fragments. The methyltransferase-directed labelling of DNA in these types 
of experiment would allow the DNA to be identified and the experiment to be scaled up 
to a whole bacterial genome, rather than small known fragments of DNA, that are 
currently used. This would provide novel insights into how DNA-binding proteins bind 
so rapidly to their target sequences. 
6.2.3 Advantage three: targets DNA specifically, efficiently and without 
damage 
Finally, the main advantage of methyltransferase-directed labelling of DNA, over other 
labelling strategies, is that is specific, therefore controllable, efficient and non-damaging. 
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This means it is a useful labelling strategy for any techniques that require labelled DNA, 
for instance FISH or DNA capture, as well as for generating a unique intensity profile. 
For example, in this thesis methyltransferase-directed labelling was exploited to 
fluorescently label plasmid DNA in vitro in addition to optical mapping.  
In particular, the ease of using the labelling strategy lends itself to more speculative 
techniques which require the labelling of DNA. Very large labels with a variety of 
interesting properties can be readily attached to DNA and cause fundamental changes to 
the properties of the DNA. For instance, hydrophobic labels such as long polymers, or 
nanoparticles, including magnetic beads, can be attached to DNA and will completely 
alter its properties. DNA has already been exploited in a range of applications such as 
DNA origami and methyltransferase-directed labelling offers a tool to further expand its 
utility. 
6.2.4 Summary 
Although nanopore sequencing may currently be a more attractive technology for the 
rapid identification of microorganisms, optical mapping of DNA using 
methyltransferase-directed labelling retains unique advantages. The methods developed 
and applied in this research have utilised, optimised and exemplified these unique 
advantages and should provide a useful basis for the continued development of 
associated technologies.   
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CHAPTER 7 APPENDIX 
7.1 Chapter 2 Supplementary Figures 
 
Figure 7.1 Restriction assay for M.TaqI labelling of pUC19 without cofactor, with 
purification after incubation and before restriction. Lane 1 = 2 log ladder; 
lanes 2-7, = No cofactor, 2x dilution of M.TaqI; lane 8 = AdoMet control; lane 
9 = no M.TaqI control; lane 10 = restricted pUC19; lane 11 = unrestricted 
pUC19. 
 
Figure 7.2 Modelling the effect of hemi-methylation slowing labelling reaction. 
Expected single molecule counting results for 50% labelling efficiency, 





Figure 7.3 Restriction assays for other AdoMet analogues: A) AdoHcy-amine, B) 
AdoCys-amine and C) AdoCys-azide. Lane 1= 2 log ladder; lanes 2-7 = 
AdoMet analogue, 2x M.TaqI dilution; lanes 8, 10, 12 = unrestricted pUC19; 
lane 9 = AdoMet control; lane 11 = no AdoMet control; lane 11 = restricted 
pUC19. 
 
Figure 7.4 Effect of incomplete bleaching on single molecule counting results. Sample 
4 from Figure 14B was used for single molecule counting results.  A) Effect 
of laser power, 500 frames, 20%/50%/100% (blue/red/green) 561nm 
laser power. B) Effect of number of frames (length of bleaching), 50% laser 
power, 200/1000 frames (blue/red). 
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7.2 Chapter 2 Supplementary Materials and Methods 
7.2.1 Restriction assay - Figure 2.6A 
The following were mixed and incubated at 50oC for 1 hour. 
 
0.5µl R.TaqI was added to samples 1-16 and all samples incubated at 65oC for 1 hour, 
before adding 0.5µl 18mg/ml proteinase K /0.1% Triton X-100 to all samples and 
incubation at 50oC for 1 hour. DNA was analysed by gel electrophoresis. 
7.2.2 Restriction assay - Figure 2.7A 
Oligonucleotides from IDT, both 100µM in water: 
T7_1cF 5’-CGTCTATCGGTGAACCTCCGGTATCTCGATCGATCGATCGACCCC-3’ 
T7_1cR 5’-GGGGTCGATCGATCGATCGAGATACCGGAGGTTCACCGATAGACG-3’ 
A 1:1 ratio was mixed and heated to 90oC for 15 minutes, before slow cooling overnight. 
Stored at -20oC. 
The following were mixed and incubated at 50oC for 15 minutes, followed by addition of 
pUC19 and cofactor and incubation at 50oC for 1 hour. 
All in µL 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Water 8.0 8.0 8.0 8.0 8.0 8.0 8.5 8.5 8.5 8.5 8.5 8.5 8.5 8.5 8.0 8.5 8.5
10x CutSmart 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
1mg/ml pUC19 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
15mM AdoMet-azide 0.5 0.5 0.5 0.5 0.5 0.5 0.5





0.5µl R.TaqI (100,000units/ml, NEB) was added to samples 1-19 and all samples 
incubated at 65oC for 2 hours, before adding 0.5µl 18mg/ml proteinase K/0.1% Triton 
X-100 to all samples and incubation at 50oC for 1 hour. DNA was analysed by gel 
electrophoresis. 
7.2.3 Restriction assay - Figure 2.8A 
A 500µl solution containing 1x CutSmart, 6µg M.TaqI and 1µM oligonucleotides was 
incubated overnight at 37oC. Pierce strong anion exchange spin columns (Thermo-
scientific) were used to remove oligonucleotides and the M.TaqI was concentrated to 
around 120µl in 1x CutSmart using Amicon Ultra 10K centrifugal filter units (Sigma-
Aldrich). 6µg of pUC19 was added and 10µl was used for samples 1, 7 and 13 below. 
Other samples were prepared by serial dilution and incubated at 50oC for 1 hour. 
 
0.5µl R.TaqI was added to samples 1-19 and all samples incubated at 65oC for 1 hour, 
before adding 0.5µl 18mg/ml proteinase K /0.1% Triton X-100 to all samples and 
incubation at 50oC for 1 hour. DNA was analysed by gel electrophoresis. 
All in µL 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Water 8.5 8.5 8.5 8.5 8.5 8.5 8.5 8.5 8.5 8.5 8.5 8.5 9.0 9.0 9.0 9.0 9.0 9.0 9.0 9.0
10x CutSmart 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
0.3mg/ml M.TaqI 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
50µM oligos 0.50 0.25 0.13 0.06 0.03 0.02 0.50 0.25 0.13 0.06 0.03 0.02 0.50 0.25 0.13 0.06 0.03 0.02
1mg/ml pUC19 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
15mM AdoMet-azide 0.5 0.5 0.5 0.5 0.5 0.5
Incubate @50oC for 15 minutes
All in µL 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Water 8.5 8.5 8.5 8.5 8.5 8.5 8.5 8.5 8.5 8.5 8.5 8.5 8.5 8.5 8.5 8.5 8.5 8.5 8.5 8.5
10x CutSmart 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
1mg/ml pUC19 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
Pre-incubated M.TaqI (estimated)1.60 0.80 0.40 0.20 0.10 0.05 1.60 0.80 0.40 0.20 0.10 0.05 1.60 0.80 0.40 0.20 0.10 0.05
32mM AdoMet 0.25 0.25 0.25 0.25 0.25 0.25
15mM AdoMet-azide 0.50 0.50 0.50 0.50 0.50 0.50
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7.2.4 Restriction assay - Figure 2.9 
The following samples were prepared and incubated at 37oC for 10 minutes. Samples 
were diluted 10x in 1x CutSmart and concentrated with Amicon Ultra 10K centrifugal 
filter units 3 times to a final volume of 10µl to remove excess Sinefungin (Cambridge 
BioScience). pUC19 and cofactors were then added and incubated at 50oC for 1 hour. 
 
0.5µl R.TaqI was added to samples 1-19 and all samples incubated at 65oC for 1 hour, 
before adding 0.5µl 18mg/ml proteinase K /0.1% Triton X-100 to all samples and 
incubation at 50oC for 1 hour. DNA was analysed by gel electrophoresis. 
7.2.5 Restriction assay - Figure 2.10 
An 8µl solution containing 2.8mM AdoMet-amine, 15.6mM Atto647N NHS ester (Sigma-
Aldrich) and 5x PBS (Sigma-Aldrich) was incubated at 4oC for 1 hour. The following 
were mixed and incubated at 50oC for 1 hour. (MES CutSmart buffer – 50mM potassium 
acetate, 20mM MES, 10mM magnesium acetate, 0.1mg/ml BSA, all from Sigma-Aldrich) 
 
All in µL 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Water 8.2 8.2 8.2 8.2 8.2 8.2 8.2 8.2 8.2 8.2 8.2 8.2 8.2 8.2 8.2 8.2 8.2 8.2 8.5 8.5
10x CutSmart 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
40mM Sinefungin 2.5 1.3 0.6 0.3 0.2 0.1 2.5 1.3 0.6 0.3 0.2 0.1 2.5 1.3 0.6 0.3 0.2 0.1
0.3 mg/ml M.TaqI 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50
1mg/ml pUC19 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
32mM AdoMet 0.25 0.25 0.25 0.25 0.25 0.25
15mM AdoMet-azide 0.50 0.50 0.50 0.50 0.50 0.50
Incubate @ 37oC for 10 minutes, wash with 1x CutSmart
All in µL 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19
Water 7.5 7.5 7.5 7.5 7.5 7.9 7.9 7.9 7.9 7.9 8.0 8.0 8.0 8.0 8.0 8.0 8.0 8.5 8.5
pH 6.75 6.50 6.25 6.00 5.75 6.75 6.50 6.25 6.00 5.75 6.75 6.50 6.25 6.00 5.75 6.75 5.75 6.75 6.75
10x CutSmart 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
1mg/ml pUC19 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
AdoMet-Atto647N 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
0.3mg/ml M.TaqI 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
32mM AdoMet 0.1 0.1 0.1 0.1 0.1
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0.5µl R.TaqI was added to samples 1-18 and all samples incubated at 65oC for 1 hour, 
before adding 0.5µl 20mg/ml proteinase K to all samples and incubation at 50oC for 1 
hour. DNA was analysed by gel electrophoresis. 
7.2.6 Restriction assay - Figure 2.11A 
A 10µl solution containing 3mM AdoMet-amine, 10mM Atto647N NHS ester and 1x PBS 
was incubated at 4oC for 1 hour. The following were mixed and incubated at 50oC for 1 
hour. 
 
0.5µl R.TaqI was added to samples 1-16 and all samples incubated at 65oC for 1 hour, 
before adding 0.5µl 20mg/ml proteinase K to all samples and incubation at 50oC for 1 
hour. DNA was analysed by gel electrophoresis. 
7.2.7 Restriction assay - Figure 2.13A and Figure 2.13B 
The following were mixed and incubated at 50oC for 1 hour, either at pH 5.7 or pH 7.2. 
 
All in µL 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
Water 8.0 8.0 8.0 8.0 8.0 8.0 8.0 8.0 8.0 8.0 8.4 8.4 8.5 8.5 8.0 8.0 8.5 8.5
pH 7.2 7.2 7.2 7.2 7.2 5.7 5.7 5.7 5.7 5.7 7.2 5.7 7.2 5.7 7.2 5.7 7.2 5.7
10x CutSmart 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
1mg/ml pUC19 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
AdoMet-Atto647N 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
0.3mg/ml M.TaqI 0.25 0.13 0.06 0.03 0.02 0.25 0.13 0.06 0.03 0.02 0.25 0.25 0.25 0.25
32mM AdoMet 0.1 0.1
All in µL 1 2 3 4 5 6 7 8 9 10 11
Water 8.4 8.4 8.4 8.4 8.4 8.4 8.5 8.4 8.5 8.4 8.5
10x CutSmart 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
1mg/ml pUC19 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
15mM AdoMet-azide 0.1 0.1 0.1 0.1 0.1 0.1 0.1




0.5µl R.TaqI was added to samples 1-6 and 8-11 and all samples incubated at 65oC for 1 
hour, before adding 0.5µl 20mg/ml proteinase K to all samples and incubation at 50oC 
for 1 hour. DNA was analysed by gel electrophoresis. 
7.2.8 Restriction assay - Figure 2.16 
A 5µl solution containing 3mM AdoMet-azide, 25mM TAMRA-DBCO, 0.05% formic acid 
and 50% DMSO was incubated at room temperature for 1 hour. The following were 
mixed and incubated at 50oC for 1 hour. 
 
 
*PIPES was 5X 
0.5µl R.TaqI was added to samples 1-17 and all samples incubated at 65oC for 1 hour, 
before adding 0.5µl 20mg/ml proteinase K to all samples and incubation at 50oC for 1 
hour. DNA was analysed by gel electrophoresis. 
All in µL 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
Water 6.5 7.5 7.5 7.5 6.9 7.9 7.9 7.9 7.0 8.0 8.0 8.0 7.0 8.0 8.0 8.0 8.5 8.5
Good's Buffer PIPES MOPS HEPES Tris PIPES MOPS HEPES Tris PIPES MOPS HEPES Tris PIPES MOPS HEPES Tris Tris Tris
10x* CutSmart, pH 7.2-7.4 2.0 1.0 1.0 1.0 2.0 1.0 1.0 1.0 2.0 1.0 1.0 1.0 2.0 1.0 1.0 1.0 1.0 1.0
1mg/ml pUC19 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
AdoMet-TAMRA 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
0.3mg/ml M.TaqI 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
32mM AdoMet 0.1 0.1 0.1 0.1
All in µL 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
Water 7.5 6.5 7.5 7.5 7.9 6.9 7.9 7.9 8.0 7.0 8.0 8.0 8.0 7.0 8.0 8.0 8.5 8.5
Good's Buffer MES PIPES MOPS HEPES MES PIPES MOPS HEPES MES PIPES MOPS HEPES MES PIPES MOPS HEPES HEPES HEPES
10x* CutSmart, pH 6.4-6.8 2.0 1.0 1.0 1.0 2.0 1.0 1.0 1.0 2.0 1.0 1.0 1.0 2.0 1.0 1.0 1.0 1.0 1.0
1mg/ml pUC19 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
AdoMet-TAMRA 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
0.3mg/ml M.TaqI 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
32mM AdoMet 0.1 0.1 0.1 0.1
287 
 
7.2.9 Restriction assay - Figure 2.17 
A 5µl solution containing 3mM AdoMet-azide, 25mM TAMRA-DBCO, 0.05% formic acid 
and 50% DMSO was incubated at room temperature for 1 hour. The following were 
mixed and incubated at 50oC for 1 hour. 
 
0.5µl R.TaqI was added to samples 1-16 and all samples incubated at 65oC for 1 hour, 
before adding 0.5µl 20mg/ml proteinase K to all samples and incubation at 50oC for 1 
hour. DNA was analysed by gel electrophoresis. 
7.2.10 Restriction assay - Figure 2.18 
The following were mixed and incubated for 1 hour at the indicated temperature. 
 
0.5µl R.TaqI was added to samples 1-16 and all samples incubated at 65oC for 1 hour, 
before adding 0.5µl 18mg/ml proteinase K /0.1% Triton X-100 to all samples and 
incubation at 50oC for 1 hour. DNA was analysed by gel electrophoresis. 
7.2.11 Restriction assay - Figure 2.19 
The following were mixed and incubated at 50oC for the time indicated. 
All in µL 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Water 8.0 8.0 8.0 8.0 8.0 8.0 8.0 8.0 8.0 8.0 8.0 8.0 8.5 7.4 7.5 8.0 8.5
10x MES CutSmart, pH 5.75 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
1mg/ml pUC19 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
0.1M NaOH 1.00 0.50 0.25 0.13 0.05 0.0
0.1M NaCl 1.00 0.50 0.25 0.13 0.05 0.0
AdoMet-TAMRA 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
NEB M.TaqI 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
32mM AdoMet 0.1
All in µL 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Water 8.2 8.2 8.2 8.2 8.2 7.9 7.9 7.9 7.9 7.9 8.4 8.4 8.4 8.4 8.4 8.5 8.5
10x CutSmart 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
1mg/ml pUC19 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
32mM AdoMet 0.3 0.3 0.3 0.3 0.3
15mM AdoMet-azide 0.5 0.5 0.5 0.5 0.5








































0.5µl R.TaqI was added to samples 1-16 and all samples incubated at 65oC for 1 hour, 
before adding 0.5µl 18mg/ml proteinase K /0.1% Triton X-100 to all samples and 
incubation at 50oC for 1 hour. DNA was analysed by gel electrophoresis. 
7.2.12 Restriction assay - Figure 2.20 
The following were mixed and incubated at 37oC for 3 hours. AdoHcy hydrolase was 
purchased from Sigma-Aldrich, 0.1 to 1.0 mg/ml. 
 
0.5µl R.TaqI was added to samples 1-7, 9, 11, 13 and all samples incubated at 65oC for 1 
hour, before adding 0.5µl 20mg/ml proteinase K to all samples and incubation at 50oC 
for 1 hour. DNA was analysed by gel electrophoresis. 
7.2.13 Restriction assay - Figure 2.23 
The following were mixed and incubated at 37oC for 1 hour, followed by 65oC for 15 
minutes. 
All in µL 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Water 8.0 8.0 8.0 8.0 8.0 7.8 7.8 7.8 7.8 7.8 8.3 8.3 8.3 8.3 8.0 8.5 8.5
10x CutSmart 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
1mg/ml pUC19 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
32mM AdoMet 0.3 0.3 0.3 0.3 0.3
15mM AdoMet-azide 0.5 0.5 0.5 0.5 0.5
0.3mg/ml M.TaqI 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3
Time 5 mins 10 mins 20 mins 40 mins 60 mins 5 mins 10 mins 20 mins 40 mins 60 mins 5 mins 10 mins 20 mins 40 mins 60 mins 60 mins 60 mins
Mix and incubate @ 50oC for
All in µL 1 2 3 4 5 6 7 8 9 10 11 12 13
Water 8.4 8.4 8.4 8.4 8.4 8.4 8.4 8.0 8.0 8.3 8.3 8.3 8.3
10x CutSmart 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
1mg/ml pUC19 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
15mM AdoHcy-amine 0.1 0.1 0.1 0.1 0.1 0.1 0.1
NEB M.TaqI 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
3.5mM AdoMet 0.25 0.25




0.5µl R.HhaI was added to samples 1-16 and all samples incubated at 37oC for 1 hour, 
before adding 0.5µl 18mg/ml proteinase K /0.1% Triton X-100 to all samples and 
incubation at 50oC for 1 hour. DNA was analysed by gel electrophoresis. 
7.2.14 Restriction assay - Figure 7.1 
The following were mixed and incubated at 50oC for 1 hour. 
 
0.5µl 18mg/ml proteinase K/0.1% Triton X-100 was added and incubated at 50oC for 1 
hour, before purification by GenElute PCR Clean-up kit and elution into 18µl water. 2µl 
10x CutSmart was added to each sample and 0.5µl R.TaqI was added to samples 1-9, 
followed by incubation at 65oC for 1 hour. 0.5µl 18mg/ml proteinase K/0.1% Triton X-
100 was added and incubated at 50oC for 1 hour. DNA was analysed by gel 
electrophoresis. 
7.2.15 Restriction assay - Figure 7.3 
The following were mixed and incubated at 50oC for 1 hour. 
All in µL 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Water 8.0 8.0 8.0 8.0 8.0 8.0 8.5 8.5 8.5 8.5 8.5 8.5 8.5 8.5 8.0 8.5 8.5
10x CutSmart 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
1mg/ml pUC19 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
15mM AdoHcy-azide 0.5 0.5 0.5 0.5 0.5 0.5 0.5
32mM AdoMet 0.2
NEB M.HhaI or 10mg/ml M.MpeI2.50 1.25 0.63 0.31 0.16 0.08 2.50 1.25 0.63 0.31 0.16 0.08 2.5 2.5
All in µL 1 2 3 4 5 6 7 8 9 10
Water 17.0 17.0 17.0 17.0 17.0 17.0 17.0 17.0 17.0 17.0
10x CutSmart 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0
1mg/ml pUC19 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
0.3mg/ml M.TaqI 0.50 0.25 0.13 0.06 0.03 0.02 0.50




0.5µl R.TaqI was added to samples 1-6, 8, 10, 12 and all samples incubated at 65oC for 1 
hour, before adding 0.5µl 20mg/ml proteinase K to all samples and incubation at 50oC 
for 1 hour. DNA was analysed by gel electrophoresis. 
7.2.16 Labelling for single molecule counting assay - Figure 2.6B 
Conditions as for samples 7 to 12 scaled up 4 times. Mixed and incubated at 50oC for 1 
hour. 
 
2µl 20mg/ml proteinase K was added and incubated at 50oC for 1 hour, before 
purification by GenElute PCR Clean-up kit and elution into 50µl 1xTE. 10µl DMSO and 
0.3µl 50mM TAMRA-DBCO were added to each sample and incubated at room 
All in µL 1 2 3 4 5 6 7 8 9 10 11 12
Water 7.5 7.5 7.5 7.5 7.5 7.5 8.3 8.3 8.5 8.5 8.5 8.5
10x CutSmart 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
1mg/ml pUC19 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
15mM AdoHcy-amine 1.0 1.0 1.0 1.0 1.0 1.0
NEB M.TaqI 2.00 1.00 0.50 0.25 0.13 0.06 0.25 0.25 0.25 0.25
3.5mM AdoMet 0.25 0.25
All in µL 1 2 3 4 5 6 7 8 9 10 11 12
Water 6.0 6.0 6.0 6.0 6.0 6.0 8.3 8.3 8.5 8.5 8.5 8.5
10x MES CutSmart, pH 5.75 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
1mg/ml pUC19 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
8.1mM AdoCys-amine 2.5 2.5 2.5 2.5 2.5 2.5
0.3mg/ml M.TaqI 0.100 0.050 0.025 0.013 0.006 0.003 0.10 0.10 0.10 0.10
3.5mM AdoMet 0.25 0.25
All in µL 1 2 3 4 5 6 7 8 9 10 11 12
Water 8.4 8.4 8.4 8.4 8.4 8.4 8.3 8.3 8.5 8.5 8.5 8.5
10x CutSmart 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
1mg/ml pUC19 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
55mM AdoCys-azide 0.1 0.1 0.1 0.1 0.1 0.1
NEB M.TaqI 2.00 1.00 0.50 0.25 0.13 0.06 0.25 0.25 0.25 0.25
3.5mM AdoMet 0.25 0.25
All in µL 1 2 3 4 5 6
Water 34.0 34.0 34.0 34.0 34.0 34.0
10x CutSmart 4.0 4.0 4.0 4.0 4.0 4.0
1mg/ml pUC19 2.0 2.0 2.0 2.0 2.0 2.0
0.3mg/ml M.TaqI 2.00 1.00 0.50 0.25 0.13 0.06
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temperature for 1 hour, before purification by GenElute PCR Clean-up kit  and elution 
into 50µl 1xTE. 
7.2.17 Labelling for single molecule counting assay - Figure 2.7B 
Conditions as for 8,10, 12 and two further dilutions. The following were mixed and 
incubated at 50oC for 15 minutes, followed by addition of pUC19 and cofactor and 
incubation at 50oC for 1 hour. 
 
2µl 20mg/ml proteinase K was added and incubated at 50oC for 1 hour, before 
purification by GenElute PCR Clean-up kit and elution into 50µl 1xTE. 10µl DMSO and 
0.3µl 50mM TAMRA-DBCO were added to each sample and incubated at room 
temperature for 1 hour, before purification by GenElute PCR Clean-up kit and elution 
into 50µl 1xTE. 
7.2.18 Labelling for single molecule counting assay - Figure 2.8B 
A 500µl solution containing 1x CutSmart, 6µg M.TaqI and 1µM oligonucleotides was 
incubated overnight at 37oC. Pierce strong anion exchange spin columns were used to 
remove oligonucleotides and the M.TaqI was concentrated to around 120µl in 1x 
CutSmart using Amicon Ultra 10K centrifugal filter units. 6µg of pUC19 was added and 
30µl was used for samples below. Other samples were prepared by serial dilution and 
incubated at 50oC for 1 hour. 
All in µL 1 2 3 4 5
Water 38.25 38.25 38.25 38.25 38.25
10x CutSmart 4.50 4.50 4.50 4.50 4.50
0.3mg/ml M.TaqI 2.25 2.25 2.25 2.25 2.25
50µM oligos 1.13 0.28 0.07 0.02 0.00
1mg/ml pUC19 2.25 2.25 2.25 2.25 2.25
15mM AdoMet-azide 2.25 2.25 2.25 2.25 2.25




2µl 20mg/ml proteinase K was added and incubated at 50oC for 1 hour, before 
purification by GenElute PCR Clean-up kit and elution into 50µl 1xTE. 10µl DMSO and 
0.3µl 50mM TAMRA-DBCO were added to each sample and incubated at room 
temperature for 1 hour, before purification by GenElute PCR Clean-up kit and elution 
into 50µl 1xTE. 
7.2.19 Labelling for single molecule counting assay - Figure 2.11B 
Conditions as for samples 1 and 6 Figure 6A scaled up 4 times. Mixed and incubated at 
50oC for 1 hour. 
 
2µl 20mg/ml proteinase K was added and incubated at 50oC for 1 hour, before 
purification by GenElute PCR Clean-up kit and elution into 50µl 1xTE. 
7.2.20 Labelling for single molecule counting assay - Figure 2.12 
An 8µl solution containing 2.8mM AdoMet-azide, 9.4mM TAMRA-DBCO, 0.05% formic 
acid and 50% DMSO was incubated at room temperature for 1 hour. The following were 
mixed and incubated at 50oC for 1 hour. 
All in µL 1 2 3 4 5 6
Water 25.5 25.5 25.5 25.5 25.5 25.5
10x CutSmart 3.0 3.0 3.0 3.0 3.0 3.0
1mg/ml pUC19 1.5 1.5 1.5 1.5 1.5 1.5
Pre-incubated M.TaqI (estimated) 4.80 2.40 1.20 0.60 0.30 0.15
15mM AdoMet-azide 1.50 1.50 1.50 1.50 1.50 1.50
All in µL 1 2
Water 32.0 32.0
pH 7.2 5.7
10x CutSmart 4.0 4.0
1mg/ml pUC19 2.0 2.0
AdoMet-Atto647N 1.5 1.5




2µl 20mg/ml proteinase K was added and incubated at 50oC for 1 hour, before 
purification by GenElute PCR Clean-up kit and elution into 50µl 1xTE. 
7.2.21 Labelling for single molecule counting assay - Figure 2.22 
A 200µl solution containing 1x CutSmart, 10µg pUC19, 0.45µg M.TaqI and 750µM 
AdoHcy-azide was incubated at 50oC for 1 hour. 5µl 18mg/ml proteinase K/0.1% Triton 
X-100 is added and incubated at 50oC for 1 hour, before purification by GenElute PCR 
Clean-up kit (Sigma-Aldrich) and elution into 200µl 1xTE (Sigma-Aldrich). Meanwhile a 
20µl solution containing 0.5x PBS/50% DMSO, 1mM DBCO-amine (Sigma-Aldrich) and 
12.5mM Atto647N or Atto565 NHS Ester (Sigma-Aldrich) was incubated at 4oC for 1 
hour. The DNA sample was split into 30µl aliquots and either 10µl of the NHS Ester mix 
was added or 5µl DMSO, 5µl 1x PBS and 2.5µl 50mM TAMRA or Texas Red DBCO (Jena 
Bioscience) was added and incubated at room temperature overnight, before 
purification by GenElute PCR Clean-up kit and elution into 50µl 1xTE. 
7.2.22 Labelling for single molecule counting assay - Figure 2.24 
The following were mixed and incubated at the indicated temperature for 1 hour. 
Additionally, M.HhaI and M.MpeI reaction were incubated at 65oC for an additional 15 
minutes. 
All in µL 1 2
Water 33.3 33.3
pH 7.2 5.7
10x CutSmart 4.0 4.0
1mg/ml pUC19 1.0 1.0
AdoMet-TAMRA 1.5 1.5




2.5 µl 18mg/ml proteinase K /0.1% Triton X-100 was added and incubated at 50oC for 1 
hour, before purification by GenElute PCR Clean-up kit and elution into 50µl 1xTE. 10µl 
DMSO and 0.5µl 50mM TAMRA-DBCO were added to each sample and incubated at room 
temperature for 1 hour, before purification by GenElute PCR Clean-up kit and elution 
into 50µl 1xTE. 
  
All in µL No Mtase M.TaqI M.HhaI M.MpeI
Water 34.0 30.0 20.0 26.0
10x CutSmart 4.0 4.0 4.0
10x M.HhaI buffer 4.0
1mg/ml pUC19 2.0 2.0 2.0 2.0













Mix and incubate for 1 hour @
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7.3 Chapter 3 Supplementary Figures 
 
Figure 7.5 Restriction assay for genomic DNA. A Restriction assay for M.TaqI labelling 
of pCT/EC958 with AdoHcy-azide and without added cofactor. Lane 1, 2 log 
ladder; lanes 2-7, AdoHcy-azide, 2x dilution of M.TaqI; lanes 8-13, no 
cofactor, 2x dilution of M.TaqI; lane 14, AdoMet control; lane 15, no M.TaqI 




Figure 7.6 Stretching of DNA during molecular combing. Pure samples of lambda and 
T7 DNA were M.TaqI-labelled with Atto647N, combed and imaged. 
Barcodes were extracted and aligned to the respective reference barcodes 
(see Figure 4.3 and Figure 4.4). The stretch of aligned fragments is 
displayed here as a histogram for: A) lambda and B) T7. The average and 






Figure 7.7 Effect of concentration and combing speed on DNA deposition. M.TaqI-
directed Atto647N-labelled T7 DNA is combed in 20mM MES pH5.7, onto 
zeonex-covered glass cover slips. Several stitched frames are shown A) Low 
density deposition: 100 mm/min, 2 ng/μl. B) Medium density deposition: 
20 mm/min, 2 ng/μl. C) High density deposition: 2 mm/min, 2 ng/μl. D) 





Figure 7.8 Effect of salt concentration on DNA deposition. M.TaqI-directed Atto647N-
labelled T7 DNA is combed in 50mM MES pH5.7, onto zeonex-covered glass 
cover slips. Several stitched frames are shown for varying concentrations of 





Figure 7.9 Effect of pH on DNA deposition. M.TaqI-directed Atto647N-labelled T7 DNA 
is combed in 50mM MES, onto zeonex-covered glass cover slips. Several 
stitched frames are shown for varying pH: A) pH 5.0; B) pH 5.4 C) pH 5.7; D) 
pH 6.0; E) pH 6.4. 
 
Figure 7.10 Labelling efficiency of T7 DNA for different commercial dyes, but with high 
density molecular combing. T7 was labelled with M.TaqI and AdoHcy-azide 
and coupled post-transalkylation. A) Single molecule counting results for 
each dye. B) Labelling efficiencies for each dye. The high density of combing 
meant many DNA molecules were overlapping, which increased the 





Figure 7.11 Monte-Carlo simulation to test sensitivity of parameters. 5000 sets of 
parameters were run for 100 fragments each. Experimental barcodes were 
generated and aligned from/to the T7 genome. Shown is a 2D histogram for 






Figure 7.12 Reference barcodes for T7 genome, labelled by different 
methyltransferases. Shown in black are the labelling sites, and in blue the 
reference barcode with a PSF of 250 bp. A) M.EcoRI-directed labelling 
(GAATTC sites). B) M.TaqI-directed labelling (TCGA sites). C) M.HhaI-




7.4 Chapter 3 Supplementary Tables 
 
Variables Description Typical 
values 
meth_efficiency  Labelling efficiency 50% 
false_methylation  Chance of non-specific labelling (per base pair) 0.0001 
flu_intensity_var  Variation in fluorophore intensity 20% 
min_fragment_length  Minimum length of fragment (in base pairs) 30,000 
max_fragment_length  Maximum length of fragment (in base pairs) 50,000 
base_length_var  Variation in stretching 2.5% 
sample_freq_mean  Average pixel size (base pairs per pixel) 350 
sample_freq_distr  Variation in pixel size (will depend on 
direction) 
50 
pixel_distr  Variation in pixel sampling (in base pairs) 40 
noise_mag  Magnitude of noise 20% 
PSF_frag [sigma] sigma for experimental PSF (in base pairs) 400 
PSF_frag_var  Variation in experimental PSF 10% 
 




7.5 Chapter 4 Supplementary Figures 
 
Figure 7.13 Effect of dam methylation on M.TaqI-directed labelling confirmed by de 
novo alignment. Dam methylation occurs at 5’-GATC-3’ sites and M.TaqI-
labelling at 5’-TCGA-3’ sites. Therefore, for dam-methylated DNA 5’-
TCGATC-3’ sites will be unlabelled, although the effect on 5’-GATCGA-3’ 
sites is not obvious. De novo alignment can be used to confirm results for A) 
Dam-negative lambda DNA and B) Dam-positive DNA. Dam-blocked 
reference barcode for lambda DNA (blue), de novo consensus barcode 
(brown), difference (black) and expected difference if dam-methylated 
sites are labelled. This shows that both consensus barcodes are similar, and 
that the expected and experimental differences are also similar. Both 




Figure 7.14 Alignment of a second colour using M.TaqI-directed labelling. Lambda DNA 
is labelled using M.TaqI with Atto647N, then labelled using YOYO-1. A) An 
example of an individual barcode. The M.TaqI-barcode (red) is used for 
alignment to the reference barcode (blue), and for alignment of the affinity-
barcode (green). B) Barcodes with an alignment weight greater than 0.65 
are used to calculate a mean M.TaqI-barcode (red), which aligns well to the 
reference barcode (blue). C) The mean affinity-barcode (red) can be 
calculated and aligned to the expected barcode (blue) – generated by CG 
labelling. D) The background is removed from the mean affinity-barcode 






Figure 7.15  Assignment of lambda DNA sample by separation, de novo alignment and 
assignment of consensus barcode to reference library. A) 1077 
experimental barcodes were extracted and produced 15 consensus 
barcodes for alignment to around 2000 reference barcodes from a library 
of phages. B) Barcodes are assigned to the genome with the maximum 
alignment weight. C) 751 of 1077 barcodes are assigned to lambda with a 





Figure 7.16 Assignment of T7 DNA sample by separation, de novo alignment and 
assignment of consensus barcode to reference library. A) 1166 
experimental barcodes were extracted and produced 21 consensus 
barcodes for alignment to around 2000 reference barcodes from a library 
of phages. B) 394 of 1166 barcodes are assigned to T7 with a weight greater 





Figure 7.17 Assignment of lambda/T7 DNA sample by separation, de novo alignment 
and assignment of consensus barcode to reference library. A) 1756 
experimental barcodes were extracted and produced 13 consensus 
barcodes for alignment to around 2000 reference barcodes from a library 
of phages. B) Barcodes are assigned to the genome with the maximum 
alignment weight. C) 329 of 1756 barcodes are assigned to lambda and 582 





Figure 7.18 Gel electrophoresis showing Adenovirus A DNA. DNA is extracted from cells 
pre-infection, 48hr post-infection and 72hr post-infections. A clear band 





Figure 7.19 Identification of bacteriophage DNA in genomic mixture by alignment of 
experimental barcodes to reference barcodes. DNA is labelled using M.TaqI 
with Atto647N and a 4:1 mixture of E. coli:T7 is combed and imaged. 8124 
barcodes are extracted from the images. A) 229 (3%) of barcodes aligned 
with weight>0.7 to T7 reference barcode. B) Alignment weight of all 
experimental barcodes to T7 reference. C-D) Identification of barcodes 
against a library of 20 phage genomes. C) Each barcode is assigned to the 
genome for which the largest alignment weight was obtained. D) The 
number of barcodes assigned to each genome with an alignment weight 





Figure 7.20 Identification of bacteriophage DNA in genomic mixture by de novo 
separation and alignment of experimental barcodes. A) t-SNE visualisation 
of network generated from adjacency matrix. Colour is given by alignment 
weight to T7 reference genome. B) Community detection. Each colour 
represents a community that has been detected. C) Example of alignment of 
consensus barcode. Barcodes are assigned to the genome with the 






Figure 7.21 Identification of bacteriophage DNA in genomic mixture by alignment of 
experimental barcodes to reference barcodes. DNA is labelled using M.TaqI 
with Atto647N and a 4:1:1 mixture of E. coli:lambda:T7 is combed and 
imaged. 8124 barcodes are extracted from the images. A) 554 (7%) of 
barcodes aligned with weight>0.7 to lambda reference barcode and 208 
(3%) of barcodes aligned with weight>0.7 to T7 reference barcode. B) 
Alignment weight of all experimental barcodes to T7 and lambda 
references. C-D) Identification of barcodes against a library of 20 phage 
genomes. C) Each barcode is assigned to the genome for which the largest 
alignment weight was obtained. D) The number of barcodes assigned to 






Figure 7.22 Identification of bacteriophage DNA in genomic mixture by de novo 
separation and alignment of experimental barcodes. A-B) t-SNE 
visualisation of network generated from adjacency matrix. Colour is given 
by alignment weight to: A) lambda and B) T7 reference genomes. C) 
Community detection. Each colour represents a community that has been 
detected. D) Barcodes are assigned to the genome with the maximum 
alignment weight. 1306 (16%) and 407 (5%) of barcodes are assigned to 






Figure 7.23 Community detection for experimental barcodes from samples of DH10B, 
EC958 and blaDNM-1. A) t-SNE visualisation of network generated from 
adjacency matrix. Each colour represents a different genome: DH10B 
(blue), EC958 (cyan) and blaDNM-1 (yellow). B) Community detection. Each 
colour represents a community that has been detected. Note how 
communities have not be correctly identified by genome compared to in 




7.6 Chapter 5 Supplementary Figures 
 
Figure 7.24 Restriction assay for pRSET B-EGFP. M.TaqI labelling of pRSET B-EGFP with 
AdoHcy-amine. Lanes 1-6 = AdoHcy-amine, 2x dilution of M.TaqI; lane 7 = 
AdoMet control; lane 8 = no cofactor control; lane 9 = no M.TaqI control; 
lane 10 = restricted pRSET B-EGFP, lane 11 = unrestricted pRSET B-EGFP. 
 
Figure 7.25 Localisation and dynamics of pRSET B-EGFP during long term growth. T7 
Express (green) was transformed with Atto 647N-labelled pRSET B-EGFP 
(red) and grown on agarose pads (without IPTG) for 12 hours at room 
temperature. Individual transformants are clearly visible by EGFP 




7.7 Chapter 5 Supplementary Materials and Methods 
7.7.1 Restriction assay - Figure 7.24 
The following were mixed and incubated at 50oC for 1 hour. 
 
0.5µl R.TaqI was added to samples 1-10 and all samples incubated at 65oC for 1 hour, 
before adding 0.5µl 18mg/ml proteinase K /0.1% Triton X-100 to all samples and 
incubation at 50oC for 1 hour. DNA was analysed by gel electrophoresis. 
  
All in µL 1 2 3 4 5 6 7 8 9 10 11
Water 3.5 3.5 3.5 3.5 3.5 3.5 3.9 4.0 3.5 4.0 4.0
10x CutSmart 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
0.1mg/ml pRSET B-EGFP 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0
15mM AdoHcy-amine 0.5 0.5 0.5 0.5 0.5 0.5 0.5
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